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(16 x 1 mm2) after bonding a cover plate and dicing. DNA arrays are printed
onto the bottom of the microreactor cavities, but cannot be seen in this image
because of their small size. Holes of 1 mm in diameter are drilled in the cover
glass for the filling of the µ-DAAD reactors with reagent. (C) Back-side view of
the device with platinum heater coil and thermoresistors placed at the
corresponding area of the micro-reactor. Reproduced from [81] with
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Figure 1.5 Chip for CF PCR. Three well-defined isothermal zones are poised at 95 (A),
77 (B), and 60 °C (C) by means of thermostated copp er blocks. The sample is
hydrostatically pumped through a single channel etched into a glass wafer.
The channel passing through the three temperature zones defines the
thermal cycling process. Reproduced from [87] with permission................... 16
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Figure 1.6 High throughput CF PCR multireactor platform consisting of three functional
units: a fluidic controller for distributing reagents and analyte to the reactors, a
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denaturation heaters (90 – 95 °C), H A the annealing heaters (50 – 70 °C), and
H E the extension heaters (70 – 77 °C). Reproduced fro m [92] with
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Figure 1.7 (A) Principle of electrokinetic synchronized cyclic CF PCR process. Sample
injection (a): DNA was filled into reservoir 5 and a voltage was applied to the
electrodes in reservoirs 5 (GRND indicates ground) and 6 (+ indicates high
voltage input). Sample moved across the reactor channel to fill the crossed-T
injector. Sample cycling (b): Following injection, the sample is shuttled
through the various isothermal zones by moving the position of the applied
electric field in a cyclic fashion as denoted in diagrams 1 – 4. (B) Schematic
view and photographs of the electrokinetically synchronized CF PCR
microchip. The actual microchip, fabricated via replication technology into PC,
is shown in the middle photograph next to the quarter. Poised on the PC chip
are electrode contacts for applying the voltage in an automated fashion to the
various reservoirs. Reproduced from [97] with permission............................ 19
Figure 1.8 Experimental set up for microwave-heated PCR that is used to perform
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Figure 1.10 (A) Droplet shuttle hybridization in a microchannel. P1, P2… Pn refer to the
probe spots. (B) Illustration showing that scrambled discrete plugs sweep
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match and mismatch probes, respectively. (C) Microtrench plate is stacked on
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Figure 1.11 (A) Monolithic integrated polycarbonate DNA analysis system. The system
contained a serpentine PCR channel (PCR), a hybridization channel (HC), a
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coupled to a waste syringe, Pluronic traps (T), one hydrophobic air-permeable
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sample driving syringe pump (P1), waste-withdrawing syringe pump (P2), and
wash syringe pump (P3). The dimensions of the system were 5.4 cm x 8.6 cm
x 0.75 mm. (B) PCR hybridization results from the monolithic integrated
system. (1) E. coli 221-bp hybridization after amplification. Portions of the
channel are enlarged for better viewing. (2) Fluorescent image of portion of
the channel after E. faecalis amplification and hybridization. (3) Fluorescent
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amplification and hybridization. Reproduced from [98] with permission. ....... 36
Figure 1.12 Topographical layout of a CF PCR/CF LDR/universal zipcode array biochip.
The microchip possessed channels that were 50 µm in width and 100 µm in
depth with a 400 µm interchannel spacing. The total length of the thermal
cycling channel was 2.28 m and consisted of a 30-cycle PCR (1.57 m long)
and a 13-cycle LDR (0.71 m long). The top inset represents a microscope
image of the turns of the CF thermal cycling channel. The bottom inset is an
enlarged schematic of the Y-shaped passive micromixer for mixing the PCR
product with the LDR cocktail. Three different Kapton film heaters were
attached to the appropriate positions on the CF PCR/CF LDR chip for
providing the required isothermal zones. Thermocouples were inserted
between the microchip cover plate and the film heaters for monitoring the
temperatures. Reproduced from [162] with permission. ................................ 38
Figure 1.13 Integrated, modular microfluidic chip for TB analysis. (A) Overview of the
integrated system. The system had dimensions 12” (length) x 12” (width) x 12”
(height), and all fluid handling, thermal management, and optical detection
were controlled by off-chip supporting peripherals and assembled into a small
form factor instrument. (B) Schematic and photograph of the fluidic cartridge.
The fluidic cartridge was composed of two modules and a fluidic motherboard.
The fluidic motherboard was made from PC and consisted of processing
steps for cell lysis, PCR, and LDR. One module was made from PC and used
for SPE of genomic DNA, while the other module was made from PMMA and
contained an air-embedded planar waveguide and the DNA array. Sample
inlet (1), PCR mixture inlet (2), LDR mixture inlet (3), ethanol and air inlet (4),
array wash inlet (5), vacuum connection (6), and waste outlet (7). V1 – V6 are
on-chip membrane valves. V2 is positioned next to the SPE module on the
cell lysis microchannel and is not visible in current view. (C) Molecular assay
results from drug-susceptible Mycobacterium tuberculosis (Mtb) strains and
drug-resistant Mtb strains. 516WT, 531WT, and 526WT are probes targeting
drug-susceptible Mtb strains. 516MT, 531MT, and 526MT are probes
targeting drug-resistant Mtb strains. Reproduced from [166] with
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Figure 2.1 Integrated microfluidic system for MRSA Identification. (A) Schematic of the
fluidic cartridge. The fluidic cartridge was composed of one module and a
fluidic motherboard. The motherboard was made from PC and consisted of
processing steps for PCR and LDR, while the module was made from PMMA
and contained an air-embedded planar waveguide in which a DNA microarray
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rates of 0.25, 0.5 and 1 µL/min (0.66, 1.33 and 2.65 mm/s), respectively.
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Intensities from CF PCR product gel bands normalized to that from the
bench-top PCR products. CF PCR yielded amplicons of the expected size,
i.e., 98, 148, 161 and 176 bp for the spa, mecA, SG16S and PVL genes,
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Figure 2.3 Effects of the chamber pressure on the probe density covalently tethered to
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probes in 200 mM phosphate solution and allowed to incubate for 1 h. The
data points represent the mean of three measurements with the error bars
showing ±1 standard deviation unit. .............................................................. 78
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ABSTRACT
Methods for bacterial detection and identification has garnered renewed interest in
recent years due to the infections they may cause and the antimicrobial resistances
they can develop, the potential for bioterrorism threats and possible contamination of
food/water supplies. Therefore, the rapid, specific and accurate detection of pathogens
is crucial for the prevention of pathogen-related disease outbreaks and facilitating
disease management as well as the containment of suspected contaminated food
and/or water supplies. In this dissertation an integrated modular-based microfluidic
system composed of a fluidic cartridge and a control instrument has been developed for
bacterial pathogen detection. The integrated system can directly carry out the entire
molecular processing pipeline in a single disposable fluidic cartridge and can detect
sequence variations in selected genes to allow for the identification of the bacterial
species and even its strain. The unique aspect of this fluidic cartridge is its modular
format with a task-specific module interconnected to a fluidic motherboard to permit the
selection of a material appropriate for the given processing step(s). In addition, to
minimize the amount of finishing steps for assembling the fluidic cartridge, many of the
functional components were produced during the polymer molding step used to create
the fluidic network. The operation of the fluidic cartridge was provided by electronic,
mechanical, optical and hydraulic controls located off-chip and assembled into a small
footprint instrument. The fluidic cartridge was capable of performing cell lysis, solidphase extraction of genomic DNA from the whole cell lysate, continuous flow PCR
amplification of specific gene fragments, continuous flow ligase detection reaction to
discriminate sequence variations and universal DNA array readout, which consisted of
DNA probes patterned onto a planar polymer waveguide for evanescent excitation. The
xviii

performance of the fluidic system was demonstrated through its successful application
to the genetic detection of bacterial pathogens, such as Escherichia coli O157:H7,
Salmonella, methicillin-resistant Staphylococcus aureus and multi-drug resistant
Mycobacterium tuberculosis, which are major threats for global heath. The integrated
system, which could successfully identify several strains of bacteria in <40 min with
minimal human intervention and also perform strain identification, represents a
significant contribution to pathogen detection.
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CHAPTER 1 INTEGRATED MICROFLUIDIC SYSTEMS FOR DNA ANALYSIS*
1.1

Introduction
The potential utility of genome-related research in terms of evolving basic

discoveries in biology has generated widespread use of DNA diagnostics and DNA
forensics and driven the accelerated development of fully integrated microfluidic
systems for genome processing. To produce a microsystem with favorable performance
characteristics for genetic-based analyses, several key operational elements must be
strategically chosen, including device substrate material, temperature control, fluidic
control, and reaction product readout. As a matter of definition, a microdevice is a chip
composed of a single processing step, for example microchip electrophoresis. Several
microdevices can be integrated to a single wafer or combined on a control board as
separate devices to form a microsystem. A microsystem is defined as a chip composed
of at least two microdevices. Among the many documented analytical microdevices,
those focused on the ability to perform the polymerase chain reaction (PCR) have been
reported extensively due to the importance of this processing step in most geneticbased assays. Other microdevices that have been detailed in the literature include
those for solid-phase extractions, microchip electrophoresis, and devices composed of
DNA microarrays used for interrogating DNA primary structure. Great progress has also
been made in the areas of chip fabrication, bonding and sealing to enclose fluidic
networks, evaluation of different chip substrate materials, surface chemistries, and the
architecture of reaction conduits for basic processing steps such as mixing. Other
important elements that have been developed to realize functional systems include
miniaturized readout formats comprising optical or electrochemical transduction and
*
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interconnect technologies. These discoveries have led to the development of fully
autonomous and functional integrated systems for genome processing that can supply
“sample in/answer out” capabilities. In this chapter, we focus on microfluidic systems
that are composed of two or more microdevices directed toward DNA analyses. Our
discussions will primarily be focused on the integration of various processing steps with
microarrays. The advantages afforded by fully integrated microfluidic systems to enable
challenging applications, such as single-copy DNA sequencing, single-cell gene
expression analysis, pathogen detection, and forensic DNA analysis in formats that
provide high throughput and point-of-analysis capabilities will be discussed as well.
1.1.1 The Human Genome Project
The completion of the human genome sequence in 2003 was one of the most
important scientific accomplishments in human history1 and marked a significant
milestone for the Human Genome Project (HGP). This achievement has led to
compelling genomic and proteomic research discoveries with unprecedented impacts in
areas such as forensic DNA analysis,2-5 medical diagnostics,6,

7

infectious disease

management,8-11 and chemical and biological sciences.12, 13 Some of the important tools
for DNA processing include solid-phase extraction (SPE) and purification of DNA, PCR
or other thermally induced amplification strategies, electrophoresis, and DNA
microarrays. Although many conventional bench-top tools currently exist to process
DNA samples, efforts are being heavily invested into further automating the processing
strategy, reducing the cost of performing the assay, and increasing the sample
throughput. In this chapter, we will discuss the use of microfluidics, in particular
integrated systems, for processing a variety of DNA samples.
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1.1.2 Molecular Processing Pipeline for DNA Analyses
Complete nucleic acid analyses (RNA or DNA) for a variety of applications can be
accomplished using commercial bench-top instruments, and typically consists of several
molecular processing steps including: (1) lysis of cells to release the nucleic acids of
interest; (2) purification and isolation of the nucleic acids from other cellular components
(e.g. cell debris and proteins); (3) amplification of trace amounts of nucleic acids to
generate sufficient copy numbers for detection; and (4) analysis of unique regions within
the genetic material using a combination of techniques. To complete an entire assay, a
well-equipped laboratory and significant technical expertise are commonly required, with
intervention at several stages of the processing pipeline to manipulate samples and/or
reagents. In addition, the total time required for sample processing can be several hours
to several days.
Derived from the concept of micro-total analysis systems or lab-on-a-chip platforms
first proposed by Manz et al.14 in the early 1990s, integrated microfluidic systems have
emerged that incorporate several molecular processing steps into a single platform with
sample-to-answer capabilities. These systems are particularly compelling for DNA/RNA
analyses. To create such a system, a series of discrete devices performing specific
molecular functions such as cell lysis, nucleic acid extraction and purification, nucleic
acid

amplification,

and

other

supporting

analysis

techniques

(e.g.

capillary

electrophoresis, microarrays) must be interconnected with minimal dead volumes due to
the ultrasmall samples processed (picoliters to nanoliters). Fluids are manipulated using
on-chip or off-chip components, such as micropumps, microvalves, and micromixers
(see Figure 1.1). As noted previously, microsystems are composed of 2 or more
microdevices and, in many cases, microdevices consist of components such as on-chip
3

valves, mixers, and/or pumps. In most cases, DNA/RNA processing requires multiple
processing steps and therefore devices need to be combined, either in a single wafer
format or a modular format, to form the system targeted for a given genetic analysis
(see Figure 1.1).

Figure 1.1 Flow diagram showing the molecular processing steps required for analyzing
nucleic acids. The main steps include cell lysis, nucleic acid extraction and purification,
PCR amplification, and analysis methods for identifying the resultant products. For each
of the processing steps shown, a device will have poised on it a component of one of
these functional steps, and each device may be comprised of various components
(such as pumps, valves, and micromixers) in order to carry out the desired operation. A
system comprises of two or more devices, meaning that it will have integrated onto it
multiple processing steps. The ultimate goal is to incorporate all of the molecular
processing steps onto a single platform to provide sample in/answer out capabilities
with no operator intervention.
1.2

Microfluidics and DNA Analysis
The capability of handling a volume of liquid as small as a few nanoliters and even a

few picoliters, the common sample size in most microfluidic systems, can be utilized to
permit DNA extraction following cell lysis and thermal reactions without creating sample
dilution, minimize reagent usage, provide process automation, allow in-the-field
4

analyses, and minimize possible contamination. Microfluidic systems also offer rapid,
accurate, and cost-effective analyses. Performing sequencing or genotyping using
microfluidic platforms can lead to significant increases in throughput. For example, DNA
sequencing read lengths of 600 – 800 bases can be achieved in 25 min using
microcapillary electrophoresis (µCE) with a separation channel length of 20 cm (Sanger
sequencing),15 whereas the same separation would require 1 – 2 h in a capillary array
electrophoresis (CAE) system.16,

17

In the sections that follow, we will give a brief

introduction to the various microdevices that have been fabricated to handle steps in the
processing of nucleic acids, such as cell lysis, extraction and/or purification of the
nucleic acids, their amplification, determination sequence variations, and readout.
1.2.1 Cell Lysis
Cell lysis is the first step in most DNA analyses and involves disassembly of the cell
membranes and release of the genomic material and other cellular contents. A variety
of lysis methods, including chemical lysis,18, 19 thermal lysis,20 and lysis by mechanical
forces,21, 22 or electrical pulse,23-26 have been successfully demonstrated in microfluidic
devices.
Transitioning chemical lysis methods commonly used in macro-scale workups to
microfluidic devices is straightforward. Chemical lysis methods involve mixing the target
cells with lytic agents, such as sodium dodecyl sulfate or guanidium hydrochloride and
hydroxide that can solubilize the lipid membranes. One issue associated with the use of
chemical lysis is that lytic agents can interfere with downstream processing, such as
PCR, and therefore must be removed from the sample before subsequent reactions,
increasing the microfluidic design complexity. Carol and co-workers18 reported a
polydimethylsiloxane (PDMS) microfluidic device for on-chip cell lysis based on local
5

hydroxide electro-generation. In this device, hydroxide ions porated the cell membrane,
leading to cell lysis. During lysis, hydrogen ions, which were simultaneously generated
on-chip, reacted with excess hydroxide ions creating a neutral pH lysate and eliminating
the need for a final washing step.
Thermal lysis, which involves disrupting the cell membranes by heating cells to near
boiling temperatures, is another method that can be incorporated into a microfluidic
device as long as the microfluidic material can withstand the temperature required to
lyse the cells. The advantage of thermal lysis is that no interfering reagents are required
that may interfere with downstream reactions.27 The device design can be further
simplified by lysing cells in the initial denaturation step of downstream PCRs.28 But,
thermal methods are not applicable for certain cell types, such as Gram-positive
bacteria.
Mechanical forces, such as sonication, can be integrated to the microdevice to
disrupt cells via gaseous cavitation. In this process, air pockets form from dissolved
gases in the aqueous media and collapse rapidly, creating high pressure and high
temperature environments sufficient to break cell membranes. This method is suitable
for hard-to-lyse cells or spores, but can generate considerable amounts of heat and free
radicals.29 Belgrader et al.21 reported a minisonicator combined with a spore lysis
cartridge. Bacillus spores were sonicated in the presence of glass beads and were
successfully lysed to release DNA for PCR amplification in ~30 s.
Electrical pulse methods represent another method for cell lysis and are based upon
electroporation of the membrane. In the electroporation process, the application of high
electric field pulses causes the formation of small pores in cell membranes.30 However,
the use of high electric fields can lead to heating and gas generation. To overcome this
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limitation, a microfluidic electroporation device for the lysis of human carcinoma cells
was demonstrated by Lu et al.23 In their design, a straight microchannel was
constructed in glass, where the side-walls consisted of gold saw-tooth-shaped
electrodes supported by the polymer, SU-8. Using pressure-driven flow, cells were
directed through the channel and electroporated by the saw-tooth electrodes (see
Figure 1.2). The magnitude of the electric field was in the range of a few kilovolts per
centimeter, while the AC voltage was >10 V peak-to-peak, minimizing heat generation
and bubble formation.

Figure 1.2 (A) Microelectroporation device for cell lysis. (B) Devices at various steps of
the fabrication process: after metallization and electrode-mold formation (left) and after
electroplating (right). (C) Dielectrophoresis (DEP) effect observed in the flow channels
(top). Saw-tooth microelectrodes acting as a DEP device for focusing intracellular
materials after electroporation (bottom). Reproduced from [23] with permission.
1.2.2 Nucleic Acid Extraction, Purification and Pre-concentration
Following cell lysis, DNA extraction, purification, and pre-concentration are usually
achieved by micro-solid phase extraction (micro-SPE) devices. This step is essential in
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order to purify and isolate the genomic materials from other cellular components,
contaminants, and chemicals introduced in the cell lysis step that might potentially
interfere with downstream enzymatic reactions. In addition, the nucleic acids may be
enriched in this phase of the processing strategy to pre-concentrate the targets to a
level that is amenable for further downstream processing.
A variety of well-established macro-scale SPE methods for nucleic acid extraction
have been successfully transferred to micro-scale devices.10, 31-57 Although the physical
principles of these methods may be different (e.g. chaotropic interactions, electrostatic
interactions, affinity interactions, etc.), micro-SPE protocols typically consist of three
steps: (1) selective adsorption of nucleic acids onto a solid phase; (2) removal of
contaminants by a washing step; and (3) elution of the pre-concentrated nucleic acids
from the solid support using water or a low salt buffer.31 Like their macro-scale
counterparts, micro-SPE devices possess a loading level of target material that is
dependent upon the available surface area within the extraction bed and, thus, are
manufactured either by packing the solid phase (typically consisting of silica beads) into
the device or by directly fabricating microstructures inside the device to increase the
available load capacity of the device.
As noted above, micro-SPE devices can be fabricated by packing silica beads, solgel immobilized silica beads, photo-polymerized monoliths, or modified magnetic
particles into microfabricated channels.10, 31-43 For example, Landers and his research
group32 demonstrated the extraction of PCR-amplifiable DNA from lysed white blood
cells using silica particles packed into a capillary tube; the DNA recovery was found to
be ~70% in a 10 min processing time. The load of DNA into the device was found to be
on the order of 10 – 30 ng/mg of DNA. To circumvent the high backpressure introduced
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by flowing silica beads into a microchannel and to improve reproducibility, a silica
bead/sol-gel hybrid matrix was packed into a glass microchip (see Figure 1.3A).31, 33
Other matrices, such as a sol-gel monolith35 or photo-polymerized monoliths36 were
explored by the same group in effort to overcome the aging and shrinkage problems
associated with the silica bead/sol-gel hybrid matrix. Klapperich and co-workers37-39
used a similar photo-polymerized monolith as a solid-support matrix to confine silica
beads within a cyclic olefin copolymer (COC) microchip to extract a variety of samples,
such as lambda (λ)-DNA, Gram-positive and Gram-negative bacterial genomic DNA,
inoculated human blood and urine samples (see Figure 1.3B).

Figure 1.3 (A) SEM image of the cross-section of a glass microchip channel packed
with silica bead/sol-gel hybrid at 500x magnification. Reproduced from [33] with
permission. (B) SEM image of a porous polymer monolith filled with silica beads at
10,000x magnification. Reproduced from [39] with permission. (C) Photograph of a 96well polycarbonate solid phase extraction microfluidic plate and a commercial 96-well
titer plate (left). SEM image of the micro-pillars that were fabricated in the purification
bed (right). Reproduced from [47] with permission.
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Issues associated with SPE beds comprised of silica beads or polymerized polymer
monoliths include: (1) residual chaotropic reagents, such as guanidinium or sodium
iodide salts, present in the initial elution phase and interfering with downstream
amplification steps; (2) packing the matrix, which requires a post-fabrication process
that can be tedious and demands experienced engineers to accomplish; and (3) aging
and shrinkage of the packing material, which can affect the efficiency and reproducibility
of the extraction process.
Alternatively, one can produce a SPE surface directly in the device via
microfabrication techniques. Micro-post or micro-pillar structures can be fabricated
inside the extraction chamber to increase the available surface area, thus enhancing the
load of target material as well as enhance the interaction probability between the
solution borne nucleic acids and the SPE bed. Christel et al.44 fabricated, using deep
reactive ion etching (DRIE) and anodic bonding, a micro-SPE device in silicon that
contained high aspect ratio (aspect ratio = structure height divided by structure diameter)
micro-pillars with a total surface area of 3.5 mm2. The binding capacity of DNA was
found to be 40 ng/cm2 with a 50% extraction efficiency for short (500 bp) and medium
sized (48 kbp) DNAs. Cady et al.45 extended this work to Escherichia coli cell lysates.
To circumvent the tedious DRIE and bonding processes required for fabricating these
high aspect ratio microstructures in silicon, Soper and co-workers46 developed a microSPE device made from photo-activated polycarbonate (PPC). This micro-SPE device
contained high aspect ratio (5/1) micro-pillars, hot embossed from a LIGA-fabricated
nickel molding tool. The SPE bed possessed a total active surface area of 2.3 x 107 µm2.
Nucleic acids were selectively immobilized onto the PPC surface, which contained
carboxylic acid groups generated using UV radiation, using an immobilization buffer
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containing polyethylene glycol, NaCl, and ethanol. After cleanup using ethanol, purified
and concentrated nucleic acids were eluted from the PPC surface using water or PCR
buffer. The load capacity and recovery of E. coli genomic DNA were estimated to be
790 ng/cm2 and 85 ±5%, respectively. This work was followed by a report on the
fabrication of a high-throughput device consisting of 96 micro-SPE beds, each
containing an array of 3,800 20-µm diameter micro-pillars (see Figure 1.3C).47, 48 Both
genomic DNA and total RNA could be extracted and purified from bacterial cells seeded
into mammalian blood samples.
Another approach for the SPE of nucleic acids is the use of commercially available
nano-porous aluminum oxide membranes (AOM). In a high salt concentration buffer,
genomic DNA or RNA will aggregate and bind to the nano-porous membrane; both
nano-filtration and electrostatic interactions contribute to the retention and purification of
the target DNA or RNA. The retained DNA/RNA can be recovered using a PCR buffer.
Kim et al.49 investigated the extraction of genomic DNA from blood samples with a
recovery of ~90% using an AOM sandwiched between PDMS microchannels. The AOM
SPE device was later integrated to a micro-chamber PCR device, demonstrating
successful amplification of both DNA from a bacterial sample and RNA from virus
samples.50 The advantages of this method included the ability to use high flow rates to
shorten processing time and low protein absorption onto the AOM. However, the
handling of the thin and brittle AOM remains a challenge.
In addition to genomic DNA or RNA purification and pre-concentration before an
amplification step, some applications, for example the purification of dye terminator
Sanger sequencing products, require high quality DNA free of background species such
as salts, unincorporated primers, dNTPs, and dye-labeled ddNTPs prior to the
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electrophoresis step. Soper and co-workers51 demonstrated the use of a PPC microSPE device for the purification of Sanger sequencing products to provide high quality
DNA free from background species. PPC micro-SPEs were successfully coupled to
capillary gel electrophoresis54 that also contained a continuous flow Sanger extension
thermal cycler.51, 52
Mathies and his group53 purified Sanger extension products using a micro-chamber
containing

a

sparsely

crosslinked

polyacrylamide

gel

co-polymerized

with

complementary oligonucleotide probes appended onto the target DNA products. DNA
elution was achieved by thermal denaturation of the hybrids. This micro-chamber was
coupled to a Sanger extension chamber and microchip electrophoresis to form an
integrated Sanger sequencing bioprocessor. With a 400-fold reduction in sequencing
reagents and 10- to 100-fold reduction in DNA template required compared to benchtop approaches, 556 continuous bases were sequenced using this bioprocessor with 99%
accuracy.54
1.3

Microfluidic Polymerase Chain Reactors (Micro-PCR)
Since the discovery of the PCR in 1986 by Mullis et al.,58 PCR has become a crucial

tool in basic molecular biology discovery, genome sequencing, clinical research, in vitro
diagnostics, and evolutionary studies.59 PCR is an enzymatic reaction that allows any
nucleic acid fragment to be generated in vitro and in high abundance. Theoretically, the
amount of product doubles during each PCR cycle, as shown by the following equation:
ܰ = ܰ 2

(1)

where N is the number of amplified DNA molecules, N0 is the initial copy number of
DNA molecules and n is the number of amplification cycles.60,

12

61

Experimentally, the

amplification efficiency (E) can range from 0 to 1, and therefore the true copy number
produced is given by:
ܰ = ܰ (1 + )ܧ

(2)

In PCR, denaturation and annealing are nearly instantaneous events that occur as
soon as the correct temperature is reached (e.g., ~94 °C for denaturation; 50 – 60 °C
for annealing) and at 72 °C the extension step is l imited only by the kinetics of the
polymerase enzyme. Implementation of the thermostable Taq polymerase as a
substitute for the Klenow fragment of E. coli DNA polymerase I62 has made it possible to
automate the PCR amplification step by using various thermal cycles carried out by a
block thermal cycler. Investigators have shown that Taq DNA polymerase has an
extension rate of 60 – 100 nucleotides/s at 72 °C. 63 For efficient amplification, a device
with low heat capacity that can transfer heat quickly to the sample and quickly draw
away the heat when cooling is preferable. Most conventional thermal cyclers have large
thermal masses resulting in high power requirements and slow heating and cooling
rates with long reaction times, typically exceeding 1.5 h in spite of the fact that
kinetically, a 500 bp PCR product should be produced in as little as 5 s.
Due to the intrinsically small PCR chamber volumes and mass, exquisite heat
transfer capabilities can be realized in micro-PCR devices that can significantly reduce
the processing time compared to conventional bench-top thermal cyclers. Short thermal
cycling times can be realized and still provide amplification efficiencies comparable to
their macro-scale counterparts with designs that are sometimes not conducive to
macro-scale formats. Micro-PCR devices have adopted design formats such as
chamber-type PCR devices, in which the PCR cocktail and target are mixed inside a
micro-chamber and the chamber is then cycled between the various temperatures
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required for the amplification process. Another design approach uses the continuousflow format, in which the PCR device consists of isothermal zones brought to
equilibrium prior to the amplification process. The PCR cocktail is shuttled between
these isothermal zones either electrokinetically or hydrodynamically to affect the thermal
processing. Another format that has been employed for micro-scale PCR devices is a
thermal convection-driven PCR device in which a temperature gradient is applied to a
closed reaction chamber and the fluid is shuttled through the temperature gradient using
a Rayleigh-Bénard convection cell. In the following sections, we will briefly introduce
these PCR designs.
1.3.1 Chamber-type Micro-PCR Devices
In chamber-type micro-PCR devices, a static PCR cocktail containing the target is
repeatedly cycled between three different temperatures: one for denaturation, a second
for renaturation, and a third for polymerase extension, which is similar to that used in a
conventional PCR thermal cycler. Chamber-type micro-PCR devices consist of either a
single chamber or multiple chambers configured on a single wafer with the appropriate
heating modalities to allow thermal cycling. The primary advantage of these types of
micro-thermal cyclers is the low thermal masses that must be heated/cooled, providing
faster reaction times compared to block thermal cyclers.
1.3.1.1

Single-chamber Micro-PCR Devices

In 1993, Northrup et al.64 reported the first PCR microfluidic device, which consisted
of a 50-µL well structure serving as the reaction chamber and was fabricated in silicon
using wet chemical etching. Twenty amplification cycles were carried out, with the
cycling time four times faster than a conventional bench-top PCR device. In 1994,
Wilding et al.65, 66 developed a silicon/glass hybrid device that held 5 – 10 µL of reaction
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mixture in a chamber, whose performance was improved by surface passivation through
salinization of the microchamber surface67 and was heated using an external copper
block. Single-chamber PCR devices have been widely investigated since these initial
reports.68-77 However, single-chamber micro-PCR devices possess low throughput.

Figure 1.4 Photographs of µ-DAAD production steps. (A) Front side of a 4” silicon wafer
populated with etched microreactors; 16 µ-DAAD are processed in parallel, each
consisting of four microreactors. (B) Front side view of a single µ-DAAD (16 x 1 mm2)
after bonding a cover plate and dicing. DNA arrays are printed onto the bottom of the
microreactor cavities, but cannot be seen in this image because of their small size.
Holes of 1 mm in diameter are drilled in the cover glass for the filling of the µ-DAAD
reactors with reagent. (C) Back-side view of the device with platinum heater coil and
thermoresistors placed at the corresponding area of the micro-reactor. Reproduced
from [81] with permission.
1.3.1.2

Multi-chamber Micro-PCR Devices

Multiple PCR chambers have been fabricated on a single microfluidic chip and
explored for high throughput PCRs.78-83 An example of a multi-chamber micro-PCR
device, micro-DNA amplification and analysis device (µ-DAAD) consisted of 16 µDAADs in parallel with each µ-DAAD consisting of four microreactors fabricated on a 4”
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silicon wafer (see Figure 1.4). Multi-chamber micro-PCR devices84 have been
demonstrated for DNA amplifications of five gene sequences related to E. coli from
three different DNA templates and detected by TaqMan chemistry with a limit of
detection (LOD) of 0.4 copies of target DNA.

Figure 1.5 Chip for CF PCR. Three well-defined isothermal zones are poised at 95 (A),
77 (B), and 60 °C (C) by means of thermostated copp er blocks. The sample is
hydrostatically pumped through a single channel etched into a glass wafer. The channel
passing through the three temperature zones defines the thermal cycling process.
Reproduced from [87] with permission.
1.3.2 Continuous Flow PCR (CF PCR) Devices
Another configuration for micro-PCR devices employs a flow-through format with a
“time–space conversion” concept, in which the sample is continuously transitioned
through isothermal zones for denaturation, annealing, and extension. This is in contrast
to chamber-type PCR devices, in which heating and cooling occurs on a static sample
with the entire device heated and cooled to the desired temperatures.79, 83, 85, 86 The CF
PCR approach allows for short reaction times because the small-volume fluid elements
can be heated or cooled to the required temperature within 100 ms.59 In 1998, Kopp et
16

al.87 reported the first CF PCR microdevice (see Figure 1.5). This device consisted of
20 thermal cycles comprised of a serpentine channel design whose dimensions were 40
µm in width and 90 µm in depth, with a total length of 2.2 m, producing a pressure drop
of ~14.5 psi. For DNA amplification, 10 µL of a PCR mixture was hydrostatically
pumped at volumetric flow rates ranging from 5.8 to 72.9 nL/s with a flow-through time
of 18.7 to 1.5 min.87 The channel walls were silanized with dichlorodimethylsilane to
reduce possible adsorption of the polymerase enzyme (Taq polymerase) and DNA onto
the glass surface. A zwitterionic buffer and nonionic surfactant were used as the PCR
buffer additives to impart a dynamic coating.88

Figure 1.6 High throughput CF PCR multireactor platform consisting of three functional
units: a fluidic controller for distributing reagents and analyte to the reactors, a CF PCR
multireactor, and a distributed temperature controller. HD denotes the denaturation
heaters (90 – 95 °C), H A the annealing heaters (50 – 70 °C), and H E the extension
heaters (70 – 77 °C). Reproduced from [92] with per mission.
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Using a 20-cycle spiral microchannel hot embossed into a polycarbonate (PC)
substrate configured for performing CF PCR,89 the PCR cycle time was reduced to the
kinetic limit set by the polymerase incorporation rate; 500-bp and 997-bp fragments
were amplified in a total time of 1.7 min (5.2 s/cycle) and 3.2 min (9.7 s/cycle),
respectively. The amplification efficiency was further optimized through proper thermal
management using numerical models and experiments to evaluate the effects of
different combinations of temperature distribution in a typical CF PCR device fabricated
by hot embossing PC substrates.90 Chen et al.91-93 reduced the footprint of each spiral
reactor to 8 mm by 8 mm and arranged 96 reactors in titer-plate format (12 x 8) for high
throughput processing (Figure 1.6).
The attractive features of CF PCR devices consist of: (1) very rapid heat transfer
during the PCR, with run times on the order of minutes; (2) low possibility of
contamination (closed architecture);4, 10, 94 and (3) facile integration with various liquid
transport processes, such as magneto-hydrodynamic (MHD) actuation.95 Additional
advantages include reduced sample consumption and reagents (lower cost) and simple
integration to other DNA processing devices.11,

96

A limitation of this approach is the

fixed cycle number that can be employed by the chip, which is dictated by the device
layout. To overcome this drawback, Chen et al.97 demonstrated the use of a
microfabricated PC chip for DNA amplification in a CF mode using electrokinetically
driven synchronized pumping (Figure 1.7). A 500-bp fragment from λ-DNA was
obtained with a total time of amplification of ~18.1 min for 27 cycles.
The arrangement of the three temperature zones on most rectangular serpentine
channel CF PCR devices consists of denaturation, extension, and annealing in that
order. Although this arrangement can establish a smooth temperature gradient,
18

amplification efficiency may degrade because the melted single-stranded DNA is likely
to form double strands with the template DNA or their complementary fragments when
passing through the extension zone. To circumvent this problem, a novel three
temperature zones arrangement in a “circular” format consisting of denaturation,
annealing, and extension has been exploited.95, 98-100

Figure 1.7 (A) Principle of electrokinetic synchronized cyclic CF PCR process. Sample
injection (a): DNA was filled into reservoir 5 and a voltage was applied to the electrodes
in reservoirs 5 (GRND indicates ground) and 6 (+ indicates high voltage input). Sample
moved across the reactor channel to fill the crossed-T injector. Sample cycling (b):
Following injection, the sample is shuttled through the various isothermal zones by
moving the position of the applied electric field in a cyclic fashion as denoted in
diagrams 1 – 4. (B) Schematic view and photographs of the electrokinetically
synchronized CF PCR microchip. The actual microchip, fabricated via replication
technology into PC, is shown in the middle photograph next to the quarter. Poised on
the PC chip are electrode contacts for applying the voltage in an automated fashion to
the various reservoirs. Reproduced from [97] with permission.
The PCR channel for these CF PCR devices can also consist of either capillary
tubes99, 100 or an on-chip annular channel95, 101. The serpentine channel formats on a
monolithic chip can utilize thermal insulation with the aid of air gaps102, 103 or by utilizing
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glass chips with a low thermal conductivity.104,

105

Recently, a novel spiral channel

configuration was also used to perform CF PCR on a single PC wafer with a circular
arrangement of three temperature zones, allowing for a compact footprint and a minimal
number of heaters for temperature control.106, 107 CF PCR microfluidics can also use a
unidirectional PCR or oscillatory flow.108
1.3.3 Thermal Convection-driven PCR
Convectively driven PCR is an alternative thermal cycling process, which was first
reported in 2002 by Krishnan et al.109 The authors used a Rayleigh-Bénard convection
cell consisting of a 35-µL cylindrical cavity to perform the PCR amplification of the βactin gene (295-bp fragment). Rayleigh-Bénard convection is generated by buoyancydriven instability in a confined fluid layer heated from below.110. The inherent structure of
Rayleigh-Bénard convection-steady circulatory flow between surfaces employs two
fixed temperature zones to facilitate the convection-driven sample flow. In contrast to
CF PCR, the temperature cycling is achieved as the fluid continuously shuttles vertically
between the two temperature zones poised for annealing/extension (top, 61 °C) and
denaturation (below, 97 °C). Therefore, there is no need of an external force to drive the
fluid through different temperature zones, simplifying its operation and allowing the
implementation of the desired number of thermal cycles.
1.3.4 Microfluidic Thermal Heating Methods
The choice of a heating method for micro-PCR devices is important in achieving
efficient temperature ramping rates. The diversity of materials exhibiting differences in
thermal mass means that different heating methods may be required. At present,
temperature cycling on microfluidic devices can be performed either with contact or
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noncontact heating methods. Summarized below are various heating methods that have
been employed in microfluidic devices.
1.3.4.1

Contact Heating

For contact heating, heaters are fabricated directly within the microchip or are in
contact with the outside of the microchip. Contact heating utilizes an electrothermal
conversion to heat the PCR solution.111 Contact heating can be achieved through the
use of thin film heating elements, which are mainly fabricated using deposition
techniques; through the use of metal heating blocks, which primarily consist of inserting
a heating cartridge into the metal blocks; or by utilizing Peltier elements.
1.3.4.1.1 Thin Film Heating
Heating elements can be fabricated on-chip using thin film deposition. Platinum,78, 79,
112-116

is the most commonly used material for heating elements due to its ability to

withstand high temperatures, good chemical stability, and ease of micromanufacturing.
Some other metals, alloys, or inorganic compounds have also been used as thin film
heaters in micro-PCR devices, such as Al,70,

81, 82, 117

Ni,104 W,101 Ag/graphite inks,85

Ag/Pd,102, 118 Ni/Cr,119 Cr/Al,82 Al2N3,120 and indium-tin oxide (ITO).121-123 Microheaters
fabricated by Pt thin film deposition often require a thin layer of Ti serving as an
adhesion layer. The Ti layer exhibits a high diffusion rate at high temperatures, which
can deteriorate the Pt heater.124 Commercial thin film resistive heaters85,

106, 107

have

proven to be efficient and robust for achieving fast PCR cycling, in contrast to
conventional PCR devices.
1.3.4.1.2 Metal Heating Blocks
Conventional PCR instruments typically utilize contact heating, which involves a
metal heating block in contact with the sample container, to cycle the temperature of the
21

PCR solution that is held within a thin-walled polypropylene tube. In spite of their large
thermal mass and slow temperature ramping rates, metallic heating blocks and Peltierbased Thermo-Electric (TE) ceramic heating blocks are widely applied in micro-PCR
devices.69,

84, 87, 125-130

To achieve fast thermal transition, two8,

98, 125, 131

or more TE

devices can be coupled to thermally cycle the PCR solution, and a total of six TE
devices have been used in a portable miniaturized thermal cycling system.84 The
temperature of the peltiers could be independently controlled and programmed to be at
different temperature levels necessary for effective annealing and denaturation. To
ensure good thermal contact between the TE element and the cycled region of the
device, supporting substances with higher thermal conductivity, such as mineral oil8, 131
or a metallic thin wafer,132 can be added to the interface of the TE element. Normally,
the TE cell consists of an array of parallel P–N junctions and each parallel P–N junction
establishes its own temperature differential for a given voltage. The P–N junction is
formed by joining P-type and N-type semiconductors and when an electric current flow
through the junction, either heat is absorbed or released depending on the direction of
the current flow. Consequently, a radial temperature gradient on the hot surface of the
TE cell is created, which causes non-homogeneity of the surface temperature of the TE
cell and compromises the efficiency of the PCR.111 To achieve a homogenous
temperature distribution across the surface of the TE cell, an oxygen-free thin copper
wafer is necessary to redistribute the surface temperature.128 Other reliable contact
heaters are resistive heating coils99,

129, 133

and single-sided flexible printed circuits

(FPCs).134
It is important to note that the thermal-cycling rate is limited by the thermal mass of
the heating element itself and of the entire micro-PCR device as well. Moreover, in the
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case of an external contact element, localized heating is ultimately limited in terms of
lateral resolution by the thermal conductivity of the substrate material. In the case of onchip integrated heaters, these devices still require tedious and complicated
micromanufacturing processes, which restrict the flexibility to reconfigure the PCR
design.135
1.3.4.2

Non-contact Heating

The inherent problem with contact thermal heaters is their relatively large thermal
mass. More thermal mass is added to the PCR device when contacting the chamber
containing the PCR solution, which hinders fast thermal cycling rates. For the
integration of PCR with µCE, thermal management becomes difficult because contact
resource is regarded as part of the PCR chip and not part of the electrophoresis chip
itself. These restrictions have triggered interest in the development of non-contact
thermal cycling in which the heating is remote from the microfluidic device and not in
physical contact with the PCR chamber.111
1.3.4.2.1 Non-contact Heating based on IR Radiation
Non-contact heating method using IR radiation was first reported by Oda et al.136 in
1998. In their work, an IR light, which used a single and inexpensive tungsten lamp as
the non-contact heat source, was used for heating glass microchambers. The authors
achieved temperature ramping rates of 10 °C/s for h eating and 20 °C/s for cooling. In
2000, Hühmer and Landers71 reported IR-mediated fused-silica capillary cycling with
nanoliter volumes (160 nL), with improved heating and cooling rates of 65 and 20 °C/s,
respectively. Giordano et al.74 developed a novel polyimide (PI) PCR microchip, which
utilized IR-mediated thermal cycling for the amplification of a 500-bp λ-phage DNA
fragment in a 1.7-µL chamber with a total reaction time of only 240 s for 15 cycles. In
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2003, Ferrance et al.72 presented IR-mediated PCR amplification of genomic DNA using
primers defining a 380-bp fragment of the β-globin gene followed by electrophoretic
analysis on a single glass chip for the analysis of Duchenne muscular dystrophy (DMD)
in less than 15 min for 35 cycles.
1.3.4.2.2 Non-contact Heating based on Hot Air Cycling
Wittwer et al.137, 138 developed non-contact heating for PCR based on hot air cycling.
In their work, temperature cycling was performed without physical contact between the
heating source and the reaction chamber by rapidly switching streams of air set to the
desired temperature. Due to the low thermal mass of air, a high temperature ramping
rate could be obtained, which has been further improved by several research groups.68,
114, 115, 139-141

1.3.4.2.3 Non-contact Heating based on Laser-mediated Heating
The tungsten lamp is a non-coherent source with large focus projection, which limits
the heating efficiency when applied to microchips with a small cross-section. Lasermediated non-contact heating utilizes a photothermal effect produced by a diode laser
coherent light source to heat an absorbing target. Tanaka et al.142 used a diode laser to
control the temperature of a chemical reaction by heating an absorbing target of a black
ink point placed on top of a glass microchip cover plate above the reaction channel. The
integrated glass microchip with non-contact IR laser-mediated heating has been
demonstrated for fast and localized temperature control under flowing conditions with
ultrafast heating and cooling rates of 67 and 53 °C /s, which is 30 times faster than a
conventional device and 3 – 6 times faster than electrothermal miniaturized thermal
cyclers.135 This heating method may be very attractive and desirable due to its high
resolution for spatially localized heating, ease of manipulation along the chip, and its
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property of being a point light source. Unfortunately, this heating method has not been
applied for temperature control in microfluidics.
1.3.4.2.4 Non-contact Heating based on Microwave Irradiation
Non-contact heating utilizing a focused microwave source was demonstrated by
Fermér et al.143 In their work, a single-mode microwave cavity was used to heat 100 µL
PCR mixture in a 0.5-mL polypropylene tube for 25 cycles. Most recently, microwaveinduced milliliter-scale PCR (see Figure 1.8) was reported144 for real-time PCR analysis.

Figure 1.8 Experimental set up for microwave-heated PCR that is used to perform
milliliter-scale PCR utilizing highly controlled microwave thermal cycling. Reproduced
from [144] with permission.
Although the amount of amplified nucleic acid product after 33 cycles indicated
incomplete amplification, which was attributed to temperature “over-shooting” at the
denaturation phase and subsequent deactivation of the Taq polymerase,145 microwave
heating was quite promising due to the following properties:143 (1) the efficiency of the
optimized microwave conditions nearly reached 70% that of conventional PCR; (2) the
irradiation energy was used to heat only the PCR solution and not a heating block or the
sample containment tube; (3) the temperature ramping time was substantially shortened;
(4) the required temperature was reached almost instantaneously and simultaneously,

25

allowing for shortening of the incubation time; and (5) modern microwave cavities can
deliver a uniform field density without “hot-spots”.
1.3.4.2.5 Other Non-contact Heating Methods
Other non-contact heating methods have also been described, such as non-contact
heating using a halogen lamp as a low power radiation source for rapid temperature
ramping in a silicon micro-reaction chamber.146 This method achieved a rate of 4 °C/s
for heating and 4 °C/s for cooling. Another non-con tact heating method is based on
induction heating first reported by Pal et al.147 Induction heaters are much simpler to
fabricate, and heating and cooling rates of 6.5 and 4.2 °C/s can be achieved by
optimizing the heater dimensions and frequency. The advantage of this method is that
accurate positioning of the reaction mixture with respect to the heater is not necessary,
deposition steps to pattern thin-film heaters on the chip are not required, and elaborate
percentage/integrator/differentiator (PID) control is not needed.146
1.4

Analysis Methods of Reaction Products
Following amplification, the identification of amplification products must be

performed to read the results and/or to confirm that the correct product was generated.
Analysis techniques that can be used should provide short analysis times, high
sensitivity and specificity, and favorable LODs. A variety of analysis methods have been
successfully demonstrated for microdevice examples, including µCE and DNA
microarrays. While there are a number of alternative techniques for reading successful
PCRs, we will restrict our discussion to the DNA microarray technique.
1.4.1 DNA Microarrays
DNA microarrays were first developed in the early 1990s148-150 and have become an
important tool for high-throughput DNA analysis. A DNA microarray consists of a
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collection of oligonucleotide probes attached to a solid support in an orderly manner,
typically a two-dimensional array. The probes readily hybridize to amplified gene
fragments (targets) that are complementary to a specific probe. Readout of successful
hybridization events is accomplished using a fluorescent dye or other such label
attached covalently to the target. The mRNA expression levels or DNA sequence
variations from hundreds to thousands of genes can be interrogated simultaneously. A
few recent reviews of microarray technology are recommended to interested readers.151155

The basic elements required for the DNA microarray are the solid substrate, the
attachment chemistry of the probe to the solid support, the approach adopted to “spot”
the probes at particular locations of the 2-dimensional array, the method employed to
bring the solution target to the appropriate location of the array (passive or active), and
the readout modality. A brief discussion of some of these important elements will be
discussed below.
1.4.2 Substrate Materials for Microarray Construction
A variety of solid substrates have been explored for microarrays, such as glass,156,
157

polymers,69, 98, 158-166 gold,167 optical fibers168 and microbeads.169, 170 Several issues

must be considered in choosing the appropriate substrate, including the level of
scattering and fluorescence background generated from the substrate, its chemical
stability and complexity, the amenability to modification or derivatization of the substrate,
loading capacity, and the degree of non-specific interactions.156 Glass has been widely
adopted as a substrate material due to its favorable optical properties, which are highly
desired for signal readout of the microarray using fluorescence. However, the
microarray fabrication process involved for glass uses siloxane chemistry to tether
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oligonucleotide probes to the glass. These linkages are susceptible to hydrolytic
cleavage, especially at extreme pH values. Recently, polymers have been used as
alternative microarray substrate materials because of their diverse properties that can
be selected to suite different immobilization strategies of probes to the substrate, and
the ability to microfabricate structures in a low cost, mass-production mode for singleuse applications. Polymers that have been used for microarray applications include
PDMS,158, 159 PC,69, 98, 160 PMMA,161-164, 166 and polystyrene.165
The use of microbeads as substrates for the immobilization of oligonucleotide
probes has also been reported. Fan and co-workers169 described a dynamic DNA
hybridization approach using paramagnetic beads as a transportable solid support. DNA
targets were immobilized onto beads via streptavidin-biotin linkages for interrogation
with probes that were transported via pneumatic pumping. Their experiment showed
that beads containing DNA targets could be sequentially interrogated up to 12 times
with no measurable change in the hybridization signal. Ali et al.170 demonstrated a chipbased array composed of avidin-coated agarose microbeads for the discrimination of
single-nucleotide mismatches. In their work, the biotinylated oligonucleotide probes
containing microbeads were selectively arranged in micromachined cavities localized on
silicon wafers, and the fluorophore-conjugated DNA target was a complement to the
probe. The microcavities possessed trans-wafer openings allowing for both fluid flow
through the bead chambers and optical analyses at numerous bead sites. Hybridization
times on the order of minutes, with point mutation selectivity factors greater than 10,000
and an LOD of 10-13 M were achieved using this microbead array.
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1.4.3 Surface Modification for the Immobilization of Probes
Various surface modification strategies have been used to attach probes to different
solid supports. Oligonucleotide probes can be electrostatically attached to polylysinederivatized or amino-silanized glass slides, representing a non-covalent approach.171
Probes can also be covalently linked to the surface of the array by brief exposure to UV
light.172 Biotinylated DNA probes can be attached to streptavidin-coated magnetic
beads,169 or thiol-terminated oligonucleotide probes can be immobilized to gold.
Methods for the end attachment of chemically modified oligonucleotide probes to a
solid substrate have been reported as well. For example, Joos et al.157 developed the
covalent attachment of amine-terminated oligonucleotide probes to a glass substrate.
Glass slides were derivatized with aminophenyl or aminopropyl silanes, and amineterminated oligonucleotides were attached to the silanized glass with a crosslinking
reagent such as glutardialdehyde. Using this approach, up to 90% of the attached
oligonucleotides were available for hybridization.
Lenigk and co-workers160 demonstrated the use of bi-functional linkers for the
immobilization of amine-terminated oligonucleotide probes. In their work, a PC surface
was coated with a photosensitive polymer (SurModic’s photoreactive reagents) followed
by 60 s UV irradiation to generate functional groups that allowed amine-terminated
oligonucleotide probes to be covalently attached onto the surface. Detection of four
pathogenic bacteria surrogate strains from multiple samples was accomplished using
this device.
Wang et al.161 reported the covalent attachment of amine-terminated oligonucleotide
probes to a chemically modified PMMA substrate. In their protocol, the PMMA surface
was aminated using a N-lithioethylenediamine solution, where methyl-ester functional
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groups were replaced by N-lithioethylenediamine. After aminolysis, the surface was
activated with a homo-bi-functional crosslinker, glutardialdehyde, via a Schiff’s base
reaction and was converted to an aldehyde-terminated surface, which allowed for the
covalent attachment of oligonucleotide probes. They found that the oligonucleotide
coupling chemistry allowed reuse of the array >12 times without significant hybridization
signal loss.

Figure 1.9 UV activation of PMMA forming surface-confined carboxylic acid groups with
the subsequent attachment of 5’ amine-containing oligonucleotides. Reproduced from
[164] with permission.
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McCarely et al.173,

174

described a simplified photo-modification protocol of PMMA

and PC substrates through direct and controlled UV exposure of the substrates in an
oxygen-rich environment to yield surface carboxylic acid moieties. Patterns of carboxylic
acid sites could be formed by exposure of the polymers in air at 254-nm with a power
density of 15 mW/cm2 for ~60 min without significant physical damage to the polymer
surface. The so-formed chemical patterns allowed for further functionalization to yield
arrays or other structured architectures through covalent attachment chemistry.
Soper et al.164 presented the fabrication of DNA microarrays onto PMMA surfaces
using a UV modification protocol as shown in Figure 1.9. Briefly, the PMMA surface
was first activated via exposure to UV irradiation, which produced carboxylic acid
functional groups onto its surface. EDC treatment was then used to facilitate the
formation of the O-acylisourea reactive intermediates, which allowed for carbodiimide
coupling of amine-terminated oligonucleotide probes to the surface via an amide bond.
Recently, this same group enhanced the density of surface carboxylate groups by
utilizing oxygen plasma treatment to create low density arrays on the surface of a freestanding, air-embedded PMMA waveguide.163
1.4.4 Hybridization Efficiency Improvements
Merging microarrays to microfluidics is a step toward building integrated microfluidic
systems for genetic analysis. In addition, it can provide significant reductions in
target/probe hybridization reaction times resulting from diffusion-limited hybridization
kinetics. Compared to a conventional two-dimensional hybridization array in a 1 x 1 cm
format, hybridization occurring within a microfluidic channel significantly reduces the
diffusional distances between the target molecules and the probes immobilized onto the
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surface. Shuttling back-and-forth, the hybridization mixture inside a microchannel can
further facilitate mass transport and, thus, reduce hybridization time. Examples
demonstrating improvements in hybridization efficiency using microfluidics have been
reported.158, 159, 161, 175-178
Liu and Rauch175 investigated DNA hybridization in a microfluidic channel fabricated
from a variety of plastic materials. By oscillating the hybridization mixture in the
microfluidic channel, maximum signal was observed within a hybridization time of 15
min. Wang et al.161 reported a low density array constructed inside a PMMA microfluidic
device and used flow-through feed of the hybridization mixture, which successfully
reduced the hybridization time from ~5 h to 1 min and reported an LOD of 10 pM for the
identification of low abundance point mutations (one mutant in 10,000 wild-type DNA
molecules) found in a K-ras oncogene. Erickson et al.158 developed a theoretical model
for electrokinetically controlled DNA hybridization in microfluidic devices, which
predicted that reducing the height of the microchannel would effectively accelerate the
diffusion-limited reaction kinetics and reduce the time required for the hybridization
reaction to reach steady state. Following numerical simulations, the experimental results
indicated that all processes from sample dispensing to hybridization detection could be
completed within 5 min inside a glass–PDMS microchannel with a height of 8 µm. Yuen
and co-workers159 fabricated a microfluidic device consisting of two interconnected
reaction chambers molded in PDMS on a standard microscope slide for closed-loop
fluidic circulation and mixing. Fluid samples were circulated and mixed by the rotation of
a magnetic stirring bar driven by a standard magnetic stirrer. A 2 – 5 fold increase in
hybridization efficiency was observed with fluid circulation. Wei et al.176 described the
use of discrete sample plugs in a hybrid glass/PMMA microfluidic device for droplet
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hybridization (see Figure 1.10). In this case, plugs were shuttled back and forth inside a
channel sweeping over the probes, which were thoroughly mixed by the natural recirculating flows, significantly reducing the hybridization reaction volume to 1 µL. The
total reaction time was 500 s, and the LOD was 19 amol.

Figure 1.10 (A) Droplet shuttle hybridization in a microchannel. P1, P2… Pn refer to the
probe spots. (B) Illustration showing that scrambled discrete plugs sweep over different
probes in the channel. 80PM and 80MM denote the perfect match and mismatch probes,
respectively. (C) Microtrench plate is stacked on a glass microarray slide (right) with a
photograph of the assembled device (left). (D) Signal-to-noise (S/N) ratios for various
hybridization formats: (a) shuttle hybridization at 500 s, sample volume 1 µL; (b) static
microfluidic hybridization at 500 s, sample volume 10 µL; (c) flat glass hybridization at
500 s, sample volume 30 µL; and (d) flat glass hybridization at 18 h, sample volume 30
µL. The target concentration is 90 nM. The left column presents the fluorescence
images with 80 PM probe, and the right column presents the fluorescence images with
80 MM probe. Reproduced from [176] with permission.
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1.5

Integrated Microfluidic Systems with Microarray Readout
The integration of sample pretreatment with analytical processing steps for the

analysis of biological samples has remained the primary goal of micro-Total Analysis
Systems (µTAS) as described by Manz and coworkers14 over two decades ago. Many
of these visions are becoming a reality and some of these systems will be described
here. As noted previously, genetic analysis systems are defined as a single wafer or a
collection of wafers seamlessly interconnected that possess two or more processing
steps for the analysis of a genetic sample. Genetic analysis encompasses a large
number of different types of applications, for example, DNA forensics where unique
genetic markers are used for human identification either at crime scenes or in
battlefields. For in vitro diagnostics, mutations in certain gene fragments can be
detected and used to discover the presence of a disease in a particular patient, and also
provide information to the clinician on how to treat that patient. In this section, we will
discuss systems that include the sample preprocessing functions followed by microarray
readout of the preprocessing steps.
Unitizing the advantages of microchip-based DNA microarrays such as the highly
parallel nature of the readout and the ability to screen DNA sequences with high
specificity, numerous attempts have been made to incorporate front-end sample
processing strategies with DNA microarrays used as the terminal readout step onto a
single microfluidic platform. The front-end processing strategies that are needed prior to
microarray readout are similar in nature to those required for µCE and are delineated in
Figure 1. The operational differences, in terms of microsystems using arrays versus
µCE include: (1) no need for high voltage power supplies; (2) imaging over relatively
larger areas when fluorescence detection is employed (imaging optics versus point
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detection of µCE); (3) on-chip heaters to control the temperature of the array depending
on the level of hybridization stringency required; and (4) reduced processing times
compared to µCE due to the small diffusional distances associated with microfluidics.
Several examples of front-end process integration and microarrays to form functional
microsystems have been reported in literature.69, 78, 98, 116, 162, 166, 179-181
One of the initial microsystems reported was by Anderson et al.69 over a decade ago.
A monolithic biochemical processing unit (BPU) was interfaced to a GeneChip
commercialized by Affymetrix for performing multi-step molecular processing of
genomic samples and included extracting/concentrating of nucleic acids from a serum
lysate, amplification (RT-PCR and nested PCR), enzymatic reactions (fragmentation,
dephosphorylation, and labeling), metering, mixing and hybridization to the GeneChip.
The

system

was

fabricated

in

PC

using

conventional

computer-controlled

micromachining. Temperatures were controlled by pressing thermal elements against
the thin wall of the PC cartridge, with Peltier junctions used for heating and cooling.
Fluidic manipulation was achieved through the use of a fluid barrier or hydrophobic
membrane in conjunction with a pneumatically controlled diaphragm valve and
hydrophobic vent. The system performance was evaluated using serum samples loaded
with HIV virus. Analysis of the GeneChip results yielded an average accuracy of 99.7%,
as determined by independent sequencing.
Liu et al.98 presented a disposable, monolithic device that integrated PCR and DNA
microarray. The system was also fabricated in PC using CO2 laser machining (see
Figure 1.11A). This system was assembled using a two-step process: (1) First, thermal
fusion bonding of PC was performed at 139 °C and un der 2 tons of pressure for 45 min
with a square window for the DNA array left open. Second, following surface activation
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Figure 1.11 (A) Monolithic integrated polycarbonate DNA analysis system. The system
contained a serpentine PCR channel (PCR), a hybridization channel (HC), a syringe
coupled to a hybridization wash solution channel, a waste channel coupled to a waste
syringe, Pluronic traps (T), one hydrophobic air-permeable membrane valve (M), four
Pluronics valves (V1 – V4), two PCR reagent loading holes (SL), and three external
syringe pumps interfaced to reservoirs–sample driving syringe pump (P1), wastewithdrawing syringe pump (P2), and wash syringe pump (P3). The dimensions of the
system were 5.4 cm x 8.6 cm x 0.75 mm. (B) PCR hybridization results from the
monolithic integrated system. (1) E. coli 221-bp hybridization after amplification.
Portions of the channel are enlarged for better viewing. (2) Fluorescent image of portion
of the channel after E. faecalis amplification and hybridization. (3) Fluorescent image of
portion of the channel after multiplex (E. faecalis and E. coli) amplification and
hybridization. Reproduced from [98] with permission.
and oligonucleotide probe immobilization using a Motorola proprietary attachment
chemistry through the access window, the window was closed with another piece of
properly sized PC using double-sided tape. The bonding was enforced by applying 2
tons of pressure for 2 min, and then the edges were sealed with epoxy. During PCR
thermal cycling, the PCR device of the monolithic chip was sandwiched between two
Peltier elements to allow thermal processing of the sample, with temperatures being
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monitored using thermocouples. Microfluidic control was accomplished through the use
of three external syringe pumps docked to the system in combination with four on-chip
Pluronics polymer valves and one hydrophobic valve. Asymmetrical PCR amplification
and subsequent hybridization analysis of both E. coli and Enterococcus faecalis was
demonstrated. However, the use of PC as the microarray platform generated a
significant amount of autofluorescence, which degraded the detection limits for
fluorescence readout (see Figure 1.11B).
To overcome this problem, Hashimoto et al.162 coupled CF PCR and continuous flow
LDR (CF LDR) devices, both fabricated using a PC substrate, with a universal
microarray fabricated using a PMMA substrate, which possesses better optical
properties with low autofluorescence levels compared to PC (see Figure 1.12). The
chip was generated via micro-replication (hot embossing) from metal molding tools
fabricated using high-precision micromilling. The CF PCR/CF LDR chip was directly
attached to thin film heaters for providing the set temperatures for the isothermal zones,
with thermocouples embedded between the cover plate and the film heaters for
monitoring the set temperatures required for both PCR and LDR. In this work, low
density universal microarrays were produced on the bottom floor of a UV-photoactivated
PMMA microchannel, with the DNA zipcode probes attached to UV-generated
carboxylic acid groups. PCR amplicons were used as templates for the allele-specific
CF LDR, which produced single-stranded targets that were uniformly flowed over the
universal array to reduce incubation times. Using a mixed population of genomic DNA
as starting materials, one mutant in 80 wild-type sequences could be successfully
discriminated in a total reaction time of 50 min, including 18.7 min for PCR, 8.1 min for
LDR, 5 min for hybridization, 10 min for washing, and 2.6 min for fluorescence imaging
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of the low-density array. The authors also showed the ability to reduce reagent
consumption by one order of magnitude compared to similar bench-top assays.

Figure 1.12 Topographical layout of a CF PCR/CF LDR/universal zipcode array biochip.
The microchip possessed channels that were 50 µm in width and 100 µm in depth with
a 400 µm interchannel spacing. The total length of the thermal cycling channel was 2.28
m and consisted of a 30-cycle PCR (1.57 m long) and a 13-cycle LDR (0.71 m long).
The top inset represents a microscope image of the turns of the CF thermal cycling
channel. The bottom inset is an enlarged schematic of the Y-shaped passive
micromixer for mixing the PCR product with the LDR cocktail. Three different Kapton
film heaters were attached to the appropriate positions on the CF PCR/CF LDR chip for
providing the required isothermal zones. Thermocouples were inserted between the
microchip cover plate and the film heaters for monitoring the temperatures. Reproduced
from [162] with permission.
A self-contained biochip that integrated cell isolation and lysis with PCR amplification
and electrochemical microarray-based detection was described by Liu et al.181 The chip
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Figure 1.13 Integrated, modular microfluidic chip for TB analysis. (A) Overview of the
integrated system. The system had dimensions 12” (length) x 12” (width) x 12” (height),
and all fluid handling, thermal management, and optical detection were controlled by offchip supporting peripherals and assembled into a small form factor instrument. (B)
Schematic and photograph of the fluidic cartridge. The fluidic cartridge was composed
of two modules and a fluidic motherboard. The fluidic motherboard was made from PC
and consisted of processing steps for cell lysis, PCR, and LDR. One module was made
from PC and used for SPE of genomic DNA, while the other module was made from
PMMA and contained an air-embedded planar waveguide and the DNA array. Sample
inlet (1), PCR mixture inlet (2), LDR mixture inlet (3), ethanol and air inlet (4), array
wash inlet (5), vacuum connection (6), and waste outlet (7). V1 – V6 are on-chip
membrane valves. V2 is positioned next to the SPE module on the cell lysis
microchannel and is not visible in current view. (C) Molecular assay results from drugsusceptible Mycobacterium tuberculosis (Mtb) strains and drug-resistant Mtb strains.
516WT, 531WT, and 526WT are probes targeting drug-susceptible Mtb strains. 516MT,
531MT, and 526MT are probes targeting drug-resistant Mtb strains. Reproduced from
[166] with permission.
was machined in a PC substrate using a conventional computer-controlled milling
machine and included a mixing unit for cell capture using immunomagnetic beads, a cell
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pre-concentration/purification/lysis/PCR unit, and a DNA microarray chamber. In this
work, fluidic components (e.g. paraffin-based microvalves, cavitation microstreaming
mixers, and electrochemical or thermopneumatic pumps), embedded resistive heaters,
and DNA microarray sensors were coupled to the system to perform DNA analysis of
biological samples. Electrical power, PCR thermal cycling, DNA electrochemical signal
readout, and magnetic elements for bead arrest were controlled by an off-chip
instrument. Implementation of cavitation microstreaming has been shown to achieve cell
capture efficiencies on the order of 73% using immunomagnetic beads and up to a 5fold reduction in hybridization time compared to passive incubation of the array with
solution targets, as well as improved signal uniformity. Detection of pathogenic E. coli
K12 cells seeded into rabbit blood and single-nucleotide polymorphism analysis from
diluted blood samples were completed in 3.5 h and 2.7 h, respectively.
Soper et al.166 designed a polymer-based modular microsystem that could accept a
crude sample and automatically carry out the entire molecular processing pipeline in an
enclosed fluidic cartridge (see Figure 1.13). The multi-step assay included bacterial cell
lysis, SPE of genomic DNA from the lysate, PCR amplification, LDR, and universal DNA
array readout. The fluidic cartridge was generated via micro-replication from the
appropriate metal molding tools, which were used to create structures on both sides of
the polymer substrate (i.e., double-sided hot embossing). The integrated fluidic cartridge
was comprised of a fluidic motherboard and two modules. One module was made from
PC and used for SPE, while the other module was made from PMMA and contained
DNA probes patterned on a planar waveguide for evanescent excitation. These
modules were interconnected to a fluidic motherboard fabricated in PC and were used
for processing steps for thermal cell lysis, PCR, and LDR. Fluid handling, thermal
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management, and optical detection were controlled by off-chip supporting peripherals,
which could be packaged into a small footprint instrument (1 ft3). Identification of multidrug resistant tuberculosis (MDR-TB) resulting from Mycobacterium tuberculosis (Mtb)
strains in clinical sputum samples were demonstrated with a detection limit of ~50
bacterial cells from sputum (processing time <40 min). In addition to MDR-TB detection,
the modular fluidic cartridge could be reconfigured for use with other assay formats,
such as PCR-µCE.
1.6

Concluding Remarks
There have been extensive reports on devices designed toward to perform a single-

step in the analysis of a variety of nucleic acids, such as DNAs and RNAs. These
devices have been fabricated using a variety of micro-manufacturing techniques in
different substrate materials. Devices have been developed for the SPE of nucleic acids
from clinical, environmental, or crime-scene samples employing beads, polymer
monoliths, or fabricated pillars to produce the desired solid phase. In addition, a
plethora of devices focused on thermal cycling (such as that required for PCR, cycle
sequencing, or allele-specific LDR) have been detailed in the literature and typically use
either a chamber-type approach, in which the chamber and its contents are cycled
between the desired temperatures, or a continuous flow operation, in which isothermal
zones are situated on the chip and the reaction fluid is transported through these
isothermal zones. Devices have also been reported that perform µCE separation of
DNAs using sieving matrices with various channel lengths to reach the desired
resolution demanded of the separation. While these represent innovative concepts, the
complete analysis of different sample types required for genetic analyses typically
requires a number of processing steps (see Figure 1.1). Therefore, it is clear that
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integration of many of the aforementioned devices to form functional and autonomously
operated systems needs to be undertaken. However, process integration to form
autonomous systems is not simply a matter of “hooking” together the various devices
outlined previously. For example, many of the upstream processing steps and the
reagents they require may be detrimental to those poised downstream. Also, some
steps demand hydrodynamically driven flow, while others require electrokinetically
driven flow. Another concern is unswept volumes, which can generate sample carryover
artifacts or sample loss, especially when dealing with ultrasmall sample volumes. Some
substrate materials do not accommodate particular processing steps, and high optical
quality materials must be used for assays employing fluorescence as the detection
mode. Finally, some process steps require thermal control, such as PCR, and these
thermally actuated units must be isolated from those that are sensitive to temperature,
such as microarrays.
Several examples of integrated microfluidic systems have been presented herein,
most of which are proof-of-concept demonstrations with only a few examples that have
actually dealt with clinical or “real-world” samples. Unfortunately, many of these
demonstrators of integrated microfluidic systems, while attractive in terms of their ability
to reduce sample processing time and reagent consumption, have only been utilized in
research settings. Some of the more compelling applications for integrated microfluidic
systems, such as in vitro diagnostics, homeland security, or forensics, will demand
systems that can accommodate field analysis and/or one-time use operation. For
example, in the case of in vitro diagnostics, it will be necessary to use the entire
microfluidic system for a single patient sample, demanding that the cost of the chip be
low. In addition, field analysis applications will require not only that the chip possesses a
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small footprint, but also that the support peripherals must have the same characteristic.
These support peripherals include pumps, valves, reagent reservoirs, electronics, and
optomechanics if some type of optical readout is used. The chip and support peripherals
must all be packaged into small form factor instrument and must consume minimal
amounts of power to enable battery operation for extended periods of time. All this must
be engineered without sacrificing assay performance in terms of reproducibility, LOD,
sensitivity, and specificity.
Another interesting aspect is related to manufacturability of the system. For wide
spread commercialization, the fluidic system must be produced in high volume and at
low cost. Chip production not only includes the microfabrication of the channel networks,
but also chip assembly, integration of various components such as electrodes, optical
elements, and valves and, finally, the surface attachment of necessary biologics to
effect the desired process step. Although microfluidics has shifted from the use of
silicon, glass, and other similar materials that require extensive microfabrication
procedures to the use of polymer substrates that can use micro-replication processes
(similar to those used to produce CDs and DVDs) to produce the desired fluidic
networks in a high production mode with good fidelity, the challenge still remains in chip
finishing following production of the fluidic network.
The driving force behind the increasing development of integrated microfluidic
systems is certainly due to their potential commercialization, but also in their diverse
applications in such areas as biology, chemistry, and other disciplines that strongly
demand the emergence of new analysis platforms to achieve higher performance and
throughput. Because direct integration of PCR with other sample preparation protocols,
including µCE, fluorescence, and microarrays has been demonstrated for a wide range
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of applications (pathogen detection, DNA typing, and DNA sequencing), these success
stories will demand higher functionality at lower cost and with higher throughput. Such
systems offer compelling advantages such as short assay turnaround times, automated
operation, improved operator protection, lower cross-contamination, reduced human
error, and lower overall assay cost. Minimization of potential carryover contamination
from run-to-run is a key consideration in providing accurate and reliable results and the
use of disposable fluidic cartridges will effectively minimize this risk.
1.7
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CHAPTER 2 IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS
AUREUS USING AN INTEGRATED AND MODULAR MICROFLUIDIC SYSTEM
2.1

Introduction
Molecular testing is of significant importance in diagnostics and prognostics of

numerous diseases and in recognizing variation that can influence response to
therapy.1-3 These tests can be accomplished using a number of task-specific
instruments and typically consists of the following set of processing steps: (1) cell lysis
and target extraction/purification from other cellular components (e.g. cell debris and
proteins) that may interfere with downstream processing; (2) amplification of trace
amounts of nucleic acids to produce sufficient copy numbers to aid in detection; and (3)
analysis of unique sequence variations within certain genes to provide the proper
clinical information. To complete an entire assay, a well-equipped laboratory and
significant technical expertise are commonly required with operator intervention required
at several stages of the processing pipeline. In addition, the total time required for
sample processing can be several hours to several days. These operational
characteristics have hampered the implementation of molecular testing into resource
limited settings, which has resulted in the limited usage of these valuable techniques.4
Derived from the concept of micro-total analysis systems or lab-on-a-chip platforms
first proposed by Manz et al.5 in the early 1990s, the emergence of integrated
microfluidic systems, which incorporate several molecular processing steps into a single
microfluidic platform with sample-in-answer-out capabilities, are particularly attractive for
automated, fast and cost-effective genotyping. These systems can incorporate many of
the sample processing steps into a single system and negate the need for extensive
operator expertise and minimize the amount of equipment required to carry out the
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analysis. In addition, when configured with the support peripherals, the instrument can
be designed to operate directly at the point-of-care, even in resource limited
environments.6
Several demonstrations of integrated microfluidic systems for DNA analyses have
been described.7-10 Many of these reports utilized microfluidic structures fabricated in
glass, silicon or glass polymer hybrids and thus, required direct photolithographic
processing steps to manufacture the desired structures incorporated into the fluidic
network. This production format leads to rather complicated fabrication processes and
as such, generates challenges for meeting the demanding of low-cost systems that can
be produced in a high production mode for realizing one-time use chips, a requirement
in many clinical applications.
Thermoplastic materials have been explored as alternatives to glass or silicon for the
production

of

microfluidic

platforms.11 The

development

of

suitable

polymer

manufacturing techniques, such as hot embossing and injection molding, can generate
high quantities of chips at low costs. Several groups have reported polymeric
microfluidic systems for carrying out nucleic acid analysis. For example, a disposable
monolithic microsystem, which integrated PCR and DNA microarrays, was described by
Liu et al.12 The chip was fabricated in PC using CO2 laser milling with an asymmetrical
PCR amplification step employed. The system was demonstrated for the analysis of
both E. coli and Enterococcus faecalis. Liu and coworkers fabricated a self-contained
biochip with integrated cell isolation and lysis units, PCR amplification and
electrochemical microarray detection for sample-to-answer DNA analyses.13 The
system was machined into a PC substrate and was capable of detecting E. coli in 3.5 h.
Klapperich’s group developed a low-cost chip system for the analysis of bacterial DNA
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using a substrate consisting of cyclic olefin copolymer, COC, with the fluidic structures
directly milled into the COC chip.14 The system contained functional devices for cell lysis,
DNA isolation and purification, PCR and end-point fluorescence detection. Wang and
coworkers15

reported

a

magnetic

bead-based

system

fabricated

using

a

polydimethylsiloxane substrate, which combined DNA extraction and isothermal
amplification of the targets followed by optical analysis utilizing a spectrophotometer.
The system was used to perform a loop-mediated isothermal amplification and to detect
Staphylococcus aureus with a limit-of-detection (LOD) of ~10 fg/µL of target DNA.
While the above examples of polymer-based systems are attractive in demonstrating
the utility of using thermoplastics for generating low-cost integrated systems for DNA
processing, however, extensive post-processing steps were required after fabrication of
the desired fluidic microstructures, which can significantly add to the cost of chip
production. Examples of post-fabrication processing steps included the lithographic
patterning of electrodes onto the fluidic chip,12 need of priming the chip with a buffer,14
integration of wax-based valves,12 or the addition of magnetic beads.13,

15

Another

challenge is the use of PC as the microarray, which can generate a significant amount
of autofluorescence16 degrading the detection limits for fluorescence readout. Also, PC
can also produce large levels of non-specific adsorption.17
S. aureus is identified as a human normal commensal and can cause a variety of
diseases ranging from minor skin infection to fatal pneumonia or septicemia.18, 19 Shortly
after the introduction of methicillin in the 1960s, MRSA strains have become a major
cause of hospital-acquired infection. In recent years, CA-MRSA infections are on the
rise and can result in illnesses more severe than HA-MRSA.20-22 It is estimated that
MRSA-related infections associated with death are approximately 19,000 annually in the
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U.S alone. Apart from their high mortality rate, MRSA is estimated to cause $3-4 billion
of additional health care costs per year.23 In 2005, the U.S. press described MRSA as a
“superbug” that killed more people than did AIDS.24 In addition, MRSA has been
identified as one of the two most out-of-control antimicrobial-resistant pathogens in U.S.
hospitals.25 Therefore, the rapid and reliable detection of MRSA strains is crucial not
only for infection control but also for patient treatment at early stages.
MRSA detection typically uses culturing techniques, which requires 2-3 days to
identify an MRSA culture. Methicillin resistance in S. aureus is mediated by the mecA
gene, which encodes a penicillin binding protein 2a called PBP2a with a low affinity of
binding to beta-lactam antibiotics.26-28 Nucleic Acid Amplification Tests (NAATs) that can
identify MRSA by interrogating the drug resistant-related signature gene (mecA)
presents a promising opportunity for rapid drug resistance screening. Reported
literatures related to NAATs-based detection of MRSA have predominately used the
amplification of the mecA gene in conjunction with a S. aureus-specific gene, such as
nuc, coa, femB, Sa442.29-32 However, these tests are unable to distinguish MRSA from
nonsterile clinical specimens (e.g. nasal swabs) due to the coexistence of S. aureus and
coagulase-negative Staphylococci (CNS) (e.g. S. epidermidis); up to 80% of strains
carry the mecA gene,21, 33 which can lead to false-positive results.
To address the aforementioned issues, we constructed an integrated modular-based
microfluidic system for the rapid and efficient identification of MRSA with high specificity.
The microfluidic system could carry out all of the molecular processing steps in a single
disposable fluidic cartridge. The unique aspect of this fluidic cartridge was that it used a
modular approach with task-specific modules interconnected to a fluidic motherboard
with the material of the modules and motherboard selected to optimize the processing
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step performance. In addition, to minimize the amount of finishing steps associated with
the fluidic cartridge, many of the functional elements were produced during the polymer
molding step used to create the fluidic network. The fluidic cartridge was capable of
performing a multi-step assay including continuous flow PCR amplification of specific
gene fragments, continuous flow LDR to generate fluorescent ligation products
containing zip-code complement sequences that directed the ligation products to a
specific location of a two-dimensional array, and a universal DNA array, which consisted
of DNA zip-code probes patterned onto a planar polymer waveguide for evanescent
excitation.
The cartridge was comprised of one functional module poised on a fluidic
motherboard stacked in a 3-dimensional configuration. On the basis of material
properties selected to optimize the module operation and meeting manufacturing
requirements, the motherboard was made from PC and used for two thermal cycling
processes, PCR and LDR, due to its relatively high glass transition temperature to allow
it to withstand the sustained high operating temperatures required for the thermal
reactions. The module was made from PMMA and contained an air-embedded planar
waveguide and the DNA microarray because PMMA has significantly lower amounts of
autofluorescence compared to PC16 as well as minimal non-specific adsorption
artifacts.17
The fluidic cartridge was generated via micro-replication from the appropriate metal
molding tools, which were used to create structures on both sides of the polymer
substrate (i.e., double-sided hot embossing). Fluid handling (e.g. pumps, valves, etc.),
thermal management (e.g. heaters, temperature sensors, etc.) and optical readout
hardware were located off-chip and packaged into a small footprint instrument. Only the
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fluidic cartridge was in contact with the sample, which eliminated any potential carryover
contamination.
To demonstrate the utility of the modular system, MRSA analysis was carried out
using a multiplexed PCR/LDR assay coupled to a universal zip-code array with four
representative strains, methicillin-susceptible S. aureus (MSSA), MRSA, methicillinsusceptible S. epidermidis (MS-CNS) and methicillin-resistance S. epidermidis (MRCNS). The multiplexed PCR described in this work used five sets of specific primers to
target SG16S, spa, femA, PVL and mecA genes followed by a multiplexed LDR that
was used to minimize false-positive results. The integrated system was further
demonstrated to be capable of detecting a mixture of MSSA and MR-CNS strains,
which are common commensal organisms found in clinical samples, for the presence of
S. aureus bacteria and determining their drug susceptibility status.
2.2

Experimental

2.2.1 Reagents
PC and PMMA sheets used as the fluidic substrates were purchased from Good
Fellow (Berwyn, PA). Chemicals used for the PMMA surface modification and
hybridization

assays

included

1-ethyl-3-(3-dimethylaminopropyl)

carbodiimide

hydrochloride (EDC), N-hydroxysuccinimide (NHS) and 20x SSC buffer (3 M sodium
chloride, 0.3 M sodium citrate, pH 7.0), which were purchased from Sigma-Aldrich (St.
Louis, MO). A 10% sodium dodecyl sulfate (SDS) stock solution, which was used for
post-hybridization washing, was received from Ambion (Austin, TX). Disodium hydrogen
phosphate (Na2HPO4), sodium phosphate (Na3PO4), and 2-propanol were obtained
from Sigma-Aldrich (St. Louis, MO). Oligonucleotide primers and probes were obtained
from Integrated DNA Technologies (Coralville, IA). Their sequences and melting
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temperatures (Tm) are listed in Table 2.1. All solutions were prepared in nuclease free
water purchased from Invitrogen Corporation (Carlsbad, CA).
2.2.2 Fabrication of the Fluidic Cartridge
The modular fluidic cartridge consisted of one module and a motherboard (see
Figure 2.1A); the motherboard made from PC was used for two thermal reactions, PCR
and LDR, while the module fabricated in PMMA contained DNA probes spotted on an
air-embedded waveguide that used evanescent excitation for fluorescence readout. The
PMMA module was interconnected to the PC motherboard using short pieces of
TefzelTM tubing (OD = 1/16”, ID = 250 µm, Upchurch) inserted between conicallyshaped holes placed on the backsides of both the motherboard and module to provide a
leak-free interconnection.
The PC motherboard was replicated using double-sided hot embossing from two
brass molding tools mounted opposite to each other on a JENOPTIK HEX02 hot
embossing machine (Jena, Germany). Brass mold masters were used to create
microstructures on the PC substrate and contained microchannels for PCR and LDR on
the frontside of the substrate and thermal isolation grooves34 and conical
interconnectors on the backside. The mold masters were fabricated using high-precision
micromilling.35 The layout of the PC motherboard is depicted in Figure 2.1A. The dualdepth serpentine channel, which consisted of 32 cycles for PCR and 15 cycles for LDR
was 80 µm in width and 80/240 µm in depth and was designed to prolong the residence
time in the extension/ligation zone by increasing the channel cross-section causing a
net decrease in the linear flow rate in these zones. The fluid access channels (DNA
sample and LDR mixture) were 200 µm in width and 240 µm in depth. The PC
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motherboard was assembled by thermal fusion bonding the substrate and a PC cover
plate (250 µm thick) placed in a convection oven at 150 °C for 20 min.
The PMMA module was assembled from two hot-embossed PMMA parts; one
consisted of a 100 µm deep microchannel for the universal microarray on the frontside
and a 1.2 mm x 10 mm air-embedded planar waveguide with an integrated prism on the
backside (see Figure 2.1B). Located on the backside were also positioned conical ports
for fluidic connections to the PC motherboard. The air-embedded waveguide was
double-sided hot embossed into the PMMA substrate via micro-replication from two
brass molding tools. Twenty-four (4 x 6) waveguide modules could be replicated on one
PMMA wafer.
PMMA surface modification for amine modified oligonucleotide zip-code probe
attachment was carried out using a previously published protocol,36-38 which is
schematically illustrated in Scheme 2.1. Briefly, surface carboxylic acids were
generated by placing PMMA substrates in the vacuum chamber of a Technics Series
8000 micro-reactive ion etcher (Surplus Process Equipment Corp., Santa Clara, CA) for
1 min using a 200 mTorr oxygen pressure and a 50 W radio frequency. Then, the
PMMA substrates were incubated in a coupling buffer containing 50 mg/mL EDC and 5
mg/mL NHS in MES (2-(N-morpholino)ethanesulfonic acid) buffer (pH 6.0) for 10 min to
form succinimidyl ester intermediates, which can react with amine-terminated
oligonucleotide probes (3’-end) to form a stable amide bond. The 3’-amino-modified
oligonucleotide zip-code probes (see Table 2.1 for sequences) were dissolved in 200
mM Na2HPO4/Na3PO4 buffer (pH 9.0) to a final concentration of 50 µM and were
dispensed on the activated PMMA surface using a Perkin-Elmer Piezorray® non-contact
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(A)

(B)

Figure 2.1 Integrated microfluidic system for MRSA Identification. (A) Schematic of the
fluidic cartridge. The fluidic cartridge was composed of one module and a fluidic
motherboard. The motherboard was made from PC and consisted of processing steps
for PCR and LDR, while the module was made from PMMA and contained an airembedded planar waveguide in which a DNA microarray was spotted onto. (B) Layout
of the PMMA module (right picture) consisting of the air-embedded waveguide, a
coupling prism and the DNA universal array. The waveguide and coupling prism (see
center picture) were located on the backside of the module and the frontside contained
the fluidic channel, which had as its floor the waveguide. DNAs could be spotted (see
picture on the top) onto the waveguide using a conventional spotter prior to thermal
fusion bonding the cover plate to this module’s substrate. Optical setup (left picture) was
composed of a laser diode and a CCD imaging sensor. Excitation of the array probes
was achieved through the evanescent field produced by a waveguide underneath
microfluidic channel with spotted probes. Fluorescence signal of the array was collected
in a single exposure and imaged onto a CCD through two 2x objectives.
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microarraying instrument (Downers Grove, IL). Dispensing volumes per spot were 330
±30 pL and the size of spots were ~150 µm in diameter. After incubation in a humidified
chamber at room temperature for 4 h, the spotted PMMA substrates were washed with
0.1% SDS to remove non-specifically adsorbed oligonucleotides and stored at 4°C until
used for the measurements. Following spotting of the DNA probes onto the waveguide,
the waveguide and the interconnection wafer were assembled together using a thermal
annealing method at 107 °C for 20 min.

Scheme 2.1 The procedure of PMMA surface modification and oligonucleotide probe
immobilization. The plasma-modification process for DNA microarray fabrication
involved three steps; (1) oxygen plasma exposure of the polymer surface; (2) EDC/NHS
treatment to facilitate the formation of the succinimidyl ester intermediate; and (3)
carbodiimide coupling of amine-terminated oligonucleotide probes to the activated
PMMA surface (via an amide bond).
2.2.3 Contact Angle Measurements
Water contact angle measurements were used to probe the effect of oxygen plasma
exposure on the PMMA surface. Substrates (2.54 cm x 1.27 cm x 0.25 cm) were cut
from a commercial PMMA sheet. After oxygen plasma treatment, contact angle values
of the PMMA surfaces were measured using a VCA 2000 contact angle system
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equipped with a CCD camera (VCA, Billerica, MA) based on the sessile drop method.
Approximately 2 µL of deionized water was placed on the PMMA surface using a
syringe and the contact angle of the water droplet was measured immediately using the
software provided by the manufacturer. The measurements were repeated at least three
times at separate positions on each sample surface. The data points represent the
mean of three measurements with the error bars showing ±1 standard deviation.
2.2.4 X-ray Photoelectron Spectroscopy
PMMA sheets (1 cm x 1 cm x 0.25 cm) treated under the chamber pressure range of
50 – 300 mTorr were analyzed with an Axis 165 X-ray photoelectron spectrometer
(Kratos Analytical) using a monochromatized X-ray source (Al Kα 1486.6 eV) with a
power of 150 W. The binding energy scale was calibrated to Au4f7/2b = 84.0 eV. The
base pressure was 2 x 10-10 Torr and the operating pressure was 2 x 10-9 Torr. The
photoelectron takeoff angle was 90° (with respect t o the sample surface). Survey and
high-resolution spectra were obtained using pass energies of 160 and 20 eV,
respectively. The neutralizer was turned on during the analysis to compensate for any
possible charge effects on the insulating polymer surfaces. Core level binding energies
for C1s and O1s were determined by referencing the methyl carbons to 285.0 eV and
carbonyl oxygens to 532.2 eV.39 Curve fitting of the high-resolution spectra of the
pristine and oxygen plasma-modified PMMA was performed using asymmetric 70%
Gaussian and 30% Lorentzian component profiles after subtraction of the baseline
using a linear background.
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Table 2.1 Sequences of oligonucleotides used in the PCR/LDR/universal zip-code hybridization assay for MRSA
PCR product
size (bp)

Oligos

148

mecA-forward

TGGTATGTGGAAGTTAGATTGG

51.2

mecA-reverse

ATATGCTGTTCCTGTATTGGC

52.8

mecA-com

a

pATTCCTGGAATAATGACGCTA–Cy5b

51.2

cZip1-mecA

c

GCTGAGGTCGATGCTGAGGTCGCAATGTATGCTTTGGTCTTTCTGC

69.2

98

161

172

Sequence (5’→3’)

Tm
(°C) e

Zip-code 1

TGCGACCTCAGCATCGACCTCAGC–sp-NH2d

64.9

spa-forward

CATTACTTATATCTGGTGGCG

50.6

spa-reverse

GTTAGGCATATTTAAGACTTG

46.5

spa-com

a

pTTGCGCAGCATTTGCAG–Cy5b

54.9

cZip21-spa

c

GGTCAGGTTACCGCTGCGATCGCATTTTGTTGAGCTTCATCGTG

69.0

Zip-code 21

TGCGATCGCAGCGGTAACCTGACC–sp-NH2d

65.3

SG16S-forward

TGGAGCATGTGGTTTAATTCGA

54.7

SG16S-reverse

TGCGGGACTTAACCCAACA

56.8

SG16S-com

a

pTTGGTAAGGTTCTTCGCG–Cy5b

52.5

cZip25-SG16S

c

GGTCTACCTACCCGCACGATGGTCGAGTTGTCAAAGGATGTCAAGAT

68.8

Zip-code 25

GACCATCGTGCGGGTAGGTAGACC–sp-NH2d

62.7

femA-foward

CAACTCGATGCAAATCAGCAA

54.1

femA-reverse

GAACCGCATAGCTCCCTGC

58.6

femA-com

a

pATAATTAATCCGTTTGAAGTAGTTT–Cy5b

49.0

cZip15-femA

c

CGCATACCAGGTCGCATACCGGTCCCATCTCTGCTGGCTTCTTT

71.0
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Table 2.1 Continued

176

Zip-code 15

GACCGGTATGCGACCTGGTATGCG–sp-NH2d

63.5

PVL-forward

ACACACTATGGCAATAGTTATTT

50.2

PVL-reverse

AAAGCAATGCAATTGATGTA

48.4

PVL-com

a

51.3

cZip5-PVL

c

Zip-code 5

GACCACCTTGCGATCGGGTACAGC–sp-NH2d

pGAGTTTTCCAGTTCACTTCATATT–Cy5b

GCTGTACCCGATCGCAAGGTGGTCTTATGTCCTTTCACTTTAATTTCAT 66.5

a

p: phosphorylated.
Cy5: λex = 649 nm, λem = 670 nm.
c
The bold sequences are complementary to the sequences of zip-code probes.
d
sp-NH2: (CH2CH2O)6PO4-NH2.
e
Conditions: oligo concentration, 1 µM; Na+ concentration, 50 mM.
b
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63.7

2.2.5 PCR and LDR
DNA samples including MSSA (ATCC 25923D-5), MRSA (ATCC BAA-1556D-5),
MS-CNS (ATCC 12228D-5) and MR-CNS (ATCC 35984D-5) were all purchased from
American Type Culture Collection (Manassas, VA). The sequences of oligonucleotide
primer pairs used for the PCR and LDR are listed in Table 2.1.40-42 The targets included
SG16S, spa, femA, PVL and mecA genes. The PCR mixture consisted of 10 mM TrisHCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 200 µM dNTPs, 0.5 µg/µL ultra-pure bovine
serum albumin (BSA), 0.5 µM of each primer, and 0.1 U/µL Taq DNA polymerase (New
England Biolabs, Beverly, MA). The LDR mixture contained 20 mM Tris-HCl (pH 7.6),
25 mM KCl, 5 mM MgCl2, 10 mM DTT, 1 mM NAD+ (a cofactor for ligase enzyme), 0.1%
Triton X-100, 0.5 µg/µL ultra-pure BSA, 50 nM of each discriminating primer, 100 nM of
each Cy5-labeled common primer, and 2 U/µL Taq DNA ligase (New England Biolabs,
Beverly, MA). Off-chip PCR and LDR were performed using a commercial thermal
cycler (Techne, Burlington, NJ) with the same assay conditions as a control. PCR
amplicons were subjected to electrophoresis on a 3% ethidium bromide-prestained
agarose gel at 5 V/cm for 30 min. The gel image was captured using Gel Logic 200
Visualizer (Carestream Molecular imaging, New Haven, CT). LDR products were
separated using a Beckman CEQ8000 capillary genetic analysis system (Beckman
Coulter, Fullerton, CA). Data acquisition was performed using the Beckman software.
2.2.6 Operational Protocol of the Fluidic Cartridge
Prior to analysis, the fluidic cartridge was loaded with the PCR mixture containing
the DNA sample and the LDR reaction mixture into individual storage reservoirs (see
Figure 2.1A). It was then aligned using a fluidic distribution board-to-motherboard
stainless steel interconnects and pressed against Cu heating blocks surface covered
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with thermal conductive tap to provide good thermal contact. This ensured both tight
fluidic connections and proper heat transfer. In the next step, the PCR mixture was
pumped out of the storage reservoir through the PCR thermal reactor. After 15 min, the
LDR mixture was introduced through the fluidic cartridge at the appropriate volumetric
flow rate and was mixed with the PCR products. Mixing was achieved using a passive
Y-shaped micromixer, which consisted of 80 µm wide and 80 µm deep inlet and outlet
channels, with the mixing ratio of PCR amplicons to the LDR mixture set at 1 to 1. The
reaction mixture was then processed through the LDR thermal reactor and further
through the array module and finally to waste. The array was flushed with a wash buffer
(2x SSC, 0.1% SDS) and DNA hybridization events were imaged using a compact
optical reader, which consisted of a laser diode (HL6320G, 10 mW, Hitachi) and a CCD
image sensor (S7030-0907; 512 x 58 pixels; 24 x 24 µm/pixel; Hamamatsu), with a 12
mm x 3 mm field-of-view using an integration time of 20 s. The reader was composed of
two 2x microscope objectives (PLAPON 2x, Olympus), a 3RD660LP long pass filter and
3RD660-680 band pass filter (Omega Optics, Brattleboro, VT).
Excitation of the array was achieved through the evanescent field produced by the
waveguide serving as the floor to the microfluidic channel housing the universal array.
The laser light was coupled into the waveguide via a 64° prism. Both the waveguide and
coupling prism were incorporated into the array microchip and fabricated using the
same embossing step that was used for making the fluidic network.
In this work, we used continuous flow thermal cycling for several reasons including
its ability to provide ultrafast cycling times ultimately limited by the kinetic rate of dNTP
incorporation by the polymerase and the lack of valves required to contain the PCR
mixture during thermal cycling as is required for batch-type thermal cyclers.34, 43, 44 The
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temperatures for the continuous flow PCR (CF PCR) were set at 95 °C for denaturation,
55 °C for annealing and 72 °C for extension. As for the continuous flow LDR (CF LDR),
the temperatures were set at 95 °C for denaturation and 60 °C for ligation. Commercial
polyimide (KAPTON®) heaters were used to deliver heat to the PCR and LDR thermal
reactors. Heaters were attached to 2 mm thick Cu blocks to achieve uniform heat flux
and distribution. Temperatures were controlled by type K thermocouples (CHAL-005,
Omega Engineering, USA) placed in microgrooves milled into the Cu blocks. An integral
part of the heat management of the fluidic chip were thermal isolation grooves formed
on the backside of the PC motherboard during the embossing process, which allowed
for efficient thermal isolation between adjacent reaction zones.34
2.3

Results and Discussion
MRSA is a leading cause of infections in U.S. hospitals and healthcare facilities. In

recent years, community-acquired MRSA (CA-MRSA) infections have caused additional
concern.45-48 It has been reported that MRSA strains carrying the Panton-Valentine
leukocidin (PVL) virulence gene have been associated with an increase in severe skin
infections and a new syndrome of community-associated necrotizing pneumonia in
children.42,

49

The PVL virulent determinant has been considered an important and

stable marker for CA-MRSA. Consequently, in addition to methicillin resistance
screening, the present work described an approach for the simple and rapid
discrimination between HA-MRSA and CA-MRSA in addition the differentiation between
MSSA and MRSA.
The assay employed in this work consisted of a multiplexed PCR followed by a
multiplexed LDR with readout via a low-density universal array configured on a
waveguide. The optimization of CF PCR, CF LDR and surface functionalization
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chemistries were investigated followed by the evaluation of the integrated system for
analyzing MRSA samples.
2.3.1 Optimization of Multiplexed CF PCR and CF LDR
We have demonstrated ultra-fast PCR that could amplify 500 bp fragments from a
λDNA template in 1.7 min.43 Using a continuous flow (CF) format, the thermal load in
the device was reduced to the sample itself and the amplification was pushed to the
enzymatic incorporation rate limit. Compared to single-plex PCR from the λDNA
template, optimizing the multiplexed PCR from real genomic DNA samples in CF PCR
devices presents two challenges: (1) different hybridization efficiencies among multiple
PCR primer sets can introduce biased exponential amplification and alter the initial
relative abundance of the target sequence. In some extreme cases, some target
fragments are not amplified due to the competition for Taq polymerase and dNTPs. The
speed of PCR is limited by the balance of hybridization among multiple primers instead
of the enzymatic incorporation rate. (2) Compared to the λDNA template, the 2.8 Mbp S.
aureus genome further complicates PCR reaction by imposing a larger amount of
background DNA burden.50 We therefore investigated the effects of different
combinations of multiple PCR primers on hybridization efficiencies in terms of the
product yields.
We carefully evaluated primer pairs from the literature40-42 and chose five sets of
primers, which targeted five markers, including: the SG16S gene, which is specific to
the Staphylococcus genus; the spa gene, which is specific to S. aureus; the femA gene,
which is specific to S. epidermidis; the PVL gene, which is associated to community
acquired MSSA/MRSA and the mecA gene, which is a determinant of methicillin
resistance. Five sets of PCR primers against these targets were combined in the same
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reaction mixture and they can interfere with each other during PCR amplification. Before
optimizing the five-plex PCR, single-plex PCRs were performed using four
representative strains including MSSA, MRSA, MS-CNS and MR-CNS. Each individual
PCR yielded fragments of the expected sizes, 98, 148, 161, 172 and 176 bp for the spa,
mecA, SG16S, femA and PVL genes, respectively (data not shown). The annealing
temperature tested for the 5-plex PCR ranged from 50 – 60 °C and was individually
evaluated using a gradient thermal cycler. An optimal annealing temperature of 55 °C
was selected for the five targets.
We next investigated the effects of flow rate on the PCR product yield. Figure 2.2
shows the PCR products generated from the CF PCR device at volumetric flow rates of
0.25, 0.5 and 1 µL/min (0.65, 1.30 and 2.60 mm/s). The fluorescence intensities from
the PCR product gel bands obtained from the CF PCR were analyzed using
ImageQuant software and were normalized with respect to those from a bench-top PCR
thermal cycler and the results are shown in Figure 2.2B. The results indicate the
product yield of the CF PCR became larger as the flow rate was reduced. For the mecA
gene, the product yield of the CF PCR at a volumetric flow rate of 0.25 µL/min was 44%
of the reference PCR, higher than 10% at a volumetric flow rate of 1 µL/min. The lower
product yield at 1 µL/min, which roughly provided 4 s for denaturation, 4 s for annealing
and 16.2 s for extension, matched our previous experiments43 and the lower yield was
most likely due to insufficient residence time in the extension zone because this is the
rate limiting step with this set by the rate of dNTP incorporation by the polymerase.
Although the CF PCR produced the lower product yield at 1 µL/min, the cycling rate of
29.6 s/cycle was much shorter as compared to 118 s/cycle required at 0.25 µL/min. The
lower overall yield of the CF PCR compared to the commercial thermal cycler even at
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the optimal linear velocity may come from the fact that the higher surface-to-volume
ratio of the microchannel as compared to a 200-µL PCR tube that provided more
probability for the Taq polymerase to adsorb on the microchannel walls.
As demonstrated in Figure 2.2, the faster the flow rate of sample through the CF
PCR device, the less amount of product that was generated due to reduced residence
time in the extension zone. However, faster flow rates can reduce the total analysis time.
Therefore, it was necessary to balance processing speed with the limit-of-detection
required. A volumetric flow rate of 0.5 µL/min was chosen because it provided adequate
PCR and LDR product yields for analysis. CF PCR were performed at a volumetric flow
rate of 0.5 µL/min provided a cycling rate of 59.2 s/cycle (8 s for denaturation, 8 s for
annealing, 32.4 s for extension and 10.8 s), completing the 32 cycles for PCR in 31.6
min.

(A)

(B)

Figure 2.2 Effects of flow rate on the CF PCR product yield using the representative
MRSA strain. (A) Agarose gel electrophoresis of CF PCR products. Lane 4: DNA size
marker. Lanes 5 – 7: CF PCR products at various volumetric flow rates of 0.25, 0.5 and
1 µL/min (0.66, 1.33 and 2.65 mm/s), respectively. Lanes 1 – 3: bench-top PCR using
the same conditions as CF PCR. (B) Intensities from CF PCR product gel bands
normalized to that from the bench-top PCR products. CF PCR yielded amplicons of the
expected size, i.e., 98, 148, 161 and 176 bp for the spa, mecA, SG16S and PVL genes,
respectively.
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The multiplexed LDR is fairly straightforward due to two factors: (1) the large amount
of templates, i.e. PCR products, are readily available and (2) LDR is a linear
amplification process, which is less effected by the hybridization efficiency difference
among multiple LDR primers compared to exponential PCR amplification. A detailed
investigation of effects of flow rates on the LDR product yields was reported.51 Our
previous studies have shown that the amount of time required for ligation in a
microfluidic device can have an impact on the LDR product yield. A significant amount
of LDR product could be generated at the ligation time of ~5 s. However, as with PCR,
the shorter ligation time (~5) showed reduced LDR product yield. In this work, the CF
LDR was operated at a volumetric flow rate of 1 µL/min, which provided a cycling rate of
30 s/cycle (3 s for denaturation and 27 s for ligation), producing a processing time of 7.5
min for 15 cycles.
2.3.2 Characterization of Oxygen Plasma-modified PMMA Surfaces
In our protocol, PMMA sheets were subjected to an oxygen plasma treatment for the
generation of surface carboxylic groups that allowed covalent attachment of amineterminated oligonucleotide zip-code probes to these surface groups through
carbodiimide coupling. The modification process is believed to be the creation of free
radicals on the polymer surface and then subsequent coupling of these free radicals
with active species from the oxygen plasma environment.52 Oxygen plasma treatment of
the PMMA sheets resulted in the sample surfaces becoming hydrophilic, which can be
monitored using sessile water contact angle measurements.53 Changes in the watercontact angles of the oxygen plasma treated PMMA surfaces under varied chamber
pressures are summarized in Table 2.2. As can be seen from this data, there was a
rapid decrease in the contact angle of the samples treated in the pressure range from
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50 to 200 mTorr. This decrease in the contact angle could be attributed to the
incorporation of polar functional groups, which caused the plasma-irritated PMMA
surfaces to become more hydrophilic.52,

54

When the chamber pressure was further

increased from 200 to 300 mTorr, the contact angle actually increased from 53.7° to
65.3°. This was most likely due to the decreased ac tivated oxygen species associated
with high rates of recombination and collisional quenching at high pressure.55 The
concentration of species is proportional to the pressure. The higher the pressure the
shorter the mean free path an active species can travel before having a collision
quenching its activity. From the results, we can conclude as the chamber pressures
increased, the PMMA surfaces became richer in oxygen-containing functional groups,
leading to hydrophilic surfaces. In contrast, the plasma-irritated surfaces obtained at
high pressure containing only a small amount of activated oxygen species was less
hydrophilic, resulting in a larger contact angle than anticipated.
Table 2.2 Chemical compositions of the PMMA substrates before and after oxygen
plasma treatment
Water contact angle
Pressure
C 1s
O 1s
O/C
(°)
(mTorr)
(Atomic conc., %)
(Atomic conc., %)
0
74.03
25.97
0.35
74.9±0.6
50
65.71
34.29
0.52
57.8±0.9
100
66.06
33.94
0.51
57.9±1.0
200
63.39
36.61
0.58
53.7±0.6
300
63.15
36.85
0.58
65.3±0.7

Pressure
(mTorr)
0
50
100
200
300

C–C
(%)
71.83
57.91
59.29
49.58
50.85

C–O
(%)
14.06
21.97
16.59
18.71
17.54
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C=O
(%)
0
2.31
6.61
12.96
14.71

O=C–O
(%)
14.12
17.81
17.51
18.75
16.90

In order to better understand the effects of plasma treatment on the PMMA surfaces,
the chemical structure of the plasma-modified PMMA surfaces treated in different
chamber pressures was analyzed by X-ray photoelectron spectroscopy (XPS). The C1s
spectra were resolved into three or four characteristic peaks, which were identified
according to the reported chemical shifts.39 The peaks at binding energies (BEs) of
285.0, 286.7, 287.9 and 289.0 eV corresponded to the functional groups, C–C, C–O,
C=O and O=C–O, respectively. The ratios of the peak area under various chamber
pressures are given in Table 2.2. It can be seen that the C=O formed for all of the
modified surfaces. In addition, the C=O functional group rapidly increased from 2.31%
at a pressure of 50 mTorr to 12.96% at a pressure of 200 mTorr and then slowly
increased to 14.71% at 300 mTorr. The C–O increased from 14.06% (pristine PMMA) to
21.97% at a pressure of 50 mTorr and then deceased to 17.54% at 300 mTorr. For
pristine PMMA with 14.12% of the O=C–O, its composition increased to 18.75 % in the
pressure of 200 mTorr, but then decreased to 16.90% at 300 mTorr. Thus, in the
pressure range from 50 to 200 mTorr the formation of hydroxyl or peroxyl (C–O),
carbonyl (C=O) and carboxylic (O=C–O) groups could contribute to the decrease in the
water contact angles. In the case of 300 mTorr, the increase of C=O group and the
decrease of C–O and O=C–O groups could account for the increase in the contact
angle because the C=O group is less hydrophilic compared to C–O and O=C–O groups.
Prediction of the predominant effect resulting in increased contact angle is difficult due
to the experimental uncertainties and overlap of native PMMA peaks with oxidized
species in the core-level spectra. Our XPS results are clear evident that the main effect
of modification is primarily determined by the concentration of oxygen in the reaction
chamber. The moderate oxygen concentration in the chamber pressure of 200 mTorr
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increased both the amount of carboxylic groups and the degree of hydrophilicity of the
PMMA surface.

Figure 2.3 Effects of the chamber pressure on the probe density covalently tethered to
PMMA surfaces. PMMA slides were oxygen plasma-irritated under various pressures
ranging from 50 to 300 mTorr. The slides were activated with EDC/NHS, spotted with
fluorescent dye double labeled oligonucleotide probes in 200 mM phosphate solution
and allowed to incubate for 1 h. The data points represent the mean of three
measurements with the error bars showing ±1 standard deviation unit.
The optimal chamber pressure of 200 mTorr was further confirmed by the
immobilization of fluorescent dye (Cy5) labeled oligonucleotide probes to the plasma
treated surface. Figure 2.3 shows the fluorescence intensities of arrays as a function of
the chamber pressure. The fluorescence intensity markedly increased when the
pressure was increased from 50 to 200 mTorr. However, when the pressure was further
increased to 300 mTorr, the fluorescence intensity decreased. We hypothesize that this
decrease was attributed to the decrease in the amount of carboxylic groups on the
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modified PMMA surfaces, which is supported by the XPS results. The optimum
chamber pressure of 200 mTorr was hence chosen in this study.
2.3.3 Detection of MRSA Using the Modular Microfluidic Cartridge
Following PCR amplification of the appropriate gene fragments, which contained the
identification loci, the amplicons were mixed with five sets of LDR primers, common
primers and discriminating primers. The discriminating primers contained a zip-code
complement sequence (cZip) at their 5’-end and a target-specific sequence at their 3’end. The common primers were phosphorylated at their 5’-end and possessed a
fluorescent dye at their 3’-end. A perfect match between the locus containing the unique
signature sequences on the target and the sequences at the 3’-end of the discriminating
primer would initiate a successful ligation event via the ligase enzyme between the
common primer and the discriminating primer, which was encoded by the specific cZip
and complementary sequence of the universal array. When the ligated dye-labeled LDR
products and unligated discriminating primers were pumped into the microchannel
containing the universal array and were captured by the appropriate zip-code probes,
the uncaptured products were removed by flushing the array with a wash buffer. The
fluorescence signal detected at a specific zip-code address indicated the presence of
the corresponding gene in the sample. The advantages of the PCR/LDR/universal array
assay employed in this work for detecting sequence variations within the DNA include:
(1) PCR associated with LDR give two rounds of target amplification, which provides
better signal-to-noise in the readout phases of the assay. (2) The ligation products are
fluorescence dye labeled single stranded targets that can be directly used for array
hybridization. A heat denaturation followed by a snap-cool step is necessary if double
stranded PCR products are used directly for hybridization. However, that process is
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very difficult to be integrated in microfluidic devices. (3) LDR and universal arrays can
be configured to detect a variety of targets by simply appending the correct cZips to the
discriminating primers used in the LDR step, which allows for a highly multiplexed assay
in a single reaction.
Figure 2.4 shows the results of CF LDR products hybridized to zip-code probes 1, 5,
15, 21 and 25 using the PMMA waveguide module. Zip-code probe 25, which targeted
the SG16S gene common to the Staphylococcus genus, was chosen as the positive
control and thus, fluorescence was observed from all assays. Zip-code probes 1, 5, 15
and 21 were designed to target mecA, PVL, femA, and spa genes, respectively. Each
strain was probed with all zip-code probes in a single hybridization step. As shown in
Figure 2.4A and 2.4B, the PVL-positive MSSA strain gave fluorescence signals when
SG16S, spa and PVL genes were present and the PVL-positive MRSA strain gave
fluorescence signals for the presence of SG16S, spa, PVL and mecA genes. The MRCNS strain was detected with zip-code probes targeting SG16S, femA, and mecA
genes, and the MS-CNS strain was detected with probes directed for SG16S and femA
genes (Figure 2.4C and 2.4D). Our results revealed that all strains were correctly
identified. The PVL-positive strains were successfully identified with the zip-code probes
for the PVL gene, and the methicillin-resistant strains were positively identified with the
zip-code probes for mecA. The specificity of each zip-code to probe the appropriate
target was evident from this data. For example, ligation products generated from MSSA
or MS-CNS strains did not hybridize to mecA zip-code probes. LDR products generated
from MS-CNS or MR-CNS strains did not hybridize to the zip-codes probes for the spa
gene and ligation products generated from MSSA or MRSA strains did not hybridize to
femA zip-code probes. The results showed that we could differentiate CA-MRSA from
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HA-MRSA based on the presence/absence of the PVL gene, S. aureus from other
Staphylococcal species based on the presence/absence of the femA gene as well as
MRSA from MSSA based on the presence/absence of the mecA gene using this
modular system and assay.

(A)

(B)

(C)

(D)

(E)

Figure 2.4 Detection of (A) MSSA, (B) MRSA, (C) MR-CNS, (D) MS-CNS and (E) a
mixture of MSSA and MR-CNS strains using the integrated microfluidic system. The
sample solution was flowed through the system using a volumetric flow rate of 0.5
µL/min for PCR and 1 µL/min for LDR. LDR products were subjected to hybridization to
surface-tethered zip-code probes, and the arrays were imaged using the evanescentfield excitation fluorescence reader with a 20 s integration time. Zip-code probe 25
served as the positive control and was complementary to the SG16S gene. Zip-code 1,
5, 15 and 21 probed for mecA, PVL, femA and spa genes, respectively. The spot size of
the universal array was ~150 µm in diameter.
CF LDR products generated from successful ligations using five sets of LDR primers
in the presence of MSSA, MRSA, MS-CNS or MR-CNS strains were confirmed using
capillary electrophoresis (Figure 2.5). Each individual LDR yielded ligation products of
the expected sizes, i.e., 61, 65, 67, 69 and 73 nt for the spa, SG16S, mecA, femA and
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PVL genes, respectively. Figure 2.5A shows CF LDR products generated from the
PVL-positive MSSA strain and three product peaks, SG16S, PVL and spa, confirming
methicillin-susceptible S. aureus. Figure 2.5B shows ligation products generated from
the PVL-positive MRSA strain. The additional presence of the mecA product peak
indicated the existence of methicillin resistance in S. aureus. Figure 2.5C shows ligation
products generated from the MR-CNS strain. The presence of three product peaks,
SG16S, mecA, and femA demonstrated this sample was S. epidermidis possessing
methicillin resistance. Furthermore, Figure 2.5D shows LDR products generated from
the MS-CNS strain and two product peaks, SG16S and femA, revealing the presence of

Figure 2.5 LDR products generated from (A) MSSA, (B) MRSA, (C) MR-CNS and (D)
MS-CNS strains and analyzed by CEQ 8000 capillary genetic analysis system (field
strength 200 V/cm). LDR was performed at capillary temperature of 60 °C, denaturation
temperature of 90 °C (3 min), injection at 2.0 kV ( 30 s) and separation at 6.0 kV (30
min). Peak (a) represents the unligated primers and peak (b) – (f) represent the LDR
products generated from the spa, SG16S, mecA, PVL and femA genes. Size markers
labeled in red are 60 nt and 70 nt. LDR yielded ligation products of the expected sizes,
i.e., 61, 65, 67, 69 and 73 nt for the spa, SG16S, mecA, femA and PVL genes,
respectively.
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methicillin-susceptible S. epidermidis. All of the electropherogram results were
consistent with the array hybridization results from the integrated system.
2.3.4 Identification of MRSA from Mixed Strains
As reported by recent studies,56 the mecA gene present in S. aureus is highly
homologous to that carried by S. epidermidis and potentially other CNS species. CNS is
a frequent human commensal found in clinical samples from non-sterile sites, so falsepositive results from MSSA and MR-CNS coexisting in the sample cannot be precluded,
which adds difficulty in differentiating methicillin-resistant strains of S. aureus from those
of S. epidermidis. We applied our integrated system with PCR/LDR/universal array
assay to test a sample containing mixed strains of MSSA and MR-CNS. Figure 2.4E
shows a fluorescence image of the universal array following CF PCR and CF LDR in the
presence of a mixture of MSSA and MR-CNS strains. The result indicated that each zipcode probe linked to SG16S, spa, PVL, femA and mecA gave positive fluorescence
signals. The results confirmed that this modular system and assay enabled us to
successfully discriminate between MRSA and MR-CNS strains.
The minimal number of bacterial cells that could be detected using our integrated
system was evaluated by conducting PCR/LDR/universal zip-code hybridization assays
with varied concentrations of MRSA as the input. We examined signals generated from
five zip-code probes for the presence of SG16S, spa, PVL, femA and mecA genes.
Figure 2.6 shows a linear fit to the fluorescence intensity as a function of different initial
MRSA concentrations. The result showed that as the concentration of MRSA increased,
the intensities of the fluorescence signals generated from successful hybridization
events increased as well. The lowest concentration that produced a positive signal with
a signal-to-background threshold of 2.5 from the mecA gene was 30 fg/µL of MRSA.
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Figure 2.6 Standard curves of fluorescence signals from the MRSA strain with different
concentrations as an input. Fluorescence intensities from the mecA gene were plotted
against the corresponding MRSA concentration. The error bars represent one standard
deviation, which was determined from two measurements. The linear regression
analysis yielded: y = 11.288x + 18.33 (r2 = 0.998)
2.4

Conclusions
We have fabricated an integrated polymer-based microfluidic system directed

towards a rapid and specific MRSA identification that can provide information on the
drug susceptibility status as well. The integrated system was realized by implementing a
CF PCR/CF LDR/universal array assay into a disposable and modular fluidic cartridge
made from two polymeric materials, PC and PMMA, selected to optimize material
characteristics to meet processing step(s) poised on the material. For example,
sequential CF PCR/CF LDR and universal array readout were distributed on a module
and a fluidic motherboard, i.e., PMMA module and PC motherboard, due to high glass
transition temperature for PC and lower fluorescence background and minimal non84

specific DNA adsorption for PMMA. The PMMA module and the PC motherboard were
assembled into a 3-dimensional architecture using a simple interconnect to form the
fluidic cartridge. All of the required structures were made via hot embossing for
producing the fluidic network and the waveguide for fluorescence readout. This could be
done in a single embossing step, using double-sided embossing. The main advantages
of the system included fast and specific detection as well as cost-effective fabrication.
The use of micro-replication, of the polymeric cartridge and off-chip active components
enabled the fluidic system to be manufactured at low cost, appropriate for one-time use
applications, a particularly attractive format for clinical applications where disposabletype devices are a necessity to eliminate carryover contamination.
We demonstrated the utility of the integrated system by detecting specifically MRSA
using four representative strains, MSSA, MRSA, MS-CNS, and MR-CNS, in the total
processing time of less than 40 min. The system was further demonstrated to be
capable of detecting mixed strains containing MSSA and MR-CNS, which provided
critical information for clinical screening that could preclude false-positive results. In
addition to methicillin resistance screening, the present study described a multiplexed
assay for the detection of the PVL gene, which can provide the early identification of
CA-MRSA strains and for the detection of the femA gene, which can serve to distinguish
S. aureus from other Staphylococcal species.
2.5
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CHAPTER
3
MODULAR
MICROFLUIDIC
SYSTEM
FABRICATED
IN
THERMOPLASTICS FOR THE STRAIN-SPECIFIC DETECTION OF BACTERIAL
PATHOGENS
3.1

Introduction
Bacterial detection and identification plays a significant role in the surveillance of

food safety, environmental quality, public health and potential patient infections. For
example, food-borne diseases caused by eating contaminated food or beverages
account for an estimated 76 million illnesses, 325,000 hospitalizations and 5,000 deaths
annually in the United States alone.1-3 In addition, the Center for Disease Control has
estimated that medical expenses and productivity losses resulting from these diseases
total nearly $5 – $6b.4, 5 Recently, an outbreak of Shiga toxin 2 (stx2)-positive, intimin
(eae)-negative Shiga toxin-producing E. coli (STEC) O104:H4 in Germany resulted in
the death of 15 people and thousands were taken ill in a time period of only one month.6,
7

Therefore, the rapid, specific and accurate detection of pathogens is crucial for the

prevention of pathogen-related disease outbreaks and facilitating disease management
as well as containment of suspected contaminated food and/or water supplies.
Conventionally, culturing and immunological techniques have been utilized for
bacterial detection.8,

9

These methods, while simple and inexpensive, take extended

periods of time to secure results and lack the specificity (i.e., strain identification) when
compared to molecular methods that utilize DNA to effectively identify the bacterial
species and/or strain.10-14
Although molecular methods represent a significant improvement over the traditional
culturing methods, sophisticated laboratory settings and extensively trained personnel
are required to ensure accurate, reliable and reproducible results, which prohibit the
widespread implementation of these valuable techniques into a variety of settings, in
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particular 3rd world countries. The challenge with DNA analyses is that the processing
pipeline involves many individual steps, such as cell lysis, DNA extraction and
purification, PCR amplification of selected gene fragments, the specific identification of
sequence variations and the readout of the results, preferably in a multiplexed fashion.
Recent advances in microfluidic-based technologies have realized the development
of molecular analysis systems that incorporate many of the aforementioned processing
steps for nucleic acid analyses onto a monolithic platform, which can provide full
process automation eliminating the need for extensive operator expertise, provide fast
and timely results and reduced assay cost. These types of technologies can provide
point-of-use operation directly in the field and because they can minimize operation
involvement in sample processing, can increase the access of molecular analyses to a
broader user community.
Several demonstrations of microfluidic systems for DNA analyses have been
described. For example, Burns et al.15 fabricated a nanoliter DNA analyzer on a
monolithic silicon wafer possessing not only the fluidic elements, but optical elements as
well and applied their system for genetic analysis. Lagally and coworkers reported a
portable microsystem fabricated in a glass wafer to perform pathogen detection and
genotyping directly from whole E. coli and S. aureus cells.16 The system contained a
single 200-nL PCR amplification chamber directly connected to a µCE device. Mathies
and coworkers integrated several fundamental biochemical processing steps including
DNA amplification, purification, and electrophoretic separation, onto a multilayer glasspolydimethylsiloxane (PDMS) wafer and utilized it for Sanger sequencing.17 Using a
similar approach, Landers’ group demonstrated a sample-in-answer-out chip capable of
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accepting a crude biological sample as an input.18 The commonality associated with
these systems is that they employed either Si or glass as the substrate material.
The challenge with glass-based systems is that extensive lithography steps must be
employed to fabricate each chip. This production format can produce challenges for
creating low-cost systems that can be produced in a high production mode appropriate
for one-time use applications. To circumvent the need for employing glass as a
substrate for the fluidic network, thermoplastic materials can be utilized, which have
chip fabrication techniques that are conducive to high rates of production and can
produce low-cost platforms; several of these manufacturing techniques include hot
embossing and injection molding.19-21
Building on this premise, several groups have reported polymer-based systems that
can analyze genetic material. For example, a monolithic system, which integrated PCR
and DNA microarrays, was described by Liu et al.22 The chip was fabricated in PC using
CO2 laser micromilling with an asymmetrical PCR amplification step employed. The
system was demonstrated for the analysis of both E. coli and Enterococcus faecalis. Liu
and coworkers fabricated a polymer-based biochip with integrated cell isolation and
lysis units; PCR amplification and electrochemical microarray detection for sample-toanswer DNA analysis was demonstrated.23 The system was machined into a PC
substrate and was capable of detecting E. coli in 3.5 h. Koh et al.24 demonstrated a
microsystem fabricated in a poly(cyclic olefin copolymer), COC, substrate, which
contained a PCR device directly interfaced to µCE to sort fluorescently-labeled PCR
products generated from different strains of E. coli. The system was used to identify E.
coli O157:H7 organisms with a limit-of-detection (LOD) of ~6 copies of target DNA. In
another report, researchers developed a low-cost biochip system for the analysis of
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bacterial DNA using a substrate consisting of COC with the fluidic structures directly
milled into the COC chip.25 The system contained functional devices for cell lysis, DNA
isolation and purification, PCR and end-point fluorescence detection.
While the above examples of polymer microfluidic systems are attractive in
demonstrating the utility of thermoplastics for generating low-cost integrated systems for
DNA processing, they do have some limitations including the extensive amount of postprocessing required after fabrication of the desired fluidic structures, which can
significantly add to the cost of the chip. Examples of post-fabrication processing steps
include the lithographic patterning of electrodes onto the fluidic chip,22 generation of
porous polymer monoliths containing silica for DNA extraction,25 integration of wax or
gel-based valves,23, 24 or the addition of magnetic beads.23
Finally, the fluidic chips were made from a single material by positioning all of the
functional devices onto a monolithic platform. The challenge with this approach is that
certain materials may or may not be optimal for the intended processing step. For
example, some polymeric material are appropriate for fluorescence detection and some
are not due to the level of autofluorescence they generate.26 Also, some polymeric
materials show non-specific adsorption artifacts that can produce problems when
performing electrophoresis or getting good contrast for microarray measurements.27, 28
In this work, we focused on addressing the aforementioned issues by constructing
an integrated polymer-based, modular microfluidic system for the rapid and efficient
identification of pathogens. The system was based on a modular design approach, in
which certain steps of the molecular processing pipeline were situated on modules
made from a material selected to suite the particular application need. In addition, the
fluidic chip was made via hot embossing to generate a number of functional elements,
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such as a SPE bed29, 30 and an air-embedded waveguide,31 minimizing the number of
post-processing steps required to create the system.
The assay employed in this work for detecting reporter sequences within the DNA
isolated from bacterial cells consisted of a primary PCR followed by allele-specific
ligation (ligase detection reaction, LDR) with readout via a low-density universal array.32,
33

The primary advantages of using this assay format is that it gives two rounds of target

amplification (PCR and LDR) to provide better signal-to-noise in the measurement, can
be easily multiplexed at the LDR phase of the assay minimizing false-positive results
associated with multiplexed PCR, can detect single base sequence variations with high
specificity even when the target is a minority in a mixed population and finally, can be
configured to search for sequence variations in any region of the genome by simply
changing primer sequences.
The system reported herein was composed of a fluidic cartridge and a control
instrument. All of the molecular processing, from sample reception to readout, was
performed on a programmable and modular fluidic cartridge. The sequence of sample
processing steps performed included cell lysis, SPE of genomic DNA (gDNA) from the
whole cell lysate, PCR, LDR and universal DNA microarray readout. The fluidic
cartridge was composed of a functional module stacked in a 3-dimensional
configuration onto a fluidic motherboard. Based on material properties to optimize each
molecular processing step and satisfy manufacturing requirements, the motherboard
was made from PC and consisted of processing steps for cell lysis, SPE, PCR and LDR
due to its ability to select DNAs from cell lysates and its high glass transition
temperature (Tg), while the array module was made from PMMA, which contained an
air-embedded planar waveguide and the DNA array. PMMA was selected for this
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module because of its low autofluorescence levels and its propensity to demonstrate
minimal amounts of non-specific adsorption of DNAs compared to PC. The integrated
fluidic cartridge was generated via double-sided hot embossing from metal molding
tools fabricated via high precision micromilling. Fluidic handling (e.g. pumps, valves,
etc.), thermal management (e.g. heaters, temperature sensors, etc.) and optical readout
hardware were situated off-chip and packaged into a small form factor instrument. Only
the fluidic cartridge was in contact with the sample, which eliminated any potential
carryover contamination and due to the ease of manufacture, could be discarded
following a single measurement. To evaluate the performance of our system, a
duplexed PCR, multiplexed LDR followed by universal zip-code array readout were
used to detect E. coli O157:H7 and Salmonella using two genes, uidA and sipB/C. The
integrated system was further evaluated by detecting E. coli O157:H7 in waste-water
samples.
3.2

Materials and Methods

3.2.1 Materials and Regents
PC and PMMA sheets were purchased from Good Fellow (Berwyn, PA). Chemicals
used for the PMMA surface modification and hybridization assays included 1-ethyl-3-(3dimethylaminopropyl) carbodiimide hydrochloride (EDC), N-hydroxysuccinimide (NHS),
and 20x SSC buffer (3 M sodium chloride, 0.3 M sodium citrate, pH 7.0), which were
purchased from Sigma-Aldrich (St. Louis, MO). A 10% sodium dodecyl sulfate (SDS)
stock solution, which was used for post-hybridization washing, was received from
Ambion (Austin, TX). Polyethylene glycol (PEG, Mw=8000), sodium chloride (NaCl),
ethanol, disodium hydrogen phosphate (Na2HPO4), sodium phosphate (Na3PO4), and 2propanol were obtained from Sigma-Aldrich (St. Louis, MO). Oligonucleotide primers
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and probes were obtained from Integrated DNA Technologies (Coralville, IA). Their
sequences and melting temperatures (Tm) are listed in Table 3.1. E. coli K12 was
obtained from American Type Culture Collection (Manassas, VA). Both E. coli O157:H7
and Salmonella cells were purchased from Kirkegaard & Perry Laboratories
(Gaithersburg, MD). All solutions were prepared in nuclease free water purchased from
Invitrogen Corporation (Carlsbad, CA).
3.2.2 Microfluidic Cartridge Fabrication
The modular fluidic cartridge was composed of one module and a motherboard (see
Figure 3.1A); the motherboard was made from PC and consisted of devices for cell
lysis (Sample Load chamber, see Figure 3.1A), SPE, PCR and LDR, while the module
attached to the motherboard was fabricated in PMMA and was used for the universal
array and contained a waveguide. The PMMA module was interconnected to the PC
motherboard using short pieces of TefzelTM tubing (OD = 1/16”, ID = 250 µm, Upchurch)
inserted between conically-shaped holes placed on the backsides of both the
motherboard and module to provide leak-free interconnections (see Figure 3.1B).
The PC motherboard contained a network of microchannels for cell lysis, SPE, PCR
and LDR on the frontside of the substrate and thermal isolation grooves34 and fluidic
interconnects on the backside all of which were replicated in one-step using doublesided hot embossing from two brass molding tools mounted opposite to each other on a
JENOPTIK HEX02 hot embossing machine (Jena, Germany). The brass mold masters
were fabricated by high-precision micromilling as described elsewhere.35 After hot
embossing, the SPE bed contained 50 µm diameter micropillars spaced by 100 µm
(center-to-center). The SPE bed on the PC motherboard as well as the corresponding
area on the PC cover plate were exposed to 254 nm UV radiation (15 mW/cm2) through
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(A)

(B)

(C)

Figure 3.1 Schematic showing the layout of the modular fluidic cartridge. (A) The fluidic
cartridge was composed of a module interconnected to a motherboard. The
motherboard was made from PC and consisted of processing steps for cell lysis
(sample load compartment), SPE of gDNA, PCR and LDR, while the module was made
from PMMA and contained an air-embedded planar waveguide in which a universal
DNA microarray was positioned. The PC motherboard was interconnected to the PMMA
module through short pieces of tubing and conically-shaped holes laser-drilled into the
PC. (B) Schematic and optical micrograph of the motherboard-to-module fluidic
interconnection. c: Connecting tube inside a conically-shaped hole in which channels
were filled with a black dye that used for visualization. The micrograph to the right
shows the laser drilled hole. (C) Layout of the PMMA module (right picture) consisting of
the air-embedded waveguide, a coupling prism and the universal array. The waveguide
and coupling prism (see center picture) were located on the backside of the module and
the frontside contained the fluidic channel, which had as its floor the waveguide. DNAs
could be spotted (see picture on the left) onto the waveguide using a non-contact
spotter prior to thermal fusion bonding the cover plate to this module’s substrate.
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a mask for 20 min to photo-oxidize the PC surface to allow for the solid-phase extraction
of DNA from a whole cell lysate.29 The PC motherboard was assembled to a PC cover
plate (250 µm thick) using thermal fusion bonding at 150 °C for 20 min.
The PMMA module (Figure 3.1C) consisted of a microchannel network for the DNA
microarray on the frontside and the backside was comprised of a planar air-embedded
waveguide with integrated coupling prism. The PMMA module was replicated by
double-sided hot embossing from two brass molding tools. Twenty-four (4 x 6)
waveguide modules could be fabricated on one PMMA wafer in a single replication step.
The PMMA module was assembled following spotting of the DNA probes onto the
waveguide by thermal fusion bonding the substrate and PMMA cover plate at 107 °C for
20 min.
3.2.3 Surface Modification of PMMA and Array Preparation
The hot embossed PMMA microchannels were activated using a previously
published method.31,

36, 37

Briefly, the PMMA substrates were placed in a vacuum

chamber for 1 min at 200 mtorr of oxygen pressure and 50 W of radio frequency using a
Technics Series 8000 micro-reactive ion etcher (Surplus Process Equipment Corp.,
Santa Clara, CA). After plasma irradiation, the substrates were soaked in 50 mg/mL
EDC dissolved in a coupling buffer (pH 6.0) containing 5 mg/mL NHS for 10 min to form
a succinimidyl ester intermediate. The PMMA substrates were then rinsed with 18 MΩ
nanopure water to remove excess EDC/NHS solution and dried with air. The freshly
prepared PMMA substrate was then mounted onto a vacuum holder of a Perkin-Elmer
Piezorray® noncontact microarraying instrument (Downers Grove, IL) through a custom
made adapter. With the aid of a camera, 50 µM of 3’-amino-modified oligonucleotide
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probes (see Table 3.1 for sequences), separately dissolved in 0.2 M Na2HPO4/Na3PO4
buffer (pH 9.0), were spotted onto the bottom (waveguide backside) of the microfluidic
channel (Figure 3.1C). Dispensing volumes per spot were 330 ±30 pL and the size of
the spots were ~150 µm in diameter. Following spotting, the PMMA substrates were
incubated in a humidified chamber at room temperature for 4 h, washed with 0.1% SDS
to remove any non-specifically bound oligonucleotides and finally dried with air. The
PMMA module substrate was thermally fusion bonded to a PMMA cover plate to
enclose the fluidic network.
3.2.4 PCR and LDR Conditions
Two sets of PCR primers (see Table 3.1 for sequences) were used to amplify a 168bp uidA gene from E. coli and a 250-bp sipB/C gene fragment from Salmonella.38, 39 The
PCR mixture consisted of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 200 µM
dNTPs, 0.5 µg/µL ultra-pure bovine serum albumin (BSA), 0.5 µM of the uidA primer
pairs, 0.8 µM of sipB/C primer pairs and 0.1 U/µL Taq DNA polymerase (New England
Biolabs, Beverly, MA). The LDR mixture contained 20 mM Tris-HCl (pH 7.6), 25 mM KCl,
5 mM MgCl2, 10 mM DTT, 1 mM NAD+ (a cofactor for ligase enzyme), 0.1% Triton X100, 0.5 µg/µL ultra-pure BSA, 50 nM of each discriminating primer, 100 nM of each
Cy5-labeled common primer and 2 U/µLTaq DNA ligase (New England Biolabs, Beverly,
MA).
We used CF thermal cycling for several reasons including its ability to provide
ultrafast cycling times ultimately limited by the kinetic rate of dNTP incorporation by the
polymerase and the lack of valves required to contain the PCR mixture during thermal
cycling as required for batch-type thermal cyclers.34, 40, 41 The temperatures for the CF
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PCR were set at 95 °C for denaturation, 60 °C for a nnealing and 72 °C for extension. As
for the LDR, the temperatures were set at 95 °C for denaturation and 65 °C for ligation.
CF PCR was performed at a volumetric flow rate of 1 µL/min, which provided a
cycling rate of 44.6 s/cycle (8.8 s for denaturation, 8.8 s for annealing, 18 s for
extension and 9 s for flowing the sample through a shallow channel connecting the
extension to the denaturation zone), completing the 32 cycles for PCR in 24 min. The
CF LDR was operated at a volumetric flow rate of 2 µL/min producing a processing time
of 4 min for 13 thermal cycles.

Table 3.1 Sequences of oligonucleotides used in the PCR/LDR/universal zip-code
hybridization assay for E. coli and Salmonella
PCR product
Oligos
Sequence (5’→3’)
Tm
size (bp)
(°C) e
168
O157-uidA- TTACGTCCTGTAGAAACCCCAACC
58.6
forward
O157-uidA- ATCGGCGAACTGATCGTTAAAACT
56.8
reverse
a
uidA-com
pCAGCGTTGGTGGGAAAGCGCG-Cy5b
59.2
cZip1-uidA-Wt cGCTGAGGTCGATGCTGAGGTCGCAGATCGC 70.0
GAAAACTGTGGAATTGAT
cZip5-uidA-Mt cGCTGTACCCGATCGCAAGGTGGTCGATCGCG 70.1
AAAACTGTGGAATTGAG
250
Sal-sipB/C- ACAGCAAAATGCGGATGCTT
56.1
forward
Sal-sipB/C- GCGCGCTCAGTGTAGGACTC
60.4
reverse
Sal-sipB/C-com apCGCTAAAGATATTCTGAATAGTATTGG-Cy5b 51.8
cZip11-Sal- cCGCAAGGTAGGTGCTGTACCCGCAGACAGCT 70.9
sipB/C
TCGCAATCCGTTAG
Zip-code 1
TGCGACCTCAGCATCGACCTCAGC-sp-NH2d
64.9
d
Zip-code 3
CAGCACCTGACCATCGATCGCAGC-sp-NH2
64.1
Zip-code 5
GACCACCTTGCGATCGGGTACAGC-sp-NH2d
63.7
Zip-code 11 TGCGGGTACAGCACCTACCTTGCG-sp-NH2d
65.2
a
p: phosphorylated.
b
Cy5: λex = 649 nm, λem = 670 nm.
c
The bold sequences are complementary to the sequences of zip-code probes.
d
sp-NH2: (CH2CH2O)6PO4-NH2.
e
Conditions: oligo concentration, 1 µM; Na+ concentration, 50 mM.
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3.2.5 Peripheral Packaging and Instrument Operation
The physical dimensions of this instrument were 12” (length) x 12” (width) x 12”
(height) and included an Instrument Control Unit (ICU), actuators, pumps, solenoid
valves, heating stage and solution reservoirs. Included in this footprint was also a
compact optical reader used to secure fluorescence signatures from the universal zipcode array.
Operation of all peripherals (pumps, valves, heaters, laser and CCD camera) was
achieved by the ICU. The ICU had an on-board microprocessor that communicated with
all electronic subunits (digital-to-analog and analog-to-digital converters, CCD and
stepper motor drivers, temperature monitors, etc.) and controlled their operation. It also
communicated with the personal computer via a USB interface and could be
programmed by the user through control software. The software allowed for control of
all peripherals and was used for data collection and analysis. The software could
operate in two distinct modes: (1) service mode that allowed for individual control of all
of the hardware components; and (2) fully automatic mode, where all processing steps
were performed according to predefined sequences without any user intervention.
Two stepper-motor driven piston micro-pumps (LPVX0502600BC, Lee Company,
USA) with a step resolution of 50 nL were used as positive displacement pumps. A DC
motor driven mini-pump (W309-011, Hargraves Technology Corp., USA) was used for
operations requiring vacuum. All inputs to the fluidic cartridge were controlled by
commercial solenoid microvalves. Pumps and valves were interfaced to the fluidic
cartridge through a fluid distribution board (FDB). The FDB was fabricated in PMMA
through direct milling and seats for mounting the solenoid valves (6604A0-140466,
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Christian Bürkert GmbH & Co. KG, Germany). The connections between the FDB and
fluidic cartridge consisted of standardized screw-type ferrule-based fluidic connectors
and stainless steel tubing interconnects (see Figures 3.2A and 3.2B).
The optical reader included an excitation laser (HL6320G, 10 mW, Hitachi),
collection optics, and CCD sensor. The reader (see Figure 3.2C) was composed of two
2x microscope objectives (PLAPON 2x, Olympus), a 3RD660LP long pass filter and
3RD660-680 band pass filter (Omega Optics, Brattleboro, VT). The image was captured

Figure 3.2 Photograph of the control instrument and support peripherals. (A) Fluidic
cartridge peripherals: 1 – collection optics, 2 – solenoid valves, 3 – FDB and 4 – Cu
heating blocks. (B) Close-up view of the fluidic elements: 5 – stepper-motor driven
micro-pumps and 6 – mini vacuum pump. (C) Close-up picture of the FDB and optical
reader: 7 – imaging objective and 8 – FDB-to-chip interconnects. The instrument
included an ICU, actuators, pumps, solenoid valves, heating stage, solution reservoirs
and optical reader. Once the fluidic cartridge was loaded, it was then aligned with
respect to the FDB using stainless steel interconnects and pressed against them by
raising them against the heating stage, which consisted for Cu blocks. This ensured
both tight fluidic connections and proper heat transfer. Operation of all fluidic and
electronic peripherals was achieved by the ICU.
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on a rectangular CCD sensor (S7030-0907; 512 x 58 pixels; 24 x 24 µm/pixel;
Hamamatsu). Excitation of the array was achieved through an evanescent field
produced by the waveguide serving as the floor of the microfluidic channel housing the
universal array. The laser light was coupled to the waveguide via an on-board 64° prism.
Both the waveguide and coupling prism were incorporated into the array microchip and
fabricated using the same embossing step for making the fluidic network (see Figure
3.1C).
Commercial polyimide (KAPTON®) heaters (Minco, USA) were used to deliver heat
to the PCR and LDR thermal reactors. Heaters were attached to 2 mm thick Cu blocks
to achieve uniform heat flux and distribution. Temperatures were controlled by type K
thermocouples (CHAL-005, Omega Engineering, USA) placed in grooves milled into the
Cu blocks. Integral to the heat management of the fluidic cartridge were thermal
isolation grooves formed on the backside of the cartridge during the embossing step,
which allowed for efficient thermal isolation between adjacent reaction zones.34 During
insertion of the fluidic cartridge into the instrument, it was pressed gently against the Cu
heating blocks surface covered with conductive tap to provide good thermal contact.
The Cu heating blocks provided the necessary temperatures for the CF PCR and CF
LDR. All pumps and valve actuators were aligned with the corresponding valves and
pumps and all external fluidic connections were made through the FDB to external bulk
reservoirs. This process occurred simultaneously for all elements so after a singleloading step, the system was ready for operation. All active fluidic and heating elements
were under microprocessor control so that once started, the process did not require
operator intervention.
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The modular system was designed to perform the following processing steps: (1) cell
lysis; (2) DNA purification; (3) ethanol wash and air dry of the SPE bed; (4) DNA release
from the SPE bed with PCR buffer; (5) CF PCR; (6) mixing the PCR products with LDR
buffer; (7) CF LDR; (8) DNA microarray incubation and wash; and (9) array readout and
data analysis. The thermally lysed bacterial cells (see Sample Load chamber, Figure
3.1A) were suspended in an SPE immobilization buffer consisting of 3% PEG, 0.5 M
NaCl and 63% ethanol. Other regents, including the PCR and LDR reaction mixtures,
were loaded into individual storage channels. Once the fluidic cartridge was inserted
into the instrument, on-chip processing was initiated with running the sample suspended
in the SPE extraction buffer through a thermal zone (95 °C) to lyse the cells and then,
the SPE bed. The SPE bed was washed with 85% ethanol to remove other cellular
components and dried with air. Finally, the purified gDNA was released using 30 µL of
the PCR mixture and pumped through the PCR CF thermal reactor at a volumetric flow
rate of 1 µL/min.
Once the PCR was completed, 30 µL of an LDR reaction mixture was pumped
through the cartridge at the appropriate volumetric flow rate. The resultant PCR
amplicons were sequentially mixed with the LDR mixture via a passive Y-shaped
micromixer possessing 40 µm wide and 100 µm deep inlet and outlet channels (aspect
ratio 3); the mixing ratio of PCR amplicons with the LDR mixture was 1 to 1. The
resultant LDR products were directly pumped through the array module with the LDR
products subjected to hybridization to surface-tethered zip-code probes. Following array
wash with buffer (2x SSC, 0.1% SDS), fluorescence images of the arrays were collected
using the optical reader consisting of a laser diode and CCD imaging sensor with a 12
mm x 3 mm field-of-view using an integration time of 20 s.
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3.3

Results and Discussion

3.3.1 Architecture of Modular System
The fluidic cartridge was fabricated using double-sided hot embossing with many of
the molecular processing functional components generated during the embossing step,
which produced not only the fluidic network, but the solid-phase extraction bed
(micropillars), micromixer, thermal reactors (continuous flow) and waveguide. The only
post-molding steps required for chip finishing were, UV activation of the appropriate
areas of the chip, spotting DNA probes onto the waveguide surface and thermal
assembly of the cover plate to the substrate.
The modular design approach adopted herein offered some attractive advantages.
For example, the module and motherboard were made from a particular thermoplastic
material selected to optimize processing step(s) performance and meet manufacturing
requirements. The motherboard was made from PC and used for SPE and thermal
cycling units, cell lysis, PCR and LDR, while the array module was made from PMMA
and contained an air-embedded planar waveguide. We chose PC as the material for the
motherboard due to its unique characteristics to allow for the specific condensation of
nucleic acids to its photo-activated surface.29 PC also has a relatively high Tg to allow it
to withstand the sustained high operating temperatures required for the thermal
reactions. On the other hand, the material for construction of the array module was
PMMA because PMMA has significantly lower amounts of autofluorescence compared
to PC42 as well as minimal non-specific adsorption artifacts.43
The modular fluidic cartridge consisted of five micro-devices with different functions
(see Figure 3.1). (1) A cell lysis unit that lysed cells thermally. The sample was placed
in the SPE extraction buffer and shuttled through a channel to allow thermal lysis. (2) A
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solid-phase extraction device for the purification of gDNA from a whole cell lysate using
an extraction bed composed of UV activated micropillars. SPE purification of gDNA is
critical because it removes material from the sample that may interfere with downstream
molecular processing, which in this work involved a duplexed PCR and multiplexed LDR.
The SPE device was populated with an array of 3,600 50 µm diameter pillars. The SPE
bed possessed a total surface area of 33.6 mm2, and the DNA load capacity was
estimated to be ~242 ng. Nucleic acids were selectively immobilized onto the
photoactivated PC surface, which contained carboxylate groups generated via UV
irradiation using an immobilization buffer containing PEG, NaCl and ethanol. After
cleanup using ethanol, purified and concentrated nucleic acids were eluted from the PC
surface using water or a PCR buffer. The PC-SPE method did not require magnetic
beads or the loading of microchannels with beads. We have shown that photoactivated
PC-SPE methods can be used for the purification of gDNA, DNA sequencing fragments
and total RNA from cell lysates and blood.29, 30, 44
(3) CF thermal reactors. The format we adopted for two thermal reactors was a
continuous flow format, which is based on flowing a reaction mixture through a
microchannel with different isothermal zones. Compared to batch-type thermal reactors,
the CF format offers some unique advantages: (1) Better thermal management because
the system is brought to thermal equilibrium prior to the start of the reactions; (2) the
speed of the thermal cycling reactions (PCR and LDR) are limited only by enzyme
kinetics not by heating-cooling rates,32, 40 providing extremely short reaction times; (3)
dynamic transport of the fluid through the thermal reaction zone, which obviates the
need for containment valves; and (4) the number of cycles or the time of the thermal
reaction can be controlled by the length of the reaction channel and the linear transport
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rate through the reaction zone.41 In addition, several thermal management strategies
were utilized to give a uniform temperature distribution throughout a particular thermal
zone. For example, insulating grooves between temperature zones on the backside of
the fluidic motherboard were designed to increase the thermal resistance to lateral heat
conduction between zones.34 Heating of the thermal reaction domains was carried out
by placing a high thermal conductivity material, such as Cu blocks, between the heating
elements and the motherboard for precise temperature control. A thin PC substrate was
used to minimize the thermal capacitance of the heated area. To prolong residence time
in the extension or ligation zones and reduce thermal reactor footprint, a dual-depth
serpentine channel geometry (200 µm and 100 µm) was included in both CF PCR and
CF LDR devices. The larger channel cross section in the extension/ligation zones
provided a longer residence time in these zones without the need for changing the
volumetric flow rate.
(4) Universal array device. An air-embedded waveguide associated with a lasercoupling prism for laser-induced fluorescence evanescent excitation of the universal
array were integrated into a single microfluidic module.31 Optical detection of the array
elements was achieved with a home-built fluorescence reader consisting of a laser
diode and a high sensitivity CCD camera. The evanescent excitation offered high spatial
resolution and a broad field-of-view (12 mm x 3 mm), allowing for imaging of the entire
array without requiring scanning, which made the data acquisition process simple and
very fast, as well as simplifying the optomechanical design of the system. Additionally,
the shallow microfluidic channel (100 µm) was designed inside this PMMA module for
fast flow-through hybridization. Our group has demonstrated that arrays constructed in
microfluidic channels have fast hybridization kinetics.28 Other groups have also reported
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reduced non-specific signal and background in microfluidically addressed arrays.45
The PC motherboard and the PMMA module were assembled in a 3-dimensional
architecture using a simple and robust fluidic interconnect, which consisted of two
conically-shaped holes placed on the backsides of both the motherboard and the
waveguide module with connecting tubes made of a semi-rigid polymeric material (e.g.,
TefzelTM, see Figure 3.1B). Following compression sealing, the semi-rigid connecting
tubing conformed to the shape of the conical holes and provided an unswept volume of
~20 nL. This interconnect was successfully tested for pressures up to 600 psi. As
compared to our previous studies utilizing a PDMS elastomer as an O-ring gasket
between two chips, which produced unswept volumes to 200 nL,32 the reported
interconnect provided several beneficial characteristics; (1) It was a press fit connection,
which allowed for quick connection and disconnection of the chips; (2) no gaskets were
needed, which eliminated material-sample compatibility issues; and (3) the interconnect
was easy to fabricate and self-aligning with minimal unswept volume.
3.3.2 Characterization of the Waveguide Module
A

protocol

that

allowed

for

end-point

attachment

of

amine-terminated

oligonucleotides to a PMMA surface was utilized herein. Briefly, PMMA microchannels,
which measured 10.9 mm x 1.2 mm x 100 µm, were irradiated with oxygen plasma and
activated with EDC/NHS. After activation, the oligonucleotide zip-code probes were
dispensed onto the PMMA surface using a noncontact spotting instrument, which
eliminated any potential damage that could incur on the waveguide surface if using
contact printing.
In the literature, different methods of bonding plastic microfluidic devices to form an
enclosed channel network have been reported, including solvent assisted bonding,46, 47
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thermal bonding,48, 49 adhesive boning,50, 51 laser welding,52 or surface modifications.53-55
In this study, the PMMA module was assembled using thermal fusion bonding at 107 °C
for 20 min following spotting of the arrays. When PMMA is heated to near its Tg, it
approaches a viscoelastic state,56 which could potentially damage the oligonucleotide
probes. Therefore, the stability of these DNA probes was evaluated to determine
whether the thermal fusion bonding process would affect the integrity of these probes.
We carried out experiments in which oligonucleotide probes (zip-code 1 and zipcode 3, see Table 3.1) were tethered to sheet PMMA using the aforementioned protocol
and then, one of the PMMA sheets was heated to 107 °C for 20 min while the other was
not. Complementary DNAs that were fluorescently labeled were dispensed onto both
PMMA sheets and subjected to hybridization to the surface-tethered probes. The results
of this evaluation are shown in Figure 3.3, which indicated no discernible decrease in
fluorescence intensity after heat treatment indicating little if any chemical degradation of
the spotted probes during thermal processing.
In our system, the PMMA module was poised on the CF LDR device. The
hybridization of LDR products bearing zip-code complements to their surface-tethered
zip-code probes is a thermally sensitive event. Due to the thermal conductivity of both
plastics, heat from the CF LDR device, which includes zones poised at 95 °C for
denaturation and 65 °C for ligation, can propagate to the hybridization chamber of the
PMMA module affecting the number of hybridions formed. To evaluate the effects of
different temperatures on the fluorescence signals obtained following hybridization,
different temperatures were tested including 40, 50 and 60 °C. Experiments were
performed in which complementary targets were pumped at a volumetric flow rate of 0.5
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µL/min for 5 min through the hybridization chamber. The results indicated no noticeable
decrease in fluorescence intensity at temperatures ranging from 40 – 60 °C (data not

(A)

(B)

(C)

Figure 3.3 Effects of the thermal fusion bonding process on the stability of the zip-code
probes. After 3’-amine-modified oligonucleotide probes (zip-code 1 and zip-code 3)
were spotted onto the activated PMMA surface, PMMA sheets were either (A) heated to
107 ºC for 20 min or (B) not heated. The LDR was carried out using a conventional
thermal cycler for a sample containing E. coli K12 only. The LDR products were
dispensed onto both PMMA sheets followed by array hybridization, buffer wash and
fluorescence imaging. The fluorescence intensity profiles from a vertical section of the
middle two spots (see dotted yellow line) in (A) and (B) are shown in (C). Zip-code
probe 3 served as the negative control and zip-code 1 probed for the target, E. coli K12.
The spot size of the universal array was ~150 µm in diameter.
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shown); any temperature leakage from the CF LDR device to the universal array sitting
atop this thermal processor would not affect hybridization yield. This is a consequence
of the fact that we are using a universal array in this example. The zip-code probes and
zip-code complements appended to the LDR primers can be designed to have a
relatively high Tm; we have decoupled the mutation detection step from the hybridization
process relaxing the need for strict hybridization stringency.
3.3.3 Detection of Pathogens Using the Integrated System
To demonstrate the utility of the modular system and the assay for the detection of
bacterial pathogens, the analysis of E. coli O157:H7 and Salmonella, which are among
the most problematic food/water pathogens,2,

4

was used as a model. The highly

conserved single nucleotide alternation in the uidA gene of the O157:H7 serotype
(T93G) was used to differentiate E. coli O157:H7 from other E coli strains.57-60 For the
PCR/LDR/universal array assay, a pair of uidA-specific primers was used to amplify a
168-bp uidA gene of E. coli O157:H7 and E. coli K12 as well as a pair of sipB/C-specific
primers to amplify a 250-bp sipB/C gene of Salmonella.
Following PCR amplification of the appropriate gene fragments, which contained the
identification loci, the amplicons were mixed with two sets of LDR primers, common
primers

and

discriminating

primers.

The

discriminating

primer

contained

a

complementary zip-code sequence (cZip) at its 5’-end and a target-specific sequence at
its 3’-end. In this work, the allele-specific discriminating primers for E. coli O157:H7
contained a G nucleotide at its 3’-terminus (cZip5-uidA-Mt, Table 3.1), while the
discriminating primer for E. coli K12 had a 3’-terminus with a T nucleotide (cZip1-uidAWt, Table 3.1). The common primer was phosphorylated at its 5’-end and possessed a
fluorescent dye at its 3’-end. If there was a perfect match between the locus containing
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the unique signature sequence of the target and the sequence at the 3’-end of the
discriminating primer, the ligase enzyme would ligate the common and the
discriminating primers. The LDR product was then directed by the cZip to a specific
location of the universal array, which used probes serving as zip-codes (24-mer with
similar Tm values, Table 3.1) that contained sequences not found in the target DNA.
The fluorescence signal detected at the specific zip-code position of the universal array
indicated the presence of the corresponding pathogen in the sample. The advantages of
the PCR/LDR/universal array assay include: (1) LDR and universal array hybridization
can be configured to detect a variety of targets by simply appending the correct cZips to
the discriminating primers used in the LDR step, which allows for a highly multiplexed
assay in a single reaction mixture. (2) LDR combined with the universal array readout
decouples the mutation discrimination step from the hybridization step, which allows for
higher specificity to detect the intended sequence variation, even in a high excess of
DNA not harboring the intended sequence variation. (3) PCR coupled with LDR gives
two rounds of target amplification, which provides better signal-to-noise in the
measurement.
Figure 3.4 shows the results of CF LDR products hybridized to zip-code probes 1, 3,
5 and 11 using the PMMA waveguide module. Zip-code probe 3 was set as the negative
control, which was complementary to neither E. coli K12, E. coli O157:H7 or Salmonella
zip-code complement sequences appended to their LDR primers and thus, no
fluorescence was seen from the zip-code 3 probes. Zip-code probes 1, 5 and 11 were
designed to target E. coli K12, E. coli O157:H7 and Salmonella, respectively. Our
results indicated that when only E. coli O157:H7 was present in the sample, zip-code
probe 5 produced a positive signal (Figure 3.4A). When both E. coli O157:H7 and
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Salmonella were present in the sample, both zip-code probes 5 and 11 gave successful
hybridization events as shown in the fluorescence image of Figure 3.4B. When both E.
coli O157:H7 and E. coli K12 were added into the sample, zip-code probes 1 and 5
generated successful hybridization signals as shown in Figure 3.4C. A sample
containing a mixture of E. coli K12, E. coli O157:H7 and Salmonella was also evaluated

(A)

(B)

(C)

(D)

Figure 3.4 Detection of bacterial pathogens using the integrated and modular system.
Fluorescence images of the universal array following CF PCR and CF LDR for a sample
containing (A) E. coli O157:H7, (B) Salmonella and E. coli O157:H7, (C) E. coli K12 and
E. coli O157:H7 and (D) E. coli K12, Salmonella and E. coli O157:H7. The sample
flowed through the system using a volumetric flow rate of 1 µL/min for PCR and 2
µL/min for LDR and then, the arrays were imaged using the fluorescence reader with a
20 s integration time. Zip-code probe 3 was the negative control and zip-code 1, 5 and
11 probed for E. coli K12, E. coli O157:H7 and Salmonella, respectively.
and each zip-code probe (1, 5 and 11) produced fluorescence signals as shown in
Figure 3.4D. The specificity of each zip-code to detect the appropriate target was
evident from this data. For example, ligation products bearing the appropriate zip code
complement sequence generated from E. coli O157:H7 or E. coli K12 did not hybridize
to zip-code probe 11, which was targeted for the detection of Salmonella. Even when a
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single nucleotide variation was required to be discerned, E. coli O157:H7 versus E. coli
K12, no cross-hybridization was observed due to the high degree of dissimilarity
between the zip-code probe sequences.

(A)

(B)

(C)

(D)

(E)

Figure 3.5 Identification of E. coli O157:H7 in the presence of background E. coli K12
with various amounts of O157:H7: (A) No DNA templates; (B) K12 only; (C) K12 to
O157:H7 ratio of 100:1 and (D) K12 to O157:H7 ratio of 10:1. The fluorescence intensity
profiles from (B), (C) and (D) are shown in (E). The error bars represent one standard
deviation, which was determined from two measurements.
114

We further tested the ability of our system for detecting the E. coli O157:H7 strain in
the presence of large amounts of background E. coli K12. This is particularly important
for screening O157:H7 serotypes in a high background of commensal E. coli because
this situation is commonly found in E. coli O157:H7 or other pathogenic E. coli
infections.16 In this study, E. coli O157:H7 was mixed with E. coli K12 at ratios of 0:1,
1:10, 1:100 and 1:250. The E. coli O157:H7 and E. coli K12 cells containing the uidA
gene were concurrently PCR amplified and appropriate strains identified using LDR
consisting of two discriminating primers (cZip1-uidA-Wt and cZip5-uidA-Mt) and one
common primer (uidA-com). In the presence of E. coli O157:H7 or E. coli K12, matched
LDR products were generated and hybridized at the appropriate locations of the
universal array. Figure 3.5 shows LDR products generated from E. coli O157:H7 and E.
coli K12 with different mixing ratios. When no E. coli cells were present in the sample,
neither zip-code probe 1 or 5 produced hybridization signals as shown in Figure 3.5A.
When only E. coli K12 was present in the sample, a ligation product was generated and
detected at zip-code probe 1 (Figure 3.5B). Universal array signals produced from E.
coli O157:H7 were distinguished from E. coli K12 at the signal-to-background ratio ≥2
with an O157:H7 to K12 ratio of 1:100.
3.3.4 Detection Limit (LOD) of E. coli O157:H7
We also were interested in evaluating the LOD in terms of the number of pathogenic
cells we could detect using our assay and integrated system. To determine the LOD,
the molecular assay was conducted using E. coli O157:H7 as a target. Figure 3.6
presents a calibration plot of the fluorescence signal as a function of the starting E. coli
O157:H7 cell number. The lowest cell number that produced a positive signal at a
signal-to-noise ratio ≥2 was 100 cfu (colony forming units) of E. coli O157:H7. This LOD
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could be improved through employing any of the following strategies: (1) generation of
an SPE bed with smaller micropillars and a smaller edge-to-edge spacing that would
improve DNA recovery and preconcentration factor;61 (2) increasing the number of PCR
and/or LDR thermal cycles; (3) improve the capture efficiency of the LDR products by
the zip-code probes by using a shallower (<100 µm) microfluidic channel;28 and/or (4)
increasing the numerical aperture of the relay microscope objective, which would
improve the amount of fluorescence collected, but at the expense of reducing the fieldof-view during universal array imaging.

Figure 3.6 Standard curves consisting of fluorescence signals from various cell
numbers of E. coli O157:H7 cells. The data points represent the mean of two
measurements with the error bars showing ±1 standard deviation unit. The linear
regression analysis yielded: y = 2.791x + 50.11 (r2 = 0.998)
3.3.5 Analysis of E. coli O157:H7 in a Water Sample
In many cases, enrichment of the target cell type is required prior to molecular
analysis due to the extremely low-abundance of the target pathogenic cells.62 The US
EPA allowable levels of E. coli are 0, 200 and 1,000 cfu per 100 mL of drinking,
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swimming and recreational waters, respectively, and the minimum infectious dose is
~10 cells. Therefore, pre-enrichment of the target cells is often required, especially in
drinking and recreational waters.

(A)

(B)

Figure 3.7 Analysis of E. coli O157:H7 in a water sample. The fluorescence image of
the array was accomplished using evanescent excitation with an integration time of 20 s
following microarray hybridization for the waste-water sample containing (A) E. coli
O157:H7 and (B) no cells. The water sample was filtered and enriched using a PMMA
microfluidic device consisting of curvilinear channels decorated with polyclonal antiO157 antibodies. After cell enrichment, cells were released and analyzed using the
integrated system targeting the gene which effectively discriminated the O157:H7
serotype from other types of E. coli.
We evaluated the ability of our modular system coupled with a cell enrichment
device to analyze the E. coli O157:H7 serotype in a waste-water sample. The microchip
enrichment procedure has been detailed elsewhere.62 Briefly, sewer water (1 mL) was
obtained from a purification plant in Baton Rouge and was filtered using a PCTE
membrane with a 10 µm pore size to remove large particulates (e.g., solid particulates
and debris) from the sample. The effluent was then processed for E. coli using a PMMA
microfluidic chip, which was equipped with 16 curvilinear high aspect ratio
microchannels covalently decorated with polyclonal anti-O157 antibodies. O-157
serotypes of E. coli were then released from the channel surface using 5 µL of a cellstripper solution and transferred into the integrated system for molecular analysis. After
the waste-water sample was processed using the microfluidic chip, those E. coli
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serotypes expressing O157 antigens, including O157:H7, O157:H12, O157:H42,
O157:H29, O157:H19 and O157:H45, were enriched by a factor of 2 x 102 with the
specific serotype confirmed via PCR/LDR/universal array processing.
Figure 3.7 presents results showing the analysis of E. coli O157:H7 in a wastewater sample using our modular system. The results indicated LDR products generated
and fluorescence signals produced at zip-code probe 5, which specifically interrogated
for the E. coli O157:H7 strain (see Figure 3.7A). No fluorescence signal was seen for E.
coli K12. A negative control sample was also performed and no E. coli O157:H7 signal
was detected as shown in Figure 3.7B. In the waste-water sample analyzed, the level
of E. coli O157:H7 determined from the calibration plot was 9.5 ±0.3 x103 cfu/10 µL.
3.4

Conclusions
We have developed an integrated and modular microfluidic system that consisted of

a module made from PMMA and a fluidic motherboard made from PC with the material
selected based on optimizing the processing step(s) poised onto the module or
motherboard. The motherboard was made from PC and used for cell lysis, SPE, CF
PCR and CF LDR due to the specific condensation of DNA to UV-activated PC and the
high Tg of PC. On the other hand, the array module was made from PMMA due to its
lower fluorescence background and minimal non-specific DNA adsorption demonstrated
by PMMA. The integrated platform was realized by implementing a CF PCR/CF
LDR/universal array molecular assay into a disposable fluidic cartridge. The use of offchip active components reduced the complexity of fluidic cartridge fabrication and
simplified operation, making it appropriate for one-time use applications. Specifically,
the use of double-sided embossing and the passive elements, such as micropillars for
the SPE, micromixers and air-embedded waveguides, formed during the embossing
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process allowed for minimizing the number of finishing steps required to produce the
final cartridge, which can in many cases dominate chip cost.
We demonstrated the utility of the integrated system by analyzing E. coli O157:H7
and Salmonella bacterial pathogens in a total processing time <40 min (10 min for
sample preparation, 24 min for PCR, 4 min for LDR and 20 s for image readout). The
assay utilized by the system provided the ability to differentiate strains based on single
nucleotide variations; discrimination between E. coli K12 and E. coli O157:H7 were
demonstrated even for one O157:H7 sequence in 100 K12 sequences.
The integrated system was further evaluated by detecting E. coli O157:H7 in a
waste-water sample. Enrichment was first carried out using another microfluidic device
consisting of serpentine channels with polyclonal anti-O157 antibodies immobilized onto
their surfaces.
While the system was demonstrated for the analysis of E. coli O157:H7 or
Salmonella, simple reprogramming of the primer sequences used for the PCR and LDR
would allow the system to be used for the detection of any pathogenic species without
requiring hardware reconfiguration, especially when used in conjunction with the
universal array; the same array can be used for any bacterial species when the correct
zip-code complements are appended to the LDR primers used for detecting specific
sequence variations. For example, by adding PCR primers and LDR primers targeting
stx2 and eaeA genes and corresponding zip-code probes, this system can easily
identify the Shiga toxin 2 (stx2)-positive, intimin (eae)-negative STEC serotype
O104:H4.6
3.5
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CHAPTER 4 FULLY INTEGRATED AND SELF-CONTAINED THERMOPLASTIC
GENOSENSOR FOR THE DIAGNOSIS OF MULTI-DRUG RESISTANT
TUBERCULOSIS (MDR-TB)
4.1

Introduction
Infectious diseases are a major global health burden, accounting for approximately

15 million deaths annually with a significant number occurring in developing countries.1-4
The recently accelerated evolution and spread of drug resistant pathogenic agents pose
two daunting challenges for the prevention, diagnosis and treatment of infectious
diseases:4-7 How to accurately and rapidly diagnose drug-resistant infections and how to
deliver these diagnostic technologies and tools to resource-limited settings?
In particular, the resurgence of tuberculosis (TB) is accompanied by rapid spreading
of multi-drug resistant TB (MDR-TB) resulting from Mycobacterium tuberculosis (Mtb)
strains that fail to respond to the first-line drugs rifampin and isoniazid. MDR-TB cannot
be differentiated from drug susceptible TB from clinical symptoms, chest X-ray
examinations or sputum smears.8 Currently, only less than 5% of approximately 1/2
million MDR-TB cases estimated globally are appropriately diagnosed and treated due
to the vastly inadequate laboratory infrastructure for conventional drug susceptibility
testing (DST) by cell culturing in high burden countries.9 Even if available, it may take
up to 8 – 12 weeks to complete culturing tests during which time patients are
ineffectively treated and thus, drug resistant strains continue to spread creating a
formidable obstacle in formulating global plans to eradicate this disease.
Several commercialized or home-brewed nucleic acid amplification tests (NAATs),
such as line probe assays or quantitative PCRs, have recently been demonstrated to
identify MDR-TB in a timeframe of 1-2 days. Although these tests are a significant
improvement over DSTs in assay turnaround time, sophisticated laboratory settings and
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extensively trained personnel must be in place to ensure accuracy, reliability, and
reproducibility of test results. The cost is prohibitive as well for the widespread
implementation of these assays to referral laboratories let alone to remote clinical
facilities, which are in urgent need for fast and reliable assays that are easy to
implement for MDR-TB testing. In addition, the performance of these assays is usually
compromised when a mixed subpopulation of drug resistance and susceptible strains
(hetero-resistance) are simultaneously presented in the clinical sample.10-12
To address the aforementioned challenges, we have developed a diagnostic tool
package consisting of a novel multistep molecular assay implemented in a fullyintegrated genosensor system. The molecular assay could interrogate single base
mutations (codon 516, 526, and 531) in the rifampin-resistance determining region
(RRDR) of the rpoB gene as surrogate markers for MDR-TB.13,

14

The multi-step

process included Mtb cell lysis, solid-phase DNA extraction and purification, duplex
PCR for amplifying a 193 bp fragment containing the RRDR and a positive control
fragment, multiplexed LDR (ligase detection reaction) for discrimination/identification of
single base mutations and universal array hybridization. All of the aforementioned
processing steps were carried out within a disposable fluidic cartridge operated by
accompanying peripherals packaged into a small footprint instrument. No operator
intervention was required once the clinical sample (sputum) was loaded into the fluidic
cartridge. This diagnostic tool package offered advantages including short analysis
times, automated operation (i.e., sample in – answer out), reduced possibility of crosscontamination, improved health-worker protection and lower overall cost of the analysis.
It’s a significant step in translating a highly specific molecular assay strategy and lab-ona-chip enabling technologies to a diagnostic tool package tackling a global health crisis.
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4.2

Methods

4.2.1 Fabrication of Fluidic Cartridge
The fluidic cartridge consists of three plastic manufacturing modules (Figure 4.1AC) including a solid phase DNA extraction (SPE) module, a thermal reactor module for
cell lysis, PCR and LDR, and a waveguide module for universal array hybridization and
fluorescence readout. Short pieces of TefzelTM tubing (OD = 1/16”, ID = 250 µm,
Upchurch) were inserted into the conical holes on the backsides of fluidic modules to
provide fluidic transport between them (Figure 4.1D and 4.1E).
4.2.1.1

Fabrication of UV-activated SPE Module

The SPE beds were replicated by one-step aligned double-sided hot-embossing
from a nickel mold insert and a brass mold insert mounted opposite to each other in a
JENOPTIK HEX-02 hot embossing system (Jena, Germany). The nickel mold insert for
molding twenty-four (3 x 8) extraction beds was fabricated by UV-LIGA process. The
brass mold insert for molding backside conical interconnectors was fabricated by highprecision micro-milling, as described elsewhere.15 After hot-embossing, the extraction
bed and a 250 µm thick PC coverslip were exposed to 254 nm UV radiation (15
mW/cm2) for 20 min. The SPE module was assembled by thermal fusion bonding at 147
°C for 20 min.
4.2.1.2

Fabrication of Thermal Reactor Module

The PC substrate (Figure 4.3A) containing microchannels for cell lysis, PCR and
LDR on the frontside and micro-valve seats, thermal isolation grooves and fluidic
interconnecting ports on the backside was replicated by double-sided hot-embossing
using two micro-milled brass mold inserts. The PC module was assembled by thermal
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fusion bonding of the PC substrate and a 250 µm thick PC coverslip at 150 °C for 20
min.

Figure 4.1 (A) Assembled modular microfluidic stack. (B) SEM of DNA-SPE bed. (C)
SEM of the universal array module with integrated waveguide (a) and coupling prism (b).
(D, E) Schematic and optical micrograph of chip-to-chip fluidic interconnects; c –
connecting tube inside a cone-shaped port; channels were filled with black dye for
visualization. (F) Cross-section of dual depth thermal reactor.
4.2.1.3

Fabrication, Spotting and Assembly of Fluorescence Readout Module

The fluorescence readout module was assembled from two hot-embossed PMMA
parts: a waveguide part and an interconnecting part containing conical ports for fluidic
connection to PC thermocycling module as described above. The waveguide part has a
1.2 mm x 10 mm recess (100 µm in depth) for zip-code probe immobilization and
hybridization on the front side and an air-embedded planar waveguide along with an
integrated laser-coupling prism on the backside. Twenty-four (4 by 6) of waveguide
parts were replicated on one piece of PMMA substrate by an aforementioned double127

sided hot-embossing process. Followed oxygen plasma activation, EDC-NHS chemistry
was used to functionalize the surface of the PMMA substrate. The freshly prepared
PMMA substrates were mounted onto the vacuum holder of a Piezorray® non-contact
microarraying system (PerkinElmer Inc.) through custom made adapters. With the aid of
visual positioning camera, the zip-code oligonucleotide probes were dispensed onto the
bottom of the recess. By carefully programming, the universal zip-code arrays were
spotted onto five pieces of PMMA substrates, each containing twenty-four waveguide
parts, in a single run. After four hours incubation in a humid box at room temperature,
the waveguide parts were thoroughly cleaned to remove the excess zip-code probes.
After drying, the waveguide and interconnection parts were assembled together using
UV curable optical adhesive (NOA 68, Norland) to form functional fluorescent readout
module.
4.2.2 Instrumentation
The field-deployable instrument has been developed to perform the molecular assay
in the disposable fluidic cartridge. The physical dimensions of this prototype instrument
are 12” (length) x 12” (depth) x 12” (height) and include the Instrument Control Unit
(ICU) board, solenoids, actuators, pumps, solenoid valves, heating stage and on-board
solution reservoirs. After the sample, PCR and LDR cocktail were manually loaded with
a pipette; the fluidic cartridge was inserted into the instrument and gently held between
the heater surface and the self-alignment pins located on a fluid distribution
motherboard. The cooper heating blocks are covered by thermal conductive tape
providing good thermal contact. The self-alignment pins made from stainless steel
tubing also serve as fluidic connection between the disposable fluidic cartridge and the
external valves, pumps and bulk reservoirs through the fluidic distribution motherboard.
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Once the fluidic cartridge was loaded, the complete analysis process, including the cell
lysis, DNA extraction, PCR, LDR and universal array hybridization, was automatically
controlled by the ICU and no further user intervention was required.
The fluorescence images were collected by a compact optical system consisting of a
laser diode and a CCD image sensor. The 635 nm emission from the laser diode
(HL6320G, 10 mW, Hitachi) was collimated using a laser collimation package (LT220PB, ThorLabs) and injected into the waveguide through an integrated prism (Figure
4.3E). The evanescent wave excited fluorescence image was collected by a CCD image
sensor (S7030-0907; 512 x 58 pixels; 24 x 24 µm/pixel; Hamamatsu) through a compact
optics composed of two of 2x objective lens (Olympus) and filter sets (3RD660LP long
pass filter and 3RD660-680 band pass filter, Omega Optics.).
4.2.3 Mycobacterium tuberculosis (Mtb) Samples
Drug susceptible Mtb strain H37Rv (ATCC 27294) and rifampin resistant Mtb strain
(ATCC) were cultured in BSL-3 laboratory in Hansen’s Disease Center in LSU. 10-fold
serial dilutions from 107 to 100 of Mtb strain H37Rv were prepared for evaluation of the
limit of detection. Samples containing mixed drug susceptible and resistant Mtb subpopulation were prepared by mixing drug resistant and drug susceptible strains at the
ratio of 0%, 1%, 2%, 5%, 10%, 50% and 100%. All cultured Mtb samples were fixed in
70% ethanol for 24 h prior to removal from the BSL-3 facility.16
4.2.4 Construction of Positive Control
A 124 bp fragment of the IS6110 gene was amplified using the following pair of
primers: CCT GCG AGC GTA GGC GTC GG (forward) and TCT CGT CCA GCG CCG
CTT CGG (reverse).17 PCR was then performed as follows: 2 min at 94 °C; 20 cycles of
1 min at 94 °C, 1 min at 56 °C, and 1 min at 72 °C; and a final extension of 15 min at
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72 °C. The PCR product was purified using a QIAquic k spin column PCR purification kit
(QIAGEN, Cat. no. 28104). The purified amplicon was cloned into pCR®4-TOPO®
plasmid using TOPO TA cloning kit for sequencing (Invitrogen, Cat. no. K4575-J10).
Two mutations were introduced into the amplified DNA using a GeneTailor sitedirected mutagenesis system (Invitrogen, Cat. no. 12397-014) according to the
manufacturer’s instructions. Briefly, the aforementioned plasmid was methylated with
DNA methylase at 37 °C for 1 h. Two mutations, incl uding a 3-base mutation of TCA →
AGT at the center of the LDR discriminating primer location and a single-base deletion
of T at the ligation site of the LDR, were introduced by amplifying the methylated
plasmid using two overlapping primers: TGT GGG TAG CAG ACC AGT CCT ATG
TG(T)C GAC CTG GGC AG (forward) and GGT CTG CTA CCC ACA GCC GGT TAG
GTG CTG (reverse), and Platinum®Pfx DNA Polymerase (Invitrogen, Cat. no. 11708013). Amplification began with a denaturation step of 2 min at 94 °C, followed by 20
cycles of 30 s at 94 °C, 30 s at 55 °C, 5 min at 68 °C; and a final extension step of 10
min at 68 °C. The mutagenic mixture was then transf ormed into One-Shot® MAX
Efficiency® DH5α™-T1R competent cells (Invitrogen, Cat. no.12297-016). The
methylated plasmid was digested by MrcBC endonuclease in the host cell while the
methylated and mutated DNA from the above amplification was circularized by the host
cell. Finally, the plasmid was purified using a QIAgen plasmid Midi kit (Cat. no. 12143)
and the mutations were confirmed by DNA sequencing using T3 and T7 primers. The
plasmid containing the two mutations (designated as PC) was used as a positive control
for the molecular analysis of clinical samples. The plasmid concentration was quantified
by measuring the absorption at 260 nm.
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Table 4.1 Sequences of oligonucleotides used in the PCR/LDR/universal
hybridization assay for MDR-TB
PCR product
Oligos
Sequence (5’→3’)
size (bp)
124
IS6110-forward CCTGCGAGCGTAGGCGTCGG

zip-code
Tm
(°C) e
65.4

IS6110-reverse TCTCGTCCAGCGCCGCTTCGG
66.7
cZip51-PC GGCTCAAGTTGCGTCCCAGACCGTGTGGG 65.4
TAGCAGACCAGTCCTATGTG
cZip43-IS6110 CCGTCAGACAAGGGCTTTGCGTCCGGGTA 64.3
GCAGACCTCACCTATGTGT
a
IS6110/PC-com pCGACCTGGGCAGGGTTCGC-Cy5b
64.0
193
rpoB-forward CGTGGAGGCGATCACACCGCAGACGTT
67.7
rpoB-reverse ACCTCCAGCCCGGCACGCTCACGTG
70.8
cZip13CGCACGATAGGTGGTCTACCGCTGCAGCT 63.1
rpoB516wt GAGCCAATTCATGGA
GGTCAGGTTACCGCTGCGATCGCACAGCT 65.3
cZip21rpoB516mt GAGCCAATTCATGGT
rpoB516-com apCCAGAACAACCCGCTGTC-Cy5b
56.3
cZip1GCTGAGGTCGATGCTGAGGTCGCACCACA 64.9
rpoB531wt AGCGCCGACTGTC
GCTGTACCCGATCGCAAGGTGGTCCCACA 63.7
cZip5rpoB531mt AGCGCCGACTGTT
rpoB531-com apGGCGCTGGGGCCCGGC-Cy5b
70.2
cZip11CGCAAGGTAGGTGCTGTACCCGCACGCTG 65.2
rpoB526wt TCGGGGTTGACCC
GGTCCGATTACCGGTCCGATGCTGCGCTG 63.3
cZip23rpoB526mt TCGGGGTTGACCT
rpoB526-com apACAAGCGCCGACTGTCGG-Cy5b
61.0
d
Zip-code 1 TGCGACCTCAGCATCGACCTCAGC-sp-NH2 64.9
Zip-code 3 CAGCACCTGACCATCGATCGCAGC-sp-NH2d 64.1
Zip-code 5 GACCACCTTGCGATCGGGTACAGC-sp-NH2d 63.7
Zip-code 11 TGCGGGTACAGCACCTACCTTGCG-sp-NH2d 65.2
Zip-code 13 CGCACGATAGGTGGTCTACCGCTG-sp-NH2d 63.1
Zip-code 15 GACCGGTATGCGACCTGGTATGCG-sp-NH2d 63.5
Zip-code 21 TGCGATCGCAGCGGTAACCTGACC-sp-NH2d 65.3
Zip-code 23 CAGCATCGGACCGGTAATCGGACC-sp-NH2d 63.3
Zip-code 25 GACCATCGTGCGGGTAGGTAGACC-sp-NH2d 62.7
Zip-code 43 GGACGCAAAGCCCTTGTCTGACGG-sp-NH2d 64.3
Zip-code 51 ACGGTCTGGGACGCAACTTGAGCC-sp-NH2d 65.4
a
p: phosphorylated.
b
Cy5: λex = 649 nm, λem = 670 nm.
c
The bold sequences are complementary to the sequences of zip-code probes.
d
sp-NH2: (CH2CH2O)6PO4-NH2.
e
Conditions: oligo concentration, 1 µM; Na+ concentration, 50 mM.
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4.2.5 Sample and Reagent Loading
Cell cultures in 70% ethanol and decontaminated clinical samples were briefly
centrifuged at 12,000g and the supernatants were removed. The sediments were resuspended in 20 µL SPE binding buffer and manually loaded to the cell lysis unit in the
fluidic cartridge (Figure 4.3). The SPE binding buffer contained 1.2 M NaCl and 6%
polyethylene glycol (PEG, Mw = 8000) and 80 fg (~2000 copies) of PC plasmid.
1x PCR cocktail consisted of 10 mM Tris-HCl buffer (pH = 8.3), 50 mM KCl, 1.5 mM
MgCl2, 200 µM dNTPs, 0.5 U/µL Taq polymerase, 0.5 µg/µL ultra-pure BSA, 500 nM
forward and reverse primers and the DNA extracted from the SPE unit. Duplex PCR
was performed to amplify 193 bp fragment containing RRDR in rpoB gene and 124 bp
fragment of IS6110 gene and PC. PCR primers are listed in Table 4.1. The temperature
zones were set at 95 °C, 62 °C and 72 °C for denatu ration, annealing and extension,
respectively. 1 x PCR cocktail was loaded in the PCR buffer storage zone (Figure
4.3A).
1x LDR cocktail consisted of 20 mM Tris-HCl buffer (pH = 7.6), 25 mM KCl, 5 mM
MgCl2, 1 mM NAD+, 5 mM DTT, 0.1 % Triton X-100, 2 U/µL Taq ligase, 0.5 µg/µL ultrapure BSA, LDR primer sets and the PCR products from PCR unit. 25 nM of the
discriminating primers and 50 nM of the common primers for codon 516, and 50 nM of
the discriminating primers and 100 nM of the common primers for codon 526 and 531,
respectively, were used. The LDR primers sequences are listed in Table 4.1. 2x LDR
cocktail was loaded in the LDR buffer storage zone (Figure 4.3A).
4.2.6 Colorimetric Line DNA Probe Assay
A PDMS stencil containing a microchannel network was cast using a mold master
made from PMMA and consisted of 250 µm wide and 30 µm deep microchannels
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spaced by 1 mm. After a brief treatment with the oxygen plasma, the PDMS stencil was
physically sealed to an EDC-NHS functionalized PMMA sheet by conformal contact.18, 19
Then, 50 µM of zip-code oligonucleotide probes in pH 9.0 carbonate buffer were flowed
through the PDMS microchannels. After 1 h of incubation, the PDMS stencil was
removed. The PMMA sheet was thoroughly cleaned and cut into 5 mm wide strips for
the line DNA probe assays (see Figure 4.6B).
Mono-maleimido functionalized Nanogold (Nanoprobes Inc.) particles (1.4 nm) were
conjugated to LDR common primers functionalized with a sulfhydryl group (-SH) at their
5’ ends and a phosphate group (PO4) at the 3’ terminus.20 Then, 10 µM common
primers were reduced by 100 µM Tris(2-Carboxyethyl) phosphine Hydrochloride
(TCEP·HCl, Pierce) in 1x TE buffer for 30 min at room temperature. Following the
disulfide cleavage, a 10-fold excess of the mono-maleimido Nanogold particles were
added and incubated at room temperature for 2 h. The LDR common primer-Au
conjugates were then purified twice using Bio-Spin 6 chromatography columns (Bio-Rad)
according to the manufacturer’s instructions. The labeling efficiency and the
concentration of the common primer-Au conjugate were determined by measuring the
absorbance of the oligonucleotide at 260 nm and the absorbance of the Nanogold
particle at its absorbance maximum of 420 nm.
Twenty µL of the ligation products generated from a fast thermal cycling (15 cycles
of 95 °C for 5 s and 60 °C for 15 s) protocol was a pplied to the line DNA probe strips
and incubated for 10 min at 50 °C. Silver enhanceme nt was performed by applying a
mixture of 20 µL of initiator and enhancer from a Li enhancer kit (Nanoprobes, Inc) to
the PMMA surface. After 15 min of incubation, the hybridization pattern was visible to
the naked eye and could be recorded by a digital camera (see Figure 4.6C).
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4.3

Results
It is estimated more than 90% of rifampin resistant Mtb strains are also resistant to

isoniazid, which makes rifampin resistance a reliable surrogate marker for MDR-TB.
Collectively, more than 95% of resistance to rifampin is associated with mis-sense,
insertion, and deletion mutations in the rifampin resistance-determining region (RRDR)
of the rpoB gene, especially single base mutations in codons 516, 526 and 531. Rapid
identification of these mutations is critical in MDR-TB case management and minimizing
the spread of drug resistant Mtb strains.13, 14, 21

Figure 4.2 Schematic representation of the molecular assay for detection of single base
variations in codons 516, 526 and 531. The left panel and the right panel demonstrate
the processes when wild-type Mtb stain H37Rv and rifampin resistant Mtb strain
(Ser531Leu) are subjected to the molecular assay, respectively.
4.3.1 MDR-TB Molecular Assay
A multi-step molecular assay, PCR/LDR/universal array hybridization, was
successfully applied for single base mutation determinations as described elsewhere.22
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A schematic representation of the molecular assay for detecting single base mutations
in codons 516, 526 and 531 in the RRDR is shown in Figure 4.2. Briefly, following PCR
amplification of a 193 bp rpoB gene fragment containing RRDR region, 3 sets of LDR
primers (mutation specific discriminating primers and common primers) were used for
interrogating the most frequent single base mutations in codons 516, 526 and 531 of the
rpoB gene. The discriminating primer was flanked by a complementary zip-code
sequence (cZip) at its 5’-end and a discriminating base for either wild-type or mutation
discrimination at its 3’-end. The common primer was phosphorylated at its 5’-end and
contained a fluorescence dye, Cy5, at its 3’-end. A perfect match at the 3’-end of the
discriminating primer would initiate a ligation reaction by a thermally stable ligase
enzyme, which also carried a specific cZip sequence to direct the product to a specific
location of a two-dimensional array. The genotype at the particular locus can be
subsequently decoded by zip-code array hybridization and read out by fluorescence or
colorimetric imaging of a universal array.
4.3.2 Fluidic Cartridge Design
The fluidic cartridge shown in Figure 4.1 and Figure 4.3 could carry out five different
processing steps including cell lysis, solid phase DNA extraction (SPE), PCR, LDR and
universal array hybridization, which were distributed on two different modules and the
fluidic motherboard according to the material and manufacturing requirements. For
example, the SPE module was made from PC that was photoactivated (PPC) due to its
unique characteristics allowing for the specific condensation of nucleic acids to its UVactivated surface.23 In addition, to avoid packing the SPE bed with beads to increase
the available surface area to provide a high DNA load, high aspect ratio micropillars
were embossed into the bed during fabrication of the fluidic network. PC also has a
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relatively high glass transition temperature, which makes it a suitable material for the
substrate used for the thermal reactors and thus was used for the fluidic motherboard.
In addition, the fluidic control elements, in this case several membrane microvalves,
also benefitted from the use of PC, because PC has a relatively large elongation at
break threshold. Thus, it can be used for fabrication of both the valve seat and the valve

Figure 4.3 Integrated, modular microfluidic chip for TB analysis. (A) 3D rendering of the
chip and the detection method. 1-7 – fluidic inlets and outlets: 1 – sample inlet, 2 – PCR
cocktail inlet, 3 – LDR cocktail inlet, 4 – ethanol and air inlet, 5 – array wash inlet, 6 –
vacuum connection and 7 – waste. V1-V6 – on-chip membrane valves (note that V2 is
positioned next to SPE module on the cell lysis microchannel and is not visible in
current view). (B) Close-up of the SPE bed showing DNA capture bed filled with an
array of high-aspect ratio pillars. (C) Schematic operation of the on-chip membrane
valve with direct mechanical actuation – electrically actuated solenoid presses on the
center of the polymer membrane closing the passage of fluid from the bottom layer
through the valve and back to bottom layer. (D) Geometry of the continuous flow PCR
reactor with dual-depth microchannels for extended residence time the extension-zone;
Den – denaturation, Ext – extension and PA – primer annealing. (E) Schematic
representation the detection mode. Laser excitation is coupled to the waveguide
through integrated prism. Light travelling through the waveguide excites the labeled
LDR products hybridized to zip code array spotted at the bottom of the waveguide.
Resulting fluorescence signal is imaged with CCD camera.
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membrane, which allows for monolithic valve construction and simplifies assembly
processes as the valve membranes can be attached in the same lamination step as the
fluidic cover plate. Unfortunately, PC is not compatible with ultra-sensitive fluorescence
detection because of its relatively high background. On the other hand, PMMA
demonstrates good optical clarity and minimal non-specific adsorption characteristics
making it an optimal material for construction of the waveguide module of the universal
array.24 In addition, printing DNA arrays on the surface of the waveguide module can be
done in a single run making the manufacturing process easier and more efficient with
the probes tethered to the surface using robust chemistry.
Figure 4.1B and Figure 4.3B presents schematic drawings and SEM images of the
SPE module. Each SPE extraction bed had a footprint of 20 mm x 1 mm and a 50 µm
depth populated with an array of 11,000 of 20 µm x 20 µm micropillars spaced by a 40
µm center-to-center distance.25 The total surface area of the immobilization bed was 74
mm2 and the DNA load was estimated to be ~600 ng,26 which is equivalent to genomic
material extracted from ~108 bacteria cells assuming a typical bacterial genome size of
5 Mbp. Figure 4.1C shows a schematic and operation of the PC membrane valves with
direct solenoid actuation. The thermal reactors poised on the fluidic motherboard
(Figure 4.1A and Figure 4.3A) incorporated a continuous flow format, which provided
PCR results that are limited by the kinetic constraints of the polymerase and not thermal
management issues.27 In addition, several thermal management technologies were
included to improve amplification efficiency, such as backside thermal isolation grooves,
thin PC substrates and copper plate thermal stages to give a more uniform temperature
distribution throughout the particular thermal zone.28 To achieve faster continuous flow
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thermal cycling in a limited footprint, a dual-depth channel (200 µm and 100 µm) was
designed to extend the resident time in the extension zone (Figure 4.1F and Figure
4.3D).
Figures 4.3E shows the PMMA module with an integrated air-embedded waveguide
and a laser-coupling prism for laser-induced fluorescence (LIF) evanescent wave
excitation of the universal array. The trapezoid prism had an entrance angle of 64°,
which exceeded the critical angle of 63.2° between the PMMA (n = 1.49 @ 635 nm) and
the buffer solution (n = 1.33) and the critical angle of 42° between PMMA and air (n =
1.0). The total surface area of the planar waveguide was 1.2 mm x 10 mm and could
accommodate about 100 probe spots (diameter ~100 µm, center-to-center spacing =
300 µm). The entire array could be imaged in a single exposure using evanescent field
excitation and a highly sensitive rectangular CCD camera, which alleviated the need for
additional optical mechanics to permit scanning of the array. The field-of-view of the
optical setup was 12 mm x 3 mm.
4.3.3 Operation of the Fluidic Cartridge
Prior to analysis, PCR and LDR reaction cocktails were dispensed into the
corresponding on-chip storage channels followed by loading sample suspended in the
SPE immobilization buffer into the lysis channel. The fluidic cartridge was then
connected to the control hardware through a fluidic interface bus. This bus allowed for
all fluidic connections to be made in one step and at the same time, aligned the
cartridge with the heaters used for thermal processing and solenoid plungers used for
actuation of the on-chip membrane valves. During operation, the membrane valves
were opened and closed according to a pre-programmed sequence of events to achieve
the desired flow path of the sample and reagents through the fluidic network.
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Processing sequence started with thermal lysis of the Mtb cells at 95 °C for 3 min
followed by extraction of released gDNA using PPC-SPE module. After washing of the
SPE bed with 70% ethanol and drying with air, extracted gDNA was released directly
into a PCR cocktail and pumped through a continuous flow thermal reactor at an
optimized flow rate, which allowed the sample to be processed through the PCR reactor
in ~5 min after which time, the LDR cocktail was pumped out from its storage channel
and mixed with the PCR product. Continuous mixing was achieved with a Y-type
diffusional mixer consisting of 80 µm wide and 200 µm deep inlet and outlet channels
(aspect ratio = 2.5). This mixer geometry provided complete mixing between PCR
product and LDR reagents in 10 s at room temperature with a mixing rate limited by
diffusion of the ligase enzyme (40 µm2/s). This mixing time corresponds to ~10 mm
channel length at a combined flow rate of 1 µL/min. In order to accommodate higher
processing speeds for future applications, we can incorporate an additional length of
microfluidic channel into the flow path prior to the continuous flow LDR reactor and
place it within the 95 °C temperature zone, which w ould increase the diffusion
coefficient of the components by a factor of ~3.5 as compared to room temperature. The
reaction mixture was then processed through the continuous flow LDR reactor and
finally, through the universal array chip and to waste. The array was washed (2x SSC
and 0.1% SDS) in order to elute any nonspecifically adsorbed fluorescent dye-labeled
products and interrogated using a CCD camera at 635 nm excitation.
4.3.4 Identification of Drug Susceptible and Resistant Strains
Figure 4.4 shows results from a series of molecular assays using five different
positive and negative control samples. The layout of the universal array is shown in
Figure 4.4A. Spots C were amino and Cy5 double labeled oligonucleotide probes used
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Figure 4.4 Universal array layout (A) and hybridization results from different input
samples (B-E). C: Cy5 (5’ end) and amino (3’ end) double labeled oligonucleotide
probes used as spotting control and markers; HC: zip3 probes used as hybridization
controls; PC: positive controls targeted spiked positive control plasmid sequence; Mtb:
Mtb-specific probed for the IS6110 insertion fragment. 516WT, 531WT and 526WT:
probes targeted rifampin susceptible Mtb strains; 516MT, 531MT and 526MT: probes
targeted rifampin resistant Mtb strains. Molecular assay results from rifampin
susceptible Mtb strain (B), rifampin resistant strain (C), E. coli (D) and human genomic
DNA (E). (F) shows molecular assay results when the thermal stage was turned off to
simulate the hardware failure.
as spotting quality control and mark spots. Spots HC were zip3 probes used as the
hybridization control. Spots PC were used as positive control targeting spiked positive
control plasmids in cell lysis buffer. PC were used to distinguish true negative samples
(no TB infection) from the failure of DNA extraction, amplification or hybridization, either
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a result from degraded bio-reagents, enzymatic inhibitors, or failed fluidic/thermal
control. Spots Mtb were Mtb complex specific probes targeting the IS6110 insertion
fragment. Wild-type spots, 516, 531 and 526, were used to target rifampin susceptible
strains while mutation spots, 516, 531 and 526 used to target rifampin resistant strains.
Figure 4.4B shows results from a cultured drug susceptible Mtb stain (H37Rv), while
Figure 4.4C shows results from a cultured rifampin resistant strain (S531L) carrying a
TCG → TTG mutation at codon 531 in the rpoB gene. Successful identification of the
drug susceptible and resistant samples was demonstrated by the high fluorescence
intensities from spots 531WT in Figure 4.4B and from spots 531MT in Figure 4.4C.
The fluorescence intensities from the spots 531MT in Figure 4.4B and from the spots
531WT in Figure 4.4C, respectively, were close to the background, which demonstrated
excellent single base discrimination capabilities of the diagnostic tool package. In both
Figures 4.4B and 4.4C, spots C, HC and PC showed high fluorescence intensities as
expected. Figures 4.4D and 4.4E present negative control results run with a cultured E.
coli sample and human genomic DNA, respectively. Figure 4.4F shows results obtained
from a cultured drug susceptible Mtb strain (H37Rv); however, the heater at the PCR
denaturation zone (95 °C) was intentionally turned off. The PC spots showed strong
fluorescence signals in both Figure 4.4D and 4.4E but no fluorescence signal in Figure
4.4F, demonstrating that the PC spots were successfully used as a positive control
circumventing the false negative diagnostic results.
We were also interested in evaluating the minimum number of Mtb cells required to
provide reasonable signal-to-noise ratios using our system and whether results could
meet the need for clinical diagnosis. To determine the limit-of-detection, molecular
assays were conducted using a 10-fold serial dilution of cultured H37Hv cells as inputs.
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As few as 50 Mtb cells could be successfully detected, representing a 100-fold
sensitivity improvement compared to current clinical smear tests, which require 5,000 –
10,000 bacilli in 1 mL of sputum.
4.3.5 Identification of Hetero-resistance of Mtb Strains
Hetero-resistance of Mtb is defined as the coexistence of mixed subpopulations of
drug susceptible and resistant Mtb strains in the same patient, which is considered as a
preliminary stage to full resistance. It is typically a result of super-infection arising under
the selection pressure during antibiotic treatment. The occurrence rate of heteroresistance could be as high as 20% as reported in recent studies.11, 12 To evaluate the
ability of our diagnostic tool for the identification of drug resistant Mtb strains in the
presence of an excessive amount of drug susceptible strains, a series of artificial
hetero-resistance samples containing a certain percentage of rifampin resistant strains,
ranging from 0%, 1%, 2%, 5%, 10%, 50% and 100%, in drug susceptible stains of
H37Rv were prepared and analyzed. The results are shown in Figure 4.5. The
fluorescence signals from the 531MT spots increased with an increased percentage of
the rifampin resistant strains present in the sample. The fluorescence signals from the
spots 531MT were discernible when the rifampin resistant strains only constitute as little
as 1% of the total population (see Figure 4.5). After background subtraction, the
fluorescence signals from the spots 531MT run with samples containing 1% of rifampin
resistant strains were calculated to be ~10-fold higher than fluorescence signals from
those spots run with samples containing 0% of rifampin resistant strains (100% of drug
susceptible strains). Therefore, less than 1% of the drug resistant strains can be
discriminated when 3-times the standard deviation from nonspecific signals are used to
determine the limit of specificity detection. Very low fluorescence signals from the 531M
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spots were run with 100% of drug susceptible strains, which could be attributed to misligation and nonspecific hybridization. It has been noted that a T-G mismatch as used
herein has the lowest fidelity for the Taq ligase.29 For other types of mismatches or a
single-plex LDR assay, a lower percentage of drug resistant strains are expected to be
discriminated.

Figure 4.5 Identification of mixed population of drug susceptible and drug resistant Mtb
strains. (A) Hybridization image; (B) fluorescence intensities.
4.3.6 Colorimetric Module
A colorimetric line probe assay was developed as detailed in section 4.2.6. Briefly,
PMMA strips immobilized with zip-code line probes were prepared using a PDMS
stencil containing a microchannel network (Figure 4.6B). 1.4 nm Nanogold labeled
common primers replaced fluorescence dye labeled common primers as shown in
Figure 4.6A. After LDR and hybridization, the nanogold acted as a catalytic site and
resulted in large amounts of silver deposition, which was visible to the naked eyes and
could be recorded by a digital camera. A drug susceptible Mtb stain (H37Rv) and a
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rifampin resistant strain (S531L) were tested and the results are shown in Figure 4.6C.
The successful development of the colorimetric line probe assay provides a costeffective and robust alternative to fluorescence readout.

Figure 4.6 Schematic drawing and preliminary results of low cost colorimetric readout.
(A) Schematic drawing of labeling, LDR and hybridization, silver developing chemistry.
1.4 nm monomaleimido-functionalized Nanogold particles were covalently linked to a 3’
sulfhydryl-labeled LDR common primer. Ligation products were flanked by cZip
sequences and nanogold particles, which can hybridize to the immobilized zip-code
probes. The hybridization results were visible to the naked eyes after silver staining
enhancement. (B) Fabrication of PMMA strips with line DNA probes. A PDMS sheet
containing microchannel network of 250 µm wide and 1 mm spacing was physically
sealed with a piece of oxygen plasma activated and EDC-NHS functionalized PMMA
sheet by conformal contact. 50 µM zip-code oligonucleotide probes in pH 9.0 carbonate
buffer were filled the microchannel. After one hour incubation, the PMMA sheet was
cleaned and cut to 5 mm wide strips. (C) Preliminary results of colorimetric readout. A
fast thermal cycling (15 cycles of 95 °C for 5 s an d 60 °C for 15 s using a bench-top
thermocycler) in a modified LDR buffer was carried out for minimizing the possible
degradation of the Nanogold-conjugated common primer. Drug susceptible and
resistant Mtb strains were successfully identified by bare eyes and the image shown
was recorded by a digital camera. WT: drug susceptible wild-type Mtb stains; MT:
rifampin resistant Mtb strains.
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4.4

Discussion
Developing and implementing rapid and accurate MDR-TB diagnostic tools to high

burden developing countries are of paramount importance to the Stop TB Strategy by
the World Health Organization (WHO). NAATs that can identify MDR-TB by
interrogating drug resistant related signature genetic mutations present a promising
opportunity for rapid drug resistance assays. The WHO expert group recently
recommended two line probe assays, INNO-LiPA Rif.TB from Innogenetics and
MTBDRplus from Hain Lifescience, both of which employ multiplexed PCR reverse
hybridization approach, for rapid screening of MDR-TB. However, the performance of
line probe assays is compromised when a mixed population of drug resistant and
susceptible bacterial subpopulations exists.10 This is because the conventional
sequence-specific array hybridization is unable to detect low abundance single base
mutations due to cross hybridization, especially in high GC content regions where
secondary structures are prevalent, e.g. RRDR in rpoB gene. Quantitative PCR (qPCR)
using molecular beacons or Taqman probes is another NAAT approach used by
Cepheid’s GeneXpert MDR-TB assay and several other home-brew assays. However,
there are several intrinsic limitations: first, only limited number of mutations can be
interrogated in a single assay; second, hetero-resistant infection may lead to falsenegative results; third, silent mutations, which do not confer drug resistance, may lead
to inaccurate interpretations and false-positive results.
We have developed a NAAT using PCR-LDR-universal array hybridization
approach, which decouples the mutation discrimination step from the hybridization step
and employs a high fidelity Taq ligase. It has several attractive advantages for
developing MDR-TB assays: (1) The closely clustered drug resistance mutations of
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MDR-TB can be effectively interrogated. (2) Only the specific drug resistance mutations
will generate positive results. Silent mutations not conferring drug resistance won’t
generate false positive results using this assay strategy. (3) Hetero-resistance Mtb
containing low abundance of drug resistant strains (<1%) in a patient with emerging
drug resistance can be easily detected, which enables timely treatment strategy
adjustments.
After developing this highly specific molecular assay, the next challenge was how to
implement this assay to low resource settings. Similar to line probe assays and qPCRs,
the NAAT we developed is based on PCR amplification, which could detect the
pathogen biomarkers from just a few DNA molecules, making it very sensitive
contamination. Carryover contamination could be a serious problem in a clinical
laboratory because a large amount of same types are carried out on a daily basis.
Therefore, sophisticated laboratory infrastructure, such as segregated, controlled
environment rooms for uni-directional work flow of DNA extraction, pre-PCR, PCR
amplification, and post-PCR hybridization and extensively trained personnel must be
enforced to ensure reliable results, which hampers the wide implementation of NAATs
and creates a gap between advanced diagnostic technology and healthcare needs in
developing countries. This gap has been acknowledged by a panel of global healthcare
experts and they ranked “modified molecular technologies for affordable, simple
diagnostics of infectious diseases” as the highest priority in biotechnologies directed for
improving health in developing countries in the next 5 to 10 years.30 Fully-integrated
point-of-care (POC) genosensor systems using the lab-on-a-chip concept that can
accept crude biological samples and automatically perform multi-step molecular assays
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in an enclosed, disposable format is one of the most promising enabling technologies to
bridge the gap.
Significant progress has recently been made in the development of partially or fully
integrated systems,31-36 which represent the summit of technologists’ capabilities in
fabrication and manufacturing. However, the disconnections between these delicate and
comprehensive proof-of-concept devices and the desired robust end-user diagnostic
tools are also apparent. Several issues need to be taken into consideration in designing
real world diagnostic tools.36 For example, the economic conditions in the developing
countries rule out the use of expensive silicon/glass materials and clean room
manufacturing procedures. The transportation cost for the fragile silicon/glass material
may be prohibitive. The regeneration and/or reassembling of the microfluidic chip32 are
an unachievable task for under trained health workers. After carefully evaluating these
constrains, we developed a disposable fluidic cartridge and a control instrument for
delivering the NAAT to resource limited settings. First, the fluidic cartridge used a hybrid
modular architecture, which combined several task-specific modules interconnected to a
fluidic motherboard with the material selected to optimize performance. These modules
included a UV-photoactivated polycarbonate (PPC) module containing micropillars for
solid phase DNA extraction and purification and another module made from
poly(methylmethacrylate), PMMA, consisting of a planar waveguide array. The solid
phase extraction module was made from PC due to its high specificity for the
condensation of nucleic acids to its surface when photoactivated and PMMA was used
for the array module because of its excellent optical properties, simple surface
activation protocols and robust attachment chemistry of oligonucleotides to its surface.
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The thermal reactions were carried out on a fluidic motherboard also made from PC due
to its high glass transition temperature to withstand thermal processing without
experiencing structure deformation. In addition, the fluidic control system was also
poised on this motherboard and consisted of several on-chip valves made from a PC
membrane serving as the cover plate for the fluidic network, which has a large
elongation at break point to allow reversible operation of the valves even when
employing traditional non-elastomeric materials. The fluidic cartridge can also be easily
reconfigured, for example, the fluorescence universal array readout module can be
reconfigured to a colorimetric readout module to further reduce instrument cost. As
opposed to a monolithic approach31-35 or a LEGO approach37, 38 already reported in the
literature, the hybrid modular structure balanced the efficiency and flexibility in fluidic
cartridge design. Second, robust and low-cost manufacturing processes have been
developed. The disposable fluidic cartridge presented in this paper was fabricated by a
one-step replication process from a metal mold insert containing multi-scale and
complex structures (e.g. micropillar bed, waveguide prism, etc.). In addition, the number
of active components on the disposable fluidic cartridge was minimized and designed to
be compatible with mass production processes, e.g. on chip membrane valves. Thermal
management (e.g. heaters, temperature sensors, etc.), optical detection and most of the
fluidic manipulation (e.g. pumps) are operated by off-chip supporting peripherals
packaged in a cubic foot sized box. Finally, minimal end-user operation is required.
Tedious pre- and post- processing steps, such as loading silica beads for DNA
purification or regeneration/reassembly of the fluidic cartridge,31, 32 are difficult tasks for
untrained healthcare workers in resource-limited settings. The operator only needs to
load the patient sample and push a run button to use the diagnostic tool presented in
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this paper. On chip storage of dried bio-reagents is under investigation, which will
further reduce the work load of the end-user to sample loading only.
In summary, the development of the accurate, fast and affordable diagnostic tool
package presented here demonstrates a unique modular concept consisting of task
specific modules interfaced to a fluidic motherboard. The performance of the diagnostic
tool has been validated by cultured drug susceptible and drug resistant Mtb strains. As
little as 1% of rifampin resistant Mtb strain could be discriminated from artificial heteroresistance samples containing a mixed subpopulation of drug susceptible and resistant
Mtb strains. When challenged with smear positive clinical sputum samples, the results
from our diagnostic tool were consistent with the clinical records. Compared to the
turnaround time of 8 – 12 weeks for DST and 1-2 days for line probe assays available in
centralized laboratories, our system was able to identify MDR-TB in less than 40 min,
which will contribute significantly to the MDR-TB case treatment and management. The
total cost of the diagnostic tool package with fluorescence detection is around $15,000,
with the disposable of <$10 per test. Lower cost systems (<$8,000) using colorimetric
hybridization readout or conductivity hybridization readout are under development.
Recently, a variety of mutations closely related to XDR-TB have been reported. By
incorporating multiplex PCR and additional LDR primers, the diagnostic tool we
presented here can also be expended to detect gene mutations responsible for second
line drugs resistant Mtb (XDR-TB). It also holds the potential to be a universal platform
for identifying genetic signature sequences and mutations in a variety of disseminated
applications, including clinical diagnosis, forensic test and bioterrorism detection, in both
developing and developed countries.
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CHAPTER 5 CONCLUSIONS AND FUTURE WORK
5.1

Conclusions
“One could argue that miniaturized chemical analysis systems are just a fashionable

craze. However, it is difficult to foresee the impact a new technological concept will have,
when it is in its early stages of development.” (Manz et al. “Miniaturization of chemicalanalysis systems – a look into next century technology or just a fashionable craze?”
Chimia 1991, 45, 103-105).1
The last twenty years have witnessed microfluidics evolve from a concept first
proposed by Manz et al.2 to one of the hottest research frontiers. A variety of single
functional microfluidic devices and fluidic manipulation components have been
developed. However, these more and more sophisticated single functional devices are
more of “fashionable crazes” than impactful technologies. The gap between
microfluidics and the real world needs is still significant. The ultimate question, what is
the “killer application” of microfluidics, is yet to answer.
An integrated and modular microfluidic cartridge and a fully automated
instrumentation in this dissertation present our efforts to explore the “killer application”
aiming to bridge the gap between the microfluidic system and the diagnostic needs in
the resource limited settings. Fully integrated microfluidic systems are designed to
automatically perform all of the molecular processing steps in a single platform to
provide sample in/answer out capabilities. A series of discrete microdevices carrying out
specific molecular functions such as cell lysis, nucleic acid extraction and/or purification,
PCR amplification, and analysis techniques for reading successful PCRs are
interconnected to process the sample volume at the picoliter to nanoliter scale. In
chapter 1, we reviewed the various microdevices that have been fabricated to handle
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functional steps in the processing of nucleic acids, followed by several significant
examples of integrated microfluidic systems with DNA microarrays used as the terminal
readout. The applications of these systems, as well as future challenges were
discussed.
In chapter 2, an integrated modular-based microfluidic system for rapid and specific
identification of methicillin-resistant Staphylococcus aureus (MRSA) was demonstrated.
MRSA is a major cause of hospital-acquired (HA-MRSA) infection worldwide. In recent
years, community acquired-MRSA (CA-MRSA) strains, which cause severe infections,
are emerging as a serious problem. A multiplexed PCR/LDR coupled with the universal
array allowed for simultaneous detection of five genes that encode for 16S ribosomal
RNA (SG16S), the protein A (spa), the femA protein of S. epidermidis (femA), the
virulence factor of Panton-Valentine leukocidin (PVL) and confer methicillin resistance
(mecA). The multi-step assay included continuous flow PCR (CF PCR) amplification of
the mecA gene harboring methicillin resistance loci that can provide information on drug
susceptibility, continuous flow ligase detection reaction (CF LDR) to generate
fluorescent ligation products containing a zip-code complement that directed the ligation
product to a particular address on a universal array containing zip-code probes and
universal DNA array readout, which consisted of a planar waveguide for evanescent
excitation. Each of these processing steps was optimized individually before they were
streamlined. The fluidic cartridge design was based on a modular format, in which
certain steps of the molecular processing pipeline were poised on modules made from a
thermoplastic selected for the particular processing step. In addition, to minimize the
post-processing steps for finishing the fluidic cartridge, many of the functional
components were produced during the polymer molding process, enabling low-cost
154

manufacture for one-time use applications. The cartridge was comprised of one module
interconnected to a fluidic motherboard configured in a 3-dimensional network; the
motherboard was made from polycarbonate, PC, and used for PCR and LDR, while the
module was made from poly(methylmethacrylate), PMMA, and contained an airembedded waveguide and the DNA array. Fluidic handling, thermal management and
optical readout hardware were located off-chip and configured into a small footprint
instrument. Results indicated that this modular system could differentiate CA-MRSA
from HA-MRSA based on the presence/absence of the PVL gene as well as S. aureus
from other Staphylococcal species using the sequence content in the femA gene. This
system can identify several strains of bacteria in <40 min and detect MRSA directly from
a mixture of Staphylococci.
In chapter 3, the fluidic system for bacterial genotyping was further integrated with a
micro-solid phase extraction (micro-SPE) device. The sequence of sample processing
steps performed within the fluidic cartridge including cell lysis, SPE of genomic DNA
(gDNA) from the whole cell lysate, CF PCR amplification of specific gene fragments, CF
LDR to detect single-base sequence variations and universal zip-code array readout.
The fluidic cartridge was composed of a PMMA module situated on a PC motherboard;
the PC motherboard was used for cell lysis, SPE, PCR and LDR, while the PMMA
module contained an air-embedded planar waveguide in which a DNA microarray was
spotted. The utility of the modular system was demonstrated by performing pathogen
detection directly from whole E. coli O157:H7 and Salmonella cells using a duplexed
PCR followed by multiplexed LDR with readout via a low-density universal array. The
presence of two genes, uidA and sipB/C, that discriminate between E. coli and
Salmonella, was evaluated as a model system. Results showed that the fluidic system
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could successfully identify several strains of bacteria in <40 min and also perform strain
identification, even from a mixed population with the target a minority. We further
demonstrated the ability to analyze the E. coli O157:H7 strain directly from a wastewater sample with high specificity using the integrated system.
In chapter 4, a fully integrated and field deployable system for identifying multi-drug
resistant tuberculosis (MDR-TB) was presented. The worldwide concern of MDR-TB
resulting from Mycobacterium tuberculosis (Mtb) strains that fail to respond to the firstline drugs, rifampin and isoniazid, creates a formidable challenge in formulating global
plans to eradicate this disease. Less than 5% of new MDR-TB cases occurring each
year are diagnosed and treated in a timely fashion due to the length (8 – 12 weeks) and
complexity of traditional cell culture in vitro diagnostic methods. In response to WHO’s
call for fast and accurate MDR-TB diagnostic tools, especially those that can be
operated by under-trained healthcare workers in resource limited settings, in chapter 4
the modular system was adapted for interrogating single nucleotide variations in the
rpoB gene associated with rifampin-resistant Mtb strains. All steps of the multi-step
molecular assay, including Mtb cell lysis, SPE of gDNA, PCR amplification, ligationbased discrimination/identification of single nucleotide variations and universal array
readout were incorporated into a disposable plastic fluidic cartridge. The cartridge was
comprised of two modules, the SPE module and the waveguide module, which were
interconnected to a fluidic motherboard that consisted of devices for cell lysis, PCR and
LDR. The integrated system could identify MDR-TB strains directly from clinical sputum
samples in <40 min with minimal risk of human errors or cross-contamination. This
diagnostic tool will revolutionize MDR-TB and other infectious disease diagnostic testing
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in both developed and developing countries due to its ease of implementation and
highly automated format.
5.2

Future Work
Generally, an integrated microfluidic system that streamlined several critical steps in

genetic-based analyses, including cell lysis, SPE of nucleic acids, their amplification,
determination sequence variations and readout has been demonstrated in this
dissertation. It can be easily reconfigured according to requirements of the specific
application need. The next challenge is to analysis trace or low-abundance samples that
are critical in clinical and other applications. In most cases, cells or targets of interest in
real-world samples, such as tissue, blood, soil, water or food samples are trace or lowabundant and complex and thus, need to undergo careful sample preparation for
sensitive detection.3 Also, raw samples are often large in volume for microfluidic
analysis, and this discrepancy in volumes makes pre-concentration necessary due to
time constraints and the need for rapid detection. A typical example is the detection of E.
coli O157:H7 where as few as 10 cells must be detected from a large sample volume
and complex sample background. Therefore, the next critical step is the integration of
cell isolation and pre-concentration process through a variety of cell separation and
capture techniques onto the current microfluidic platform. Several approaches, such as
affinity-based selection,4, 5 physical properties,6, 7 dielectrophoresis,8-10 immunomagnetic
interactions11 and fluorescence-activated cell sorting,12,

13

have been reported to sort

and to collect target cells from raw samples and can be integrated into microfluidicbased systems. One of the most attractive applications of this system is to analysis
circulating tumor cells (CTCs). CTCs present an exciting new biomarker for various
cancers, such as breast, colon, lung, prostate, ovarian, pancreas and bladder cancer.
157

The attractive feature associated with these biomarkers is that they can be secured
from a simple blood draw, alleviating the need for biopsies. The analytical challenge
with finding these biomarkers is they appear at only about 1 cell per 109 erythrocytes
(red blood cells). Such studies have already begun by colleagues within the Soper
research group for front-end cell capture using target-specific antibodies14,

15

or

aptamers16 immobilized onto a miniaturized microfluidic device.

Figure 5.1 Schematic of the modular fluidic cartridge. The fluidic cartridge has 3
modules: cell selection (2), gDNA SPE isolation/purification (3) and universal array
readout (4). These modules are interconnected into a fluidic mother board (1) that
contains thermal domains for performing cell lysis, PCR and LDR. Heating of the
thermal reaction domains is carried out by placing the fluidic cartridge on Cu heating
blocks set at the necessary temperatures. Also shown are locations of on-chip valves
(V), pumps (A, D and E) and high-aspect ratio mixers (M). A – sample input; B – lysing
and SPE buffer; C – SPE (elution buffer, ethanol and air); D – PCR cocktail; E – LDR
cocktail; G – vacuum pump; H – waste.
The fluidic cartridge (see Figure 5.1) is composed of 3 modules that are used for
cell selection (2), gDNA SPE isolation/purification (3) and universal array readout (4).
These modules are interconnected into a fluidic motherboard that contains processing
steps for cell lysis, PCR and LDR. In this work, the cell sorting module is fabricated in
PMMA due to its tendency to display minimal cell non-specific adsorption artifacts.14
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Crude biological samples are introduced and driven through the cell selection bed.
Following isolation of the target cells, they are lysed and the gDNAs are purified via
SPE. The purified DNAs are subjected to PCR amplification and LDR. Finally, the LDR
products are directed to a specific location of the universal array and hybridization
events are detected using evanescent excited fluorescence. The system provides a
cost-effective solution to direct sample-to-answer genetic analysis and thus, has a
potential impact in the fields of gene expression analysis, pathogen and infectious
disease detection and low-abundant DNA point mutation diagnostics, environmental
testing and biological warfare agent detection. In addition to PCR/LDR/universal zipcode array assay platform, the modular fluidic cartridge could be reconfigured for use
with other assay formats, such as PCR-µCE.
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